Processing 00000000.tx.1: The Rockefeller University Press, 0021-9525/2002/7/79 $5.00 The Journal of Cell Biology, Volume 158, Number 1, July 8, 2002 79-89 Article A novel mechanism for the regulation of amyloid precursor protein metabolism Qi Chen1, Hideo Kimura2 and David Schubert1 1 Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037 2 National Institute of Neuroscience, Kodaira, Tokyo 187-8551, Japan Address correspondence to David Schubert, The Salk Institute, 10010 N. 

Phrase: "The Rockefeller University Press,"

Phrase: "0021-9525/2002/7/79 $5.00"

Phrase: "The Journal of Cell Biology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "Volume 158,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0449468:*Volume [Quantitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "Number 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "July 8,"

Phrase: "2002 79-89 Article A novel mechanism for the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0441712:Mechanism [Functional Concept]
   738   C1706376:Mechanism [Manufactured Object]

Phrase: "of amyloid precursor protein metabolism Qi Chen1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1327340:amyloid precursor protein metabolism [Molecular Function]

Phrase: "Hideo Kimura2"

Phrase: "and"

Phrase: "David Schubert1 1 Cellular Neurobiology Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0022877:Laboratory [Manufactured Object,Organization]
   799   C3244292:laboratory [Functional Concept]

Phrase: "The Salk Institute for Biological Studies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA 92037 2 National Institute of Neuroscience,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]

Phrase: "Kodaira,"

Phrase: "Tokyo 187-8551,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "correspondence to David Schubert,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282413:Correspondence [Intellectual Product]

Phrase: "The Salk Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "10010 N."
Processing 00000000.tx.2: Torrey Pines Rd., La Jolla, CA 92037. 

Phrase: "Torrey Pines Rd.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C1667939:Torrey pine [Plant]

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA 92037."
Processing 00000000.tx.3: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.4: (858) 453-4100, ext. 

Phrase: "(858"

Phrase: ")"

Phrase: "453-4100,"

Phrase: "ext."
Processing 00000000.tx.5: 1528. 

Phrase: "1528."
Processing 00000000.tx.6: Fax: (858) 535-9062. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "(858"

Phrase: ")"

Phrase: "535-9062."
Processing 00000000.tx.7: E-mail: schubert{at}salk.edu  Abstract Top Abstract Introduction Results Discussion Materials and methods References  Modifier of cell adhesion protein (MOCA; previously called presenilin [PS] binding protein) is a DOCK180-related molecule, which interacts with PS1 and PS2, is localized to brain areas involved in Alzheimer's disease (AD) pathology, and is lost from the soluble fraction of sporadic Alzheimer's disease (AD) brains. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "schubert{at}salk.edu  Abstract Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Modifier of cell adhesion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "(MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "; previously called presenilin [PS] binding protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   858   C0950625:CALL Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "is"

Phrase: "a DOCK180-related molecule,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0567416:Molecule [Substance]
   755 E C1521991:Molecular [Qualitative Concept]

Phrase: "which"

Phrase: "interacts with PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418985:PS1 [Gene or Genome]
   790   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2,"

Phrase: "is"

Phrase: "localized to brain areas"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205146:areas [Spatial Concept]
   770   C0392752:Localized [Spatial Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0017446:Area [Geographic Area]

Phrase: "involved in Alzheimer's disease"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C1314939:Involved [Functional Concept]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(AD) pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "lost from the soluble fraction of sporadic Alzheimer's disease"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C1264633:Fraction of [Quantitative Concept]
           Fraction
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0205422:Sporadic [Temporal Concept]
   742   C0745777:Lost [Functional Concept]
   742   C1554103:Fraction [Idea or Concept]
   742   C1749467:soluble [Cell Component]
   742   C1948047:Soluble [Qualitative Concept]

Phrase: "(AD) brains."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.8: Because PS1 has been associated with -secretase activity, MOCA may be involved in the regulation of -amyloid precursor protein (APP) processing. 

Phrase: "Because"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "associated with -secretase activity,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "involved in the regulation of -amyloid precursor protein (APP) processing."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   807   C2753370:regulation of protein processing [Genetic Function]
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0033666:protein processing [Molecular Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1314939:Involved [Functional Concept]
   742   C1327622:Regulation [Biologic Function]
   742   C1709634:Precursor [Idea or Concept]
   742   C1709694:Processing [Activity]
Processing 00000000.tx.9: Here we show that the expression of MOCA decreases both APP and amyloid -peptide secretion and lowers the rate of cell-substratum adhesion. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the expression of MOCA decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "both APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "amyloid -peptide secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1819802:peptide secretion [Cell Function]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "lowers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "the rate of cell-substratum adhesion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.10: In contrast, MOCA does not lower the secretion of amyloid precursor-like protein (APLP) or several additional type 1 membrane proteins. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "the secretion of amyloid precursor-like protein (APLP)"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   853   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN [Gene or Genome]
   804   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   804   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   774   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1159339:Protein Secretion [Cell Function]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "or"

Phrase: "several additional type 1 membrane proteins."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0025255:Membrane [Tissue]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0596901:Membrane [Cell Component]
   799   C1706182:Membrane [Manufactured Object]
   727 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.11: The phenotypic changes caused by MOCA are due to an acceleration in the rate of intracellular APP degradation. 

Phrase: "The phenotypic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "caused by MOCA"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "are due to an acceleration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0000894:Acceleration [Phenomenon or Process]
   760   C1551058:Are [Quantitative Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of intracellular APP degradation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C1327161:amyloid precursor protein degradation [Molecular Function]
   840   C0597297:Protein Degradation [Molecular Function]
   840   C0597304:Protein Degradation [Molecular Function]
   840   C1623036:Protein Degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.12: The effect of MOCA expression on the secretion of APP and cellular adhesion is reversed by proteasome inhibitors, suggesting that MOCA directs nascent APP to proteasomes for destruction. 

Phrase: "The effect of MOCA expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0681891:effect modifier [Functional Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on the secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "cellular adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cellular Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "reversed by proteasome inhibitors,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   833   C2266856:Proteasome Inhibitors [Molecular Function]
   799 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   737   C1555029:Reverse [Idea or Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "directs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "nascent APP to proteasomes"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "for destruction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1261381:Destruction [Therapeutic or Preventive Procedure]
  1000   C1948029:Destruction [Activity]
Processing 00000000.tx.13: It is concluded that MOCA plays a major role in APP metabolism and that the effect of MOCA on APP secretion and cell adhesion is a downstream consequence of MOCA-directed APP catabolism. 

Phrase: "It"

Phrase: "is"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a major role in APP metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "that"

Phrase: "the effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "a downstream consequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:Consequence [Functional Concept]

Phrase: "of MOCA-directed APP catabolism."
Meta Candidates (Total=28; Excluded=0; Pruned=0; Remaining=28)
   840   C0597297:protein catabolism [Molecular Function]
   840   C1623036:protein catabolism [Molecular Function]
   832   C1327161:amyloid precursor protein catabolism [Molecular Function]
   816   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   816   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   816   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   801   C0007577:Cell Adhesion [Cell Function]
   788   C0001511:Adhesion [Pathologic Function]
   788   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0007634:Cell [Cell]
   788   C0011560:Amyloid [Pathologic Function]
   788   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0175633:Adhesion [Natural Phenomenon or Process]
   788   C0205349:Modifier [Qualitative Concept]
   788   C0332285:Of [Spatial Concept]
   788   C0543484:catabolism [Functional Concept]
   788   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0699900:Catabolism [Organism Function]
   788   C1269647:Cell [Cell]
   788   C1514623:Modifier [Conceptual Entity]
   788   C1516314:Catabolism [Physiologic Function]
   788   C1516451:Modifier [Chemical Viewed Functionally]
   788   C1704653:Cell [Medical Device]
   788   C1709634:Precursor [Idea or Concept]
   788   C1948049:Cell [Spatial Concept]
   788   C3542952:Modifier [Intellectual Product]
   717   C0439755:Directions [Spatial Concept]
   717   C0449738:Direction [Spatial Concept]
Processing 00000000.tx.14: This is a new mechanism by which the expression of APP is regulated. 

Phrase: "This"

Phrase: "is"

Phrase: "a new mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "the expression of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0851285:Regulated [Governmental or Regulatory Activity]
Processing 00000000.tx.15: Key Words: amyloid precursor protein; 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.16: proteasome; 

Phrase: "proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: ";"
Processing 00000000.tx.17: beta amyloid; 

Phrase: "beta amyloid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2825879:Amyloid, Beta [Laboratory Procedure]
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.18: secre-tion; 

Phrase: "secre-tion"

Phrase: ";"
Processing 00000000.tx.19: MOCA  Introduction Top Abstract Introduction Results Discussion Materials and methods References  Alzheimer's disease (AD)* is the most prevalent cause of dementia in the elderly. 

Phrase: "MOCA  Introduction Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0205349:Modifier [Qualitative Concept]
   736   C1514623:Modifier [Conceptual Entity]
   736   C1516451:Modifier [Chemical Viewed Functionally]
   736   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(AD)*"

Phrase: "is"

Phrase: "the most prevalent cause of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "in the elderly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001792:Elderly [Population Group]
  1000   C1999167:elderly [Population Group]
Processing 00000000.tx.20: AD is in part characterized pathologically by the presence of extracellular plaques consisting of deposits of the amyloid -peptides (As) derived from -amyloid precursor protein (APP). 

Phrase: "AD"

Phrase: "is in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "pathologically by the presence of extracellular plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0333463:plaques [Acquired Abnormality]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0521119:Extracellular [Cell Component]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "consisting of deposits of the amyloid -peptides"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C2936349:Amyloid Deposits [Acquired Abnormality]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0333562:Deposits [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C0332529:CONSIST [Qualitative Concept]

Phrase: "(As)"

Phrase: "derived from -amyloid precursor protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1441547:Derived [Qualitative Concept]
   760   C1709634:Precursor [Idea or Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.21: APP is cleaved by three proteolytic activities, -, -, and -secretases (Mills and Reiner, 1999; De Strooper and Annaert, 2000). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "cleaved by three proteolytic activities, -"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0205242:Cleaved [Spatial Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C0333853:Cleaved [Cell]
   760   C0441655:Activities [Activity]
   760   C0597304:Proteolytic [Molecular Function]
   760   C1947941:proteolytic [Enzyme]
   726 E C0205177:Activity [Functional Concept]
   726 E C0439167:% activity [Quantitative Concept]
   726 E C1561536:*Activity [Idea or Concept]

Phrase: ", -"

Phrase: ","

Phrase: "and -"

Phrase: "secretases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Mills"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599997:mills [Manufactured Object]

Phrase: "and"

Phrase: "Reiner,"

Phrase: "1999"

Phrase: "; De Strooper"

Phrase: "and"

Phrase: "Annaert,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.22: -Secretase cleaves APP within the A peptide sequence, whereas -secretase cleaves APP at the NH2 terminus of the A peptide sequence. 

Phrase: "-Secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaves"

Phrase: "APP within the A peptide sequence,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0002518:Protein Sequence [Amino Acid Sequence]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   745   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "whereas -"

Phrase: "secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cleaves"

Phrase: "APP at the NH2 terminus of the A peptide sequence."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   766   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   766   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   750   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   749   C0002518:Protein Sequence [Amino Acid Sequence]
   749   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   735   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0011560:Amyloid [Pathologic Function]
   735   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   735   C1709634:Precursor [Idea or Concept]
   732   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.23: APPs and APPs are the NH2-terminal fragments generated by - and -secretases, respectively, whereas the remaining fragments are cleaved at the COOH terminus of the A peptide sequence by -secretase. 

Phrase: "APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "and"

Phrase: "APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "are"

Phrase: "the NH2-terminal fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "generated by -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3146294:Generated [Activity]

Phrase: "and -"

Phrase: "secretases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:Secretases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "respectively,"

Phrase: "whereas"

Phrase: "the remaining fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "cleaved at the COOH terminus of the A peptide sequence"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   756   C0920679:peptide sequence [Amino Acid Sequence]
   738   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0205242:Cleaved [Spatial Concept]
   738   C0333853:Cleaved [Cell]
   738   C1519249:Sequence [Functional Concept]
   704 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "by -secretase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.24: The presence of mutant genes that encode presenilins (PSs) PS1 and PS2 have been linked to early onset familial Alzheimer's disease (FAD) (Rogaev et al., 1995; Sherrington et al., 1995), and an increased deposition of A in plaques has been associated with these mutations (Sherrington et al., 1995; Scheuner et al., 1996). 

Phrase: "The presence of mutant genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "presenilins (PSs) PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "PS2"

Phrase: "have"

Phrase: "been"

Phrase: "linked to early onset familial Alzheimer's disease (FAD)"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   835   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   814   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   800   C0814120:early disease onset [Disease or Syndrome]
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   778   C1833334:Early-onset [Finding]
   774   C0277558:Familial disease [Disease or Syndrome]
   774   C0277793:disease onset [Temporal Concept]
   774   C0679245:early disease [Temporal Concept]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015576:familial [Family Group]
   748   C0241888:Familial [Functional Concept]
   748   C0332162:Onset [Qualitative Concept]
   748   C1279919:Early [Temporal Concept]
   738 E C0344339:disease family [Finding]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "(Rogaev et al.,"

Phrase: "1995"

Phrase: "; Sherrington et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "an increased deposition of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0333562:Deposition [Functional Concept]

Phrase: "in plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333463:plaques [Acquired Abnormality]
   966 E C0011389:Plaque [Disease or Syndrome]
   966 E C0332461:Plaque [Finding]

Phrase: "has"

Phrase: "been"

Phrase: "associated with these mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0026882:Mutations [Genetic Function]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Sherrington et al.,"

Phrase: "1995"

Phrase: "; Scheuner et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.25: There are several proteins that interact with the PSs (Van Gassen et al., 2000). 

Phrase: "There"

Phrase: "are"

Phrase: "several proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "interact with the PSs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Van Gassen et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.26: Among these is the modifier of cell adhesion protein (MOCA) (Kashiwa et al., 2000; Chen et al., 2001). 

Phrase: "Among these"

Phrase: "is"

Phrase: "the modifier of cell adhesion protein (MOCA)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "(Kashiwa et al.,"

Phrase: "2000"

Phrase: "; Chen et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.27: Although MOCA has 40% sequence homology with DOCK180 and contains SH3 and Crk binding domains, its function was unknown. 

Phrase: "Although"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "has"

Phrase: "40% sequence homology with DOCK180"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0162775:Sequence Homology [Quantitative Concept]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1334043:Homology [Gene or Genome]
   760   C1519249:Sequence [Functional Concept]
   760   C2697616:Homology [Qualitative Concept]
   756 E C0162774:Sequence Homolog [Molecular Sequence]

Phrase: "and"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "SH3"

Phrase: "and"

Phrase: "Crk binding domains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "its function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "was"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.28: Because MOCA binds PS1 and because PS1 has been associated with -secretase activities in APP processing (Wolfe and Haass, 2001), it was asked if MOCA is involved in the regulation of APP metabolism.  

Phrase: "Because"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "because"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "associated with -secretase activities"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0441655:Activities [Activity]
   737 E C0205177:Activity [Functional Concept]
   737 E C0439167:% activity [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1561536:*Activity [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Wolfe"

Phrase: "and"

Phrase: "Haass,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "asked"

Phrase: "if"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "is"

Phrase: "involved in the regulation of APP metabolism."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   818   C1327340:amyloid precursor protein metabolism [Molecular Function]
   807   C1523260:regulation of protein metabolism [Molecular Function]
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   784   C1159402:regulation of metabolism [Organism Function]
           metabolism regulation
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0597299:Protein Metabolism [Molecular Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0025519:Metabolism [Organism Function]
   742   C0025520:metabolism [Functional Concept]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1314939:Involved [Functional Concept]
   742   C1327622:Regulation [Biologic Function]
   742   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.29: Results Top Abstract Introduction Results Discussion Materials and methods References  MOCA reduces APP and A secretion To investigate the effect of MOCA on APP protein secretion, a rat nerve cell line called B103 (Schubert et al., 1974) was stably transfected with APP695 and again with a plasmid harboring the full-length MOCA cDNA. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "reduces"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "A secretion To"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1327439:antibody secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on APP protein secretion,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1159339:Protein Secretion [Cell Function]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "a rat nerve cell line"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C1514733:Rat Cell Line [Cell]
   895   C0814990:neural cell line [Cell]
   861   C0007600:Cell Line [Cell]
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: "called"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0679006:Call [Mental Process]
   966   C1947967:Call [Functional Concept]

Phrase: "B103"

Phrase: "(Schubert et al.,"

Phrase: "1974"

Phrase: ")"

Phrase: "was"

Phrase: "stably"

Phrase: "transfected with APP695"

Phrase: "and"

Phrase: "again with a plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "the full-length MOCA cDNA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205349:Modifier [Qualitative Concept]
   742   C1514623:Modifier [Conceptual Entity]
   742   C1516451:Modifier [Chemical Viewed Functionally]
   742   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.30: B103 cells normally express little or no APP (Schubert et al., 1989) and no MOCA. 

Phrase: "B103 cells normally"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(Schubert et al.,"

Phrase: "1989"

Phrase: ")"

Phrase: "and"

Phrase: "no MOCA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.31: The expression of MOCA was detected in transfected clones of B103 (APP695/MOCA) at levels similar to or less than MOCA expressed in the mouse hippocampus (Fig. 1, A and D). 

Phrase: "The expression of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected in transfected clones of B103"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0009013:Clones [Cell]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   719 E C1522642:Clone [Tissue]

Phrase: "(APP695/MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: ")"

Phrase: "at levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "similar to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2348205:Similar [Qualitative Concept]

Phrase: "or"

Phrase: "less than MOCA"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   778   C0439092:Less Than [Intellectual Product]
           less
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0547044:Less [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "expressed in the mouse hippocampus"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1523990:Mouse Hippocampus [Tissue]
   760   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0949582:Hippocampus [Fish]
   760   C1029104:Hippocampus [Fish]
   760   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.32: Secreted proteins from the stably transfected cells containing either an empty vector or the MOCA gene were first studied by Western blotting using antibody 6E10, which recognizes APP and amino acid residues 117 of human A (Kim et al., 1990). 

Phrase: "Secreted proteins from the stably transfected cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "either"

Phrase: "an empty vector"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "or"

Phrase: "the MOCA gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C3178895:Modifier Gene [Gene or Genome]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "studied by Western blotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C1705493:Western [Spatial Concept]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibody 6E10,"

Phrase: "which"

Phrase: "recognizes"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "amino acid residues 117 of human A"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C2917660:Amino Acid [Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0086418:Human [Human]
   744   C0202406:Acid [Laboratory Procedure]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(Kim et al.,"

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.33: The release of secreted APP (APPs) was decreased dramatically in all independently isolated clones expressing MOCA relative to clones containing empty vector (Fig. 1 A). 

Phrase: "The release of secreted APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: ")"

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "dramatically in all independently isolated clones"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0009013:Clones [Cell]
   753   C0205409:Isolated [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C1522642:Clone [Tissue]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "relative to clones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "empty vector"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]
   861   C1880497:Empty [Qualitative Concept]
   805 E C0333668:Depleted [Functional Concept]
   777 E C1550032:Unload [Idea or Concept]
   777 E C1996907:Emptying [Activity]

Phrase: "(Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.34: To determine the specificity of the MOCA effect on APP secretion and eliminate the possibility of clonal variation, several control experiments were performed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the specificity of the MOCA effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0037791:Specificity [Quantitative Concept]
   739   C1511884:Specificity [Quantitative Concept]

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "eliminate"

Phrase: "the possibility of clonal variation,"

Phrase: "several control experiments"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0009932:control experiments [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0681814:Experiments [Research Activity]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.35: First, a transcriptional change was ruled out because the abundance of APP mRNA was not altered by both Northern blot and reverse transcription (RT)-PCR analysis (Fig. 1 B). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a transcriptional change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "because"

Phrase: "the abundance of APP mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2346714:Abundance [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered by both Northern blot"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0005861:Northern Blot [Molecular Biology Research Technique]
   806   C1621557:Northern Blot [Research Device]
   760   C0392747:Altered [Functional Concept]
   760   C1709269:Northern [Spatial Concept]

Phrase: "and"

Phrase: "reverse transcription (RT)-PCR analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0200931:PCR analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.36: Second, transient transfection of MOCA into B103 (APP695) cells led to the reduction of APP secretion in an uncloned population (Fig. 1 D). 

Phrase: "Second, transient transfection of MOCA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "into B103"

Phrase: "(APP695"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "led to the reduction of APP secretion"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159339:Protein Secretion [Cell Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1708698:LED [Manufactured Object]
   742   C1709634:Precursor [Idea or Concept]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in an uncloned population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(Fig. 1 D"

Phrase: ")."
Processing 00000000.tx.37: Third, the secretion of APP was not affected by the overexpression of DOCK180, a protein which has a 40% homology with MOCA (Fig. 2 D). 

Phrase: "Third,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205437:Third [Quantitative Concept]

Phrase: "the secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the overexpression of DOCK180,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0392760:Affected [Functional Concept]
   753   C1314939:Affected [Functional Concept]
   753   C1333245:DOCK180 [Gene or Genome]
   753   C1333263:DOCK180 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1514559:Overexpression [Genetic Function]
   719 E C0001721:Affect [Mental Process]

Phrase: "a protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "has"

Phrase: "a 40% homology with MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1334043:Homology [Gene or Genome]
   742   C2697616:Homology [Qualitative Concept]
   712   C1512488:Protein Homolog [Amino Acid, Peptide, or Protein]

Phrase: "(Fig. 2 D"

Phrase: ")."
Processing 00000000.tx.38: Fourth, the secretion of endogenous APP751 was reduced in HEK293T cells expressing MOCA (Fig. 1 D). 

Phrase: "Fourth,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205438:Fourth [Quantitative Concept]
  1000   C1706303:Fourth [Qualitative Concept]

Phrase: "the secretion of endogenous APP751"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "reduced in HEK293T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0392756:Reduced [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "(Fig. 1 D"

Phrase: ")."
Processing 00000000.tx.39: Lastly, since APP is a type I integral membrane protein we asked if MOCA alters the expression or secretion (shedding) of six other proteins. 

Phrase: "Lastly,"

Phrase: "since"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "a type I integral membrane protein"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   884   C0021699:Integral Membrane Protein [Amino Acid, Peptide, or Protein]
   875   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0025255:Membrane [Tissue]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0443238:Integral [Quantitative Concept]
   804   C0596901:Membrane [Cell Component]
   804   C1706182:Membrane [Manufactured Object]
   733 E C0205287:Membranous [Qualitative Concept]

Phrase: "we"

Phrase: "asked"

Phrase: "if"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "(shedding"

Phrase: ")"

Phrase: "of six"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205452:Six [Quantitative Concept]

Phrase: "other proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.40: The effect of MOCA expression on the secretion of another large extracellular protein, -laminin, was examined; 

Phrase: "The effect of MOCA expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0681891:effect modifier [Functional Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on the secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "of another large extracellular protein, -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ";"
Processing 00000000.tx.41: no difference was observed between cells transfected with APP and APP plus MOCA (Fig. 1 A). 

Phrase: "no difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed between cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "APP plus MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205349:Modifier [Qualitative Concept]
   742   C1514623:Modifier [Conceptual Entity]
   742   C1516451:Modifier [Chemical Viewed Functionally]
   742   C3542952:Modifier [Intellectual Product]

Phrase: "(Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.42: Neural cell adhesion molecule (N-CAM) is involved in both homotypic and heterotypic cellcell adhesions and expressed as several membrane-bound and secreted isoforms through an alternative splicing mechanism (Gower et al., 1988). 

Phrase: "Neural cell adhesion molecule (N-CAM)"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
  1000   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1413393:neural cell adhesion molecule [Gene or Genome]
   923   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   923   C1413564:neural adhesion molecule [Gene or Genome]
   861   C0007577:Cell Adhesion [Cell Function]
   861   C0027882:Neural cell [Cell]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0007634:Cell [Cell]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0567416:Molecule [Substance]
   812   C0599851:Neural [Functional Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   756 E C0027740:Nerve [Tissue]
   756 E C0027757:NERVE [Tissue]
   756 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   741 E C1521991:Molecular [Qualitative Concept]
   719 E C0027769:nervy [Sign or Symptom]

Phrase: "is"

Phrase: "involved in both homotypic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "heterotypic cellcell adhesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0001511:Adhesions [Pathologic Function]
   793 E C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "expressed as several membrane-bound"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0025255:Membrane [Tissue]
   760   C0332297:bound [Spatial Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C1706182:Membrane [Manufactured Object]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "secreted isoforms through an alternative splicing mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597298:Isoforms [Amino Acid, Peptide, or Protein]

Phrase: "(Gower et al.,"

Phrase: "1988"

Phrase: ")."
Processing 00000000.tx.43: No effect on the levels of intracellular N-CAM expression and/or N-CAM secretion was observed in B103 cells expressing MOCA (Fig. 1 A). 

Phrase: "No effect on the levels of intracellular N-CAM expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1301751:No effect [Qualitative Concept]
   736   C1280500:Effect [Qualitative Concept]
   736   C2348382:Effect [Qualitative Concept]

Phrase: "and/or"

Phrase: "N-CAM secretion"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C1327616:Cell secretion [Cell Function]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   771   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   771   C1413393:neural cell adhesion molecule [Gene or Genome]
   722   C1413564:neural adhesion molecule [Gene or Genome]
   717   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "observed in B103 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1441672:Observed [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "(Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.44: A single band with molecular weight 130 kd is detected intracellularly, whereas the secreted N-CAM was aggregated into higher molecular weight complexes (>300 kd) as described by others (Tavella et al., 1994). 

Phrase: "A single band with molecular weight 130 kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0175723:Band [Medical Device]
   742   C0439645:Band [Spatial Concept]
   742   C1521913:band [Cell Component]

Phrase: "is"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "intracellularly,"

Phrase: "whereas"

Phrase: "the secreted N-CAM"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   937   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   937   C1413393:neural cell adhesion molecule [Gene or Genome]
   888   C1413564:neural adhesion molecule [Gene or Genome]
   884   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   840   C0007577:Cell Adhesion [Cell Function]
   840   C0027882:Neural cell [Cell]
   804   C0001511:Adhesion [Pathologic Function]
   804   C0007634:Cell [Cell]
   804   C0175633:Adhesion [Natural Phenomenon or Process]
   804   C0567416:Molecule [Substance]
   804   C0599851:Neural [Functional Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   748 E C0027740:Nerve [Tissue]
   748 E C0027757:NERVE [Tissue]
   748 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   733 E C1521991:Molecular [Qualitative Concept]
   711 E C0027769:nervy [Sign or Symptom]

Phrase: "was"

Phrase: "aggregated into higher molecular weight complexes"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   816   C1979900:High molecular weight [Qualitative Concept]
   790   C0026385:Molecular Weight [Quantitative Concept]
   767   C0948775:high weight [Sign or Symptom]
   753   C0005910:weight [Organism Attribute]
   753   C0043100:Weight [Quantitative Concept]
   753   C0332621:Aggregated [Functional Concept]
   753   C1305866:weight [Diagnostic Procedure]
   753   C1521991:Molecular [Qualitative Concept]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   753   C1705104:Weight [Idea or Concept]
   742 E C0424638:Height & weight [Organism Attribute]
   719   C0205250:High [Qualitative Concept]
   719 E C0205418:Aggregate [Qualitative Concept]
   719 E C0439855:Complex [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "("

Phrase: ">300 kd)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "as"

Phrase: "described by others"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   790   C1955473:Others [Finding]

Phrase: "(Tavella et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.45: Notch-1 is involved in crucial cell fate decisions during development and the processing of Notch is similar to -secretasemediated cleavage of APP (Greenwald, 1998; De Strooper et al., 1999; Struhl and Greenwald 1999; Ye et al., 1999). 

Phrase: "Notch-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334889:notch 1 [Gene or Genome]
   861   C1235660:Notch [Body Space or Junction]

Phrase: "is"

Phrase: "involved in crucial cell fate decisions"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1540661:cell fate [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0679006:decisions [Mental Process]
   753   C1269647:Cell [Cell]
   753   C1314939:Involved [Functional Concept]
   753   C1539479:FATE [Gene or Genome]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "during development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "and"

Phrase: "the processing of Notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709694:Processing [Activity]

Phrase: "is"

Phrase: "similar to -secretasemediated cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C0597304:Protein Cleavage [Molecular Function]
   744   C0010813:cleavage [Cell Function]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]

Phrase: "(Greenwald,"

Phrase: "1998"

Phrase: "; De Strooper et al.,"

Phrase: "1999"

Phrase: "; Struhl"

Phrase: "and"

Phrase: "Greenwald 1999"

Phrase: "; Ye et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.46: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.47: 1 C shows that the expression of (intracellular) full-length (mol wt 300 kd), and truncated transmembrane forms (mol wt 120 kd) of Notch are only slightly altered in B103 cells expressing MOCA. 

Phrase: "1 C"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the expression of ("

Phrase: "intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: ")"

Phrase: "full-length"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0443225:Full [Qualitative Concept]
   861   C1444754:Length [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "(mol wt 300 kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0026691:KD [Disease or Syndrome]
   812   C1705240:KD [Gene or Genome]
   812   C1839259:KD [Disease or Syndrome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "truncated transmembrane forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "(mol wt 120 kd) of Notch"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0026691:KD [Disease or Syndrome]
   753   C1705240:KD [Gene or Genome]
   753   C1839259:KD [Disease or Syndrome]

Phrase: "are"

Phrase: "only slightly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C0750482:Slightly [Idea or Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "altered in B103 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0392747:Altered [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.48: Finally, previous studies have shown that the processing or metabolism of amyloid precursor-like protein (APLP) and cadherins are regulated by PSs (Naruse et al., 1998; Marambaud et al., 2002). 

Phrase: "Finally,"

Phrase: "previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "or"

Phrase: "metabolism of amyloid precursor-like protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   851   C1327340:amyloid precursor protein metabolism [Molecular Function]
   783   C0597299:Protein Metabolism [Molecular Function]
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
   716   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN [Gene or Genome]

Phrase: "(APLP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN [Gene or Genome]
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   875   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "cadherins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006631:Cadherins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C1413274:cadherin [Gene or Genome]

Phrase: "are"

Phrase: "regulated by PSs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   790   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Naruse et al.,"

Phrase: "1998"

Phrase: "; Marambaud et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.49: No difference in E-cadherin and APLP2 expression was observed, nor was there a decrease in APLP2 secretion. 

Phrase: "No difference in E-cadherin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "APLP2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "nor"

Phrase: "was"

Phrase: "there"

Phrase: "a decrease in APLP2 secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.50: In contrast, the expression level of N-cadherin was significantly increased in MOCA- expressing B103 and 293T cells (Fig. 1 E). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the expression level of N-cadherin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "significantly"

Phrase: "increased in MOCA- expressing B103"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0007577:Cell Adhesion [Cell Function]
   742   C0001511:Adhesion [Pathologic Function]
   742   C0007634:Cell [Cell]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0175633:Adhesion [Natural Phenomenon or Process]
   742   C0205217:Increased [Quantitative Concept]
   742   C0205349:Modifier [Qualitative Concept]
   742   C0442805:Increased [Functional Concept]
   742   C1269647:Cell [Cell]
   742   C1514623:Modifier [Conceptual Entity]
   742   C1516451:Modifier [Chemical Viewed Functionally]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "293T cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1 E"

Phrase: ")."
Processing 00000000.tx.51: The above data show that MOCA expression leads to the reduced secretion of APP but not other type-1 membrane proteins. 

Phrase: "The above data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that MOCA expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205349:Modifier [Qualitative Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "leads to the reduced secretion of APP"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1159339:Protein Secretion [Cell Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0181586:leads [Medical Device]
   742   C0392756:Reduced [Qualitative Concept]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   742   C1522538:Lead [Functional Concept]
   742   C1709634:Precursor [Idea or Concept]
   742   C2348269:Lead [Element, Ion, or Isotope]
   742   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "other type-1 membrane proteins."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0025255:Membrane [Tissue]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0596901:Membrane [Cell Component]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.52: View larger version (59K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(59K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.53: Decreased APP secretion in nerve cells expressing the MOCA protein. 

Phrase: "Decreased APP secretion in nerve cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1159339:Protein Secretion [Cell Function]
   750   C1327616:Cell secretion [Cell Function]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]

Phrase: "expressing"

Phrase: "the MOCA protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205349:Modifier [Qualitative Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.54: (A) The levels of APP secreted by two clones (clones 7 and 8) stably transfected with APP and MOCA and detected with the 6E10 antibody were significantly lower than those from cells only expressing APP. 

Phrase: "(A"

Phrase: ")"

Phrase: "The levels of APP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0428479:Protein level [Laboratory or Test Result]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "secreted by two clones"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0009013:Clones [Cell]
   770   C0205448:Two [Quantitative Concept]
   770   C1327616:Secreted [Cell Function]
   737 E C1522642:Clone [Tissue]

Phrase: "(clones 7"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "and"

Phrase: "8"

Phrase: ")"

Phrase: "stably"

Phrase: "transfected with APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "detected with the 6E10 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "significantly lower than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "from cells only"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.55: The expression level of another secreted protein, -laminin, was not affected by MOCA. 

Phrase: "The expression level of another secreted protein, -"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C3244092:expression level [Idea or Concept]
   774   C0428479:Protein level [Laboratory or Test Result]
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by MOCA."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0392760:Affected [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1314939:Affected [Functional Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714 E C0001721:Affect [Mental Process]
Processing 00000000.tx.56: Identical amounts of protein (80 g) were loaded in each of the six lanes, and Western blot assays were performed. 

Phrase: "Identical amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(80 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "loaded in each of the six lanes,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   748   C0205452:Six [Quantitative Concept]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]
   714   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "Western blot assays"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C0949466:Western blot assay [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C1705493:Western [Spatial Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.57: The secretion of N-CAM and the intracellular levels of N-CAM were also not affected by MOCA. 

Phrase: "The secretion of N-CAM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1327616:Cell secretion [Cell Function]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "the intracellular levels of N-CAM"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by MOCA."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0392760:Affected [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1314939:Affected [Functional Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714 E C0001721:Affect [Mental Process]
Processing 00000000.tx.58: Actin levels were used as loading control. 

Phrase: "Actin levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "used as loading control."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1708715:Loading [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.59: (B) The levels of APP mRNA in the corresponding cells were not significantly different as shown by Northern hybridization and the RT-PCR analysis. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The levels of APP mRNA"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the corresponding cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "not significantly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]

Phrase: "as"

Phrase: "shown by Northern hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0599862:northern hybridization [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0020202:Hybridisation [Genetic Function]
   770   C1300517:Hybridization [Laboratory Procedure]
   770   C1709269:Northern [Spatial Concept]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "the RT-PCR analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0200931:PCR analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0677874:pCR [Finding]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
Processing 00000000.tx.60: (C) MOCA had a small effect on Notch-1 expression. 

Phrase: "(C) MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "had"

Phrase: "a small effect on Notch-1 expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.61: Actin was used as loading control. 

Phrase: "Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "was"

Phrase: "used as loading control."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1708715:Loading [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.62: Notch-1 expression was quantitated and presented as percent expression in APP695. 

Phrase: "Notch-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1334889:notch 1 [Gene or Genome]

Phrase: "was"

Phrase: "quantitated"

Phrase: "and"

Phrase: "presented as percent expression"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0439165:Percent [Quantitative Concept]
   770   C0449450:Presented [Idea or Concept]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "in APP695."
Processing 00000000.tx.63: (D) The secretion of APP was significantly reduced relative to controls in B103 cells transiently transfected with MOCA and in HEK-293T cells, which secrete endogenous APP751. 

Phrase: "("

Phrase: "D)"

Phrase: "The secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "relative to controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "in B103 cells transiently"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with MOCA"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "and in HEK-293T cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0121258:HEK [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   760   C0812263:HEK [Gene or Genome]
   760   C1515981:And [Idea or Concept]
   760   C1704817:HEK [Gene or Genome]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "endogenous APP751."
Processing 00000000.tx.64: The middle panels show MOCA expression, and the bottom panel shows that the secretion of -laminin was not affected by MOCA in HEK293T cells. 

Phrase: "The middle panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "MOCA expression,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "the bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the secretion of -laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by MOCA"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0392760:Affected [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1314939:Affected [Functional Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714 E C0001721:Affect [Mental Process]

Phrase: "in HEK293T cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.65: The quantitation of the APPs, laminin, N-CAM, and Notch-1 expression was determined by scanning of the respective blots of several clones expressing MOCA (n = 3) and presented as the percentage of B103 APP695 (100%). 

Phrase: "The quantitation of the APPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709793:Quantitation [Quantitative Concept]

Phrase: "laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "N-CAM,"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
  1000   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1413393:neural cell adhesion molecule [Gene or Genome]
   923   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   923   C1413564:neural adhesion molecule [Gene or Genome]
   861   C0007577:Cell Adhesion [Cell Function]
   861   C0027882:Neural cell [Cell]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0007634:Cell [Cell]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0567416:Molecule [Substance]
   812   C0599851:Neural [Functional Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   756 E C0027740:Nerve [Tissue]
   756 E C0027757:NERVE [Tissue]
   756 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   741 E C1521991:Molecular [Qualitative Concept]
   719 E C0027769:nervy [Sign or Symptom]

Phrase: "and"

Phrase: "Notch-1 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1334889:notch 1 [Gene or Genome]

Phrase: "was"

Phrase: "determined by scanning of the respective blots of several clones"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   739   C0009013:Clones [Cell]
   739   C0034606:Scanning [Diagnostic Procedure]
   739   C0441633:Scanning [Diagnostic Procedure]
   706 E C1522642:Clone [Tissue]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "presented as the percentage of B103 APP695"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0439165:Percentage [Quantitative Concept]
   748   C0449450:Presented [Idea or Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
   714 E C0150312:Present [Quantitative Concept]

Phrase: "(100%"

Phrase: ")."
Processing 00000000.tx.66: (E) Expression of N-cadherin, E-cadherin, and APLP2 in B103 and HEK-293 cells, and the secretion of APLP2 in B103 cells. 

Phrase: "(E) Expression of N-cadherin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "E-cadherin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0042172:E-Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0694872:E-CADHERIN [Gene or Genome]
   861   C0006631:Cadherin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1413274:cadherin [Gene or Genome]

Phrase: "and"

Phrase: "APLP2 in B103"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1412467:APLP2 [Gene or Genome]

Phrase: "and"

Phrase: "HEK-293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK 293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the secretion of APLP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "in B103 cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.67: Actin served as a loading control.  

Phrase: "Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "served as a loading control."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1708715:Loading [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.68: View larger version (54K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.69: PS1 and APP secretion. 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "and"

Phrase: "APP secretion."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.70: (A) The expression of the endogenous PS1 in B103 cells was determined by Western blot analysis. 

Phrase: "(A"

Phrase: ")"

Phrase: "The expression of the endogenous PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in B103 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined by Western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.71: (B) Effects of -secretase inhibitors II (g-II) (50 M), III (g-III) (50 M), IV (g-IV) (5 M), and V (g-V) (10 M) on APP secretion and intracellular expression of COOH-terminal stubs in B103(APP695) and B103(APP695/MOCA) cells are shown. 

Phrase: "(B) Effects of -secretase inhibitors II"

Phrase: "(g-II"

Phrase: ")"

Phrase: "(50"

Phrase: "M)"

Phrase: ","

Phrase: "III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "(g-III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439070:III [Intellectual Product]
   861   C0439267:g% [Quantitative Concept]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "(50"

Phrase: "M)"

Phrase: ","

Phrase: "IV (g-IV) (5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "M)"

Phrase: ","

Phrase: "and"

Phrase: "V (g-V) (10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0560268:%V/V [Quantitative Concept]
   875   C2349105:V(V) [Element, Ion, or Isotope]
   812   C0439267:g% [Quantitative Concept]

Phrase: "M) on APP secretion"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1159339:Protein Secretion [Cell Function]
   783   C0700271:M Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "intracellular expression of COOH-terminal stubs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in B103"

Phrase: "(APP695"

Phrase: ")"

Phrase: "and"

Phrase: "B103"

Phrase: "(APP695/MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.72: Effects of Calp III (100 M), MG132 (10 M), and lactacystin (Lact) (20 M) were tested as well. 

Phrase: "Effects of Calp III"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "(100"

Phrase: "M)"

Phrase: ","

Phrase: "MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(10"

Phrase: "M)"

Phrase: ","

Phrase: "and"

Phrase: "lactacystin (Lact)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "(20"

Phrase: "M)"

Phrase: "were"

Phrase: "tested as well."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205170:Well [Qualitative Concept]
   790   C0392366:tested [Intellectual Product]
   790   C3146287:Well [Manufactured Object]
   756 E C0022885:Test [Laboratory Procedure]
   756 E C0039593:Test [Functional Concept]
Processing 00000000.tx.73: Cells were treated in the presence of various inhibitors for 16 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated in the presence of various inhibitors"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0332293:treated [Therapeutic or Preventive Procedure]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "for 16 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.74: (C) The secretion of APP in APP and MOCA-containing cells stably transfected with either wild-type human PS1 (clones 5, 6, 11, 13) or mutant form (L392V) (clones 1, A1, A12, A13). 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "The secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "in APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "MOCA-containing cells stably"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205349:Modifier [Qualitative Concept]
   744   C1514623:Modifier [Conceptual Entity]
   744   C1516451:Modifier [Chemical Viewed Functionally]
   744   C3542952:Modifier [Intellectual Product]

Phrase: "transfected with either wild-type human PS1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0086418:Human [Human]
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1418985:PS1 [Gene or Genome]
   748   C1547052:*Type [Quantitative Concept]
   748   C2986918:PS1 [Gene or Genome]

Phrase: "(clones 5,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "6,"

Phrase: "11,"

Phrase: "13"

Phrase: ")"

Phrase: "or"

Phrase: "mutant form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: "(L392V"

Phrase: ")"

Phrase: "(clones 1,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "A1,"

Phrase: "A12,"

Phrase: "A13"

Phrase: ")."
Processing 00000000.tx.75: (D) Summary of the effect of MOCA on APPs secretion. 

Phrase: "("

Phrase: "D)"

Phrase: "Summary of the effect of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1552616:summary [Intellectual Product]
   739   C1706244:Summary [Intellectual Product]

Phrase: "on APPs secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.76: The secretion of APPs was reduced by MOCA with further reduction of APPs secretion in cells coexpressing MOCA and elevated PS1. 

Phrase: "The secretion of APPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "reduced by MOCA"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "with further reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of APPs secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "coexpressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "elevated PS1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.77: The secretion level of sAPP in cells coexpressing both MOCA and mutant PS1 (L392V) was lower than that in cells only transfected with mutant PS1 (L392V). 

Phrase: "The secretion level of sAPP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "coexpressing"

Phrase: "both MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "mutant PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418985:PS1 [Gene or Genome]
   861   C2986918:PS1 [Gene or Genome]

Phrase: "(L392V"

Phrase: ")"

Phrase: "was"

Phrase: "lower than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "in cells only"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with mutant PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0596988:Mutant [Cell or Molecular Dysfunction]
   770   C1418985:PS1 [Gene or Genome]
   770   C2986918:PS1 [Gene or Genome]

Phrase: "(L392V"

Phrase: ")."
Processing 00000000.tx.78: Human PS1 holoproteins (hPS1FL) and the NH2-terminal fragment (hPS1NTF) were detected using monoclonal antibody recognizing PS1 (Borchelt et al., 1996). 

Phrase: "Human PS1 holoproteins"

Phrase: "(hPS1FL"

Phrase: ")"

Phrase: "and"

Phrase: "the NH2-terminal fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "(hPS1NTF"

Phrase: ")"

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "monoclonal antibody recognizing PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1418985:PS1 [Gene or Genome]
   812   C2986918:PS1 [Gene or Genome]

Phrase: "(Borchelt et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.79: The overexpression of DOCK180 protein in B103 cells is also indicated.  

Phrase: "The overexpression of DOCK180 protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "in B103 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "also"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.80: Because PS1 is associated with -secretase cleavage of APP (Wolfe and Haass, 2001) and in situ hybridization shows that MOCA and PS1 are expressed in overlapping areas of the brain and are colocalized on cells expressing both proteins (Kashiwa et al., 2000), it was asked if the effect of MOCA on APP secretion is altered by PS1 expression or activity. 

Phrase: "Because"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "associated with -secretase cleavage of APP"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   822   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
           secretase
   822   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   789   C0368670:Amyloid associated protein [Amino Acid, Peptide, or Protein]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C0597304:Protein Cleavage [Molecular Function]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0010813:cleavage [Cell Function]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1330957:cleavage [Cell Function]
   744   C1709634:Precursor [Idea or Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Wolfe"

Phrase: "and"

Phrase: "Haass,"

Phrase: "2001"

Phrase: ")"

Phrase: "and"

Phrase: "in situ hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "are"

Phrase: "expressed in overlapping areas of the brain"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0185027:Overlapping [Therapeutic or Preventive Procedure]
   748   C0205146:areas [Spatial Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1948020:Overlapping [Conceptual Entity]
   714 E C0017446:Area [Geographic Area]

Phrase: "and"

Phrase: "are"

Phrase: "colocalized on cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "both proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Kashiwa et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "asked"

Phrase: "if"

Phrase: "the effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "altered by PS1 expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392747:Altered [Functional Concept]
   770   C1418985:PS1 [Gene or Genome]
   770   C2986918:PS1 [Gene or Genome]

Phrase: "or"

Phrase: "activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.81: The endogenous expression of PS1 was detected in B103 cells using an antibody specific to rat PS1. 

Phrase: "The endogenous expression of PS1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected in B103 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an antibody specific to rat PS1."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   718 E C0003264:Antibody Specificity [Molecular Function]
Processing 00000000.tx.82: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.83: 2 A shows the abundant processed NH2-terminal fragments of PS1 (mol wt 1921 kd). 

Phrase: "2 A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the abundant processed NH2-terminal fragments of PS1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0332255:fragments [Functional Concept]
   744   C0486805:Fragments [Body Substance]
   711 E C1708096:Fragment [Qualitative Concept]

Phrase: "(mol wt 1921 kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0026691:KD [Disease or Syndrome]
   812   C1705240:KD [Gene or Genome]
   812   C1839259:KD [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.84: A very weak band with a mol wt 90 kd was also observed, which may be a complexed form of PS1 (unpublished data). 

Phrase: "A very weak band with a mol wt 90 kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0175723:Band [Medical Device]
   738   C0439645:Band [Spatial Concept]
   738   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "a complexed form of PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.85: To block PS1-related -secretase activities, several inhibitors, which are specific for -secretase, were used. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "PS1-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "related -"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "secretase activities,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "several inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "are"

Phrase: "specific for -secretase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.86: All of these agents have been shown to decrease A production with concomitant increases in the levels of the corresponding COOH-terminal fragments at the concentrations we used. 

Phrase: "All of these agents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737   C1521826:Agent [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "A production with concomitant increases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0003261:antibodies production [Biologic Function]
   753   C0033268:production [Occupational Activity]

Phrase: "in the levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "of the corresponding COOH-terminal fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]

Phrase: "at the concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "we"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.87: -Secretase inhibitor II is a transition-state analogue, which selectively inhibits the -secretase cleavage of APP and Notch-1 (Wolfe et al., 1998, 1999; De Strooper et al., 1999; Berezovska et al., 2000). 

Phrase: "-Secretase inhibitor II"

Phrase: "is"

Phrase: "a transition-state analogue,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   827   C0243071:Analog [Chemical Viewed Structurally]
   827   C0599156:Transition [Cell or Molecular Dysfunction]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C2700061:Transition [Activity]
   827   C3148680:State [Geographic Area]
   755 E C1182674:Transitional [Spatial Concept]
   755 E C1548597:Transitional [Idea or Concept]
   721 E C0679213:analogies [Idea or Concept]

Phrase: "which selectively"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the -secretase cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "Notch-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334889:notch 1 [Gene or Genome]
   861   C1235660:Notch [Body Space or Junction]

Phrase: "(Wolfe et al.,"

Phrase: "1998,"

Phrase: "1999"

Phrase: "; De Strooper et al.,"

Phrase: "1999"

Phrase: "; Berezovska et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.88: Several dipeptidyl aldehydes (-secretase inhibitor III [Z-LL-CHO], -secretase inhibitor IV [2-naphthoyl-VF-CHO], -secretase inhibitor V [Z-LF-CHO], and calpain inhibitor III [Z-VL-CHO, Calp III]) were also tested (Higaki et al., 1995; Figueiredo-Pereira et al., 1999; Sinha and Lieberburg, 1999). 

Phrase: "Several dipeptidyl aldehydes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0001992:Aldehydes [Organic Chemical]

Phrase: "(-secretase inhibitor III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "[Z-"

Phrase: "LL-"

Phrase: "CHO"

Phrase: "], -"

Phrase: "secretase inhibitor IV [2-naphthoyl-VF-CHO"

Phrase: "], -"

Phrase: "secretase inhibitor V [Z-LF-CHO"

Phrase: "],"

Phrase: "and"

Phrase: "calpain inhibitor III"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1700414:calpain inhibitor III [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]
   734   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[Z-VL-CHO,"

Phrase: "Calp III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "]"

Phrase: ")"

Phrase: "were"

Phrase: "also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(Higaki et al.,"

Phrase: "1995"

Phrase: "; Figueiredo-Pereira et al.,"

Phrase: "1999"

Phrase: "; Sinha"

Phrase: "and"

Phrase: "Lieberburg,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.89: No effect of -secretase inhibitors II and V on APP secretion was found in B103 cells expressing MOCA. 

Phrase: "No effect of -secretase inhibitors II"

Phrase: "and"

Phrase: "V on APP secretion"

Phrase: "was"

Phrase: "found in B103 cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0150312:Found [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0243095:Find [Finding]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.90: APP secretion was partially restored by -secretase inhibitors III and IV and by Calp III in B103 cells expressing MOCA and wild-type cells. 

Phrase: "APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "partially"

Phrase: "restored by -secretase inhibitors III"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C0439070:III [Intellectual Product]
   760   C1705160:III [Qualitative Concept]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "IV"

Phrase: "and by Calp III"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439070:III [Intellectual Product]
   770   C1428931:CALP [Gene or Genome]
   770   C1515981:And [Idea or Concept]
   770   C1705160:III [Qualitative Concept]

Phrase: "in B103 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "wild-type cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C0449475:type cell [Intellectual Product]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.91: As controls, MG132 and lactacystin dramatically affected APP secretion and intracellular expression (see the following). 

Phrase: "As controls,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "lactacystin dramatically affected APP secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   818   C1159339:Protein Secretion [Cell Function]
   795   C0036536:secretion [Biologic Function]
   795   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "intracellular expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "the following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.92: All of the secretase inhibitors were functional because they all increased the accumulation of COOH-terminal stubs (Fig. 2 B). 

Phrase: "All of the secretase inhibitors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C0444868:All [Quantitative Concept]
   760   C3539085:All [Idea or Concept]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "functional"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205245:Functional [Functional Concept]
  1000   C0542341:Functional [Functional Concept]
  1000   C2700217:Functional [Conceptual Entity]

Phrase: "because"

Phrase: "they all"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the accumulation of COOH-terminal stubs"

Phrase: "(Fig. 2 B"

Phrase: ")."
Processing 00000000.tx.93: There was much less accumulation of these molecules in MOCA-expressing cells, probably because of the limited substrate (APP) availability. 

Phrase: "There"

Phrase: "was"

Phrase: "much less accumulation of these molecules"

Phrase: "in MOCA-expressing cells,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   835   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007577:Cell Adhesion [Cell Function]
   793   C0001511:Adhesion [Pathologic Function]
   793   C0007634:Cell [Cell]
           Cells
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0150312:In [Quantitative Concept]
   793   C0175633:Adhesion [Natural Phenomenon or Process]
   793   C0205349:Modifier [Qualitative Concept]
   793   C0332285:In [Spatial Concept]
   793   C1269647:Cell [Cell]
   793   C1514623:Modifier [Conceptual Entity]
   793   C1516451:Modifier [Chemical Viewed Functionally]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]
   793   C3282337:Cells [Cell]
   793   C3542952:Modifier [Intellectual Product]

Phrase: "probably because of the limited substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439801:Limited [Functional Concept]
   753   C0750492:Probably [Idea or Concept]
   753   C1710236:Substrate [Manufactured Object]
   753   C3542948:Limited [Intellectual Product]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "availability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Availability [Functional Concept]
Processing 00000000.tx.94: Similar results were also observed in HEK293 cells stably transfected with MOCA (unpublished data). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "also"

Phrase: "observed in HEK293 cells stably"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C2936239:HEK293 Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with MOCA"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.95: In addition, the effect of the overexpression of human PS1 on APP secretion was studied (Fig. 2 C). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the effect of the overexpression of human PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "(Fig. 2 C)."
Processing 00000000.tx.96: The full-length wild-type or a mutant PS1 gene was stably transfected into the B103 (APP695/MOCA) cells, and APPs assayed. 

Phrase: "The full-length wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1883559:Wild Type [Organism Attribute]
   812   C0332307:Type [Qualitative Concept]
   812   C0445392:Wild [Intellectual Product]
   812   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "a mutant PS1 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0678941:mutant gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "stably"

Phrase: "transfected into the B103"

Phrase: "(APP695/MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "assayed."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.97: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.98: 2 C shows that APPs release was further reduced relative to cells expressing MOCA alone in four independently isolated clones, which coexpress MOCA and wild-type (WT) PS1 or the mutant (FAD) PS1 (L392V). 

Phrase: "2 C"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that APPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3538722:APP [Laboratory Procedure]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "relative to cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "alone in four independently isolated clones,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205171:Alone [Quantitative Concept]
   753   C0439044:alone [Finding]
   753   C0679994:alone [Group Attribute]

Phrase: "which"

Phrase: "coexpress"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "wild-type (WT) PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1418985:PS1 [Gene or Genome]
   827   C2986918:PS1 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "or"

Phrase: "the mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(FAD"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ")"

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "(L392V"

Phrase: ")."
Processing 00000000.tx.99: The effect of MOCA on APP secretion is summarized in Fig. 

Phrase: "The effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "summarized in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.100: 2 D, which also shows human PS1 overexpression (Fig. 2 D, bottom). 

Phrase: "2 D,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1705052:2-D [Spatial Concept]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "which also"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "human PS1 overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514559:Overexpression [Genetic Function]

Phrase: "(Fig. 2 D, bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511276:Bottom [Spatial Concept]
   812   C1552825:bottom [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.101: To determine the effect of MOCA expression on A peptide production, we transfected the MOCA gene into a B103 cell line, which contains the FAD Swedish form of APP (APPsw) and secretes A peptides into the medium (Xu et al., 1999). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the effect of MOCA expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0681891:effect modifier [Functional Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on A peptide production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0003261:antibodies production [Biologic Function]
   812   C0033268:production [Occupational Activity]

Phrase: "we"

Phrase: "transfected"

Phrase: "the MOCA gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C3178895:Modifier Gene [Gene or Genome]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "into a B103 cell line,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the FAD Swedish form of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1832428:Familial form [Finding]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]

Phrase: "(APPsw"

Phrase: ")"

Phrase: "and"

Phrase: "secretes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "A peptides into the medium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(Xu et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.102: The levels of APPsw secretion were significantly decreased in cells expressing MOCA (Fig. 3 A). 

Phrase: "The levels of APPsw secretion"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "decreased in cells"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0007634:Cells [Cell]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C0547047:Decrease [Quantitative Concept]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "(Fig. 3 A"

Phrase: ")."
Processing 00000000.tx.103: The intracellular levels of APPsw were also decreased by MOCA (Fig. 3 B). 

Phrase: "The intracellular levels of APPsw"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "decreased by MOCA"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 3 B"

Phrase: ")."
Processing 00000000.tx.104: Therefore, the effects of MOCA on APPsw secretion were similar to those on wild-type APP (Fig. 1). 

Phrase: "Therefore,"

Phrase: "the effects of MOCA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   750   C0681891:effect modifier [Functional Concept]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "on APPsw secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "were"

Phrase: "similar to those on wild-type APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.105: A secretion into the culture medium was then measured by immunoprecipitation and radioautography (Fig. 3 C) and independently by the sandwich ELISA (Fig. 3 D). 

Phrase: "A secretion into the culture medium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C1327439:antibody secretion [Cell Function]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "measured by immunoprecipitation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "radioautography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004400:Radioautography [Laboratory Procedure]
   888 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "(Fig. 3 C)"

Phrase: "and"

Phrase: "independently by the sandwich ELISA (Fig. 3 D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0014441:ELISA [Laboratory Procedure]
   744   C0349966:Fig [Food]
   744   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.106: The level of A in the medium derived from B103 (APPsw/MOCA) cells was considerably decreased compared with B103 (APPsw) cells (Fig. 3, C and D). 

Phrase: "The level of A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "derived from B103"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "(APPsw/MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "considerably"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared with B103"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "(APPsw"

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.107: We could not detect the intracellular expression of A in any of the B103 (APP695) or B103 (APPsw) cell lines using the techniques employed to assay extracellular A. 

Phrase: "We"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the intracellular expression of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in any"

Phrase: "of the B103"

Phrase: "(APP695"

Phrase: ")"

Phrase: "or"

Phrase: "B103"

Phrase: "(APPsw"

Phrase: ")"

Phrase: "cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025664:techniques [Intellectual Product]
  1000   C0449851:Techniques [Functional Concept]

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "extracellular A."
Processing 00000000.tx.108: The above data show that MOCA decreases the secretion of both APP and A. 

Phrase: "The above data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the secretion of both APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1159339:Protein Secretion [Cell Function]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.109: View larger version (60K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(60K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.110: Effect of MOCA on A- secretion. 

Phrase: "Effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0681891:effect modifier [Functional Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on A- secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C1327439:antibody secretion [Cell Function]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
Processing 00000000.tx.111: (A) The levels of secreted and intracellular APPsw were examined in several B103 clones stably transfected with both APPsw and MOCA by Western blot analysis. 

Phrase: "(A"

Phrase: ")"

Phrase: "The levels of secreted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "intracellular APPsw"

Phrase: "were"

Phrase: "examined in several B103"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332128:Examined [Finding]

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "stably"

Phrase: "transfected with both APPsw"

Phrase: "and"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "by Western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]
Processing 00000000.tx.112: The optical density of APPsw secretion was quantitated by NIH image, normalized to the APPsw vector alone level, and the data are presented as the percentage change plus or minus the standard error or the mean (n = 3). 

Phrase: "The optical density of APPsw secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439164:Optical density [Quantitative Concept]
   790   C1268822:Optical density [Clinical Attribute]
   753   C0178587:density [Quantitative Concept]

Phrase: "was"

Phrase: "quantitated by NIH image,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027468:NIH [Health Care Related Organization]
   770   C1704254:Image [Intellectual Product]
   770   C1704922:Image [Entity]
   770   C3542466:Image [Intellectual Product]

Phrase: "normalized to the APPsw vector alone level,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205171:Alone [Quantitative Concept]
   748   C0439044:alone [Finding]
   748   C0441889:Level [Qualitative Concept]
   748   C0442335:Vector [Spatial Concept]
   748   C0456079:Level [Classification]
   748   C0679994:alone [Group Attribute]
   748   C1547707:Level [Geographic Area]
   748   C1705099:Vector [Idea or Concept]
   748   C1882115:Normalized [Research Activity]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as the percentage change"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0392747:Change [Functional Concept]
   760   C0439165:Percentage [Quantitative Concept]
   760   C0443172:change [Quantitative Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]
   760   C1705241:Change [Quantitative Concept]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "plus"

Phrase: "or"

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "the standard error"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:error [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1608199:Error [Functional Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "or"

Phrase: "the mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.113: (B) Intracellular APP was assayed by Western blotting with antibody 6E10 and quantitated as above. 

Phrase: "(B) Intracellular APP"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   897   C0377800:b protein [Amino Acid, Peptide, or Protein,Receptor]
   897   C1336694:b-PROTEIN [Gene or Genome]
   897   C1455498:B-Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "assayed by Western blotting"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   859   C0949466:Western blot assay [Laboratory Procedure]
       E   Western Blot
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   770   C1705493:Western [Spatial Concept]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]

Phrase: "with antibody 6E10"

Phrase: "and"

Phrase: "quantitated as above."
Processing 00000000.tx.114: (C) The [35S]methionine-labeled (16 h) secreted A peptides were immunoprecipitated with 6E10 antibody, separated in SDSpolyacrylamide gels, and visualized by exposure to X-films. 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "The [35S"

Phrase: "]methionine-labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1708632:Labeled [Qualitative Concept]
   827 E C0181496:Label [Manufactured Object]
   827 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(16 h) secreted A peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "immunoprecipitated with 6E10 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "separated in SDSpolyacrylamide gels,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0017243:Gels [Biomedical or Dental Material]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]
   737 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "visualized by exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0234621:Visualized [Functional Concept]
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]

Phrase: "to X-films."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086296:Films [Manufactured Object]
   827 E C1561571:film [Biomedical or Dental Material]
   827 E C1561572:film [Substance]
Processing 00000000.tx.115: The optical density of A secretion was quantitated by NIH image, and the data are presented as the percentage of change plus or minus the standard error or the mean (n = 3). 

Phrase: "The optical density of A secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0439164:Optical density [Quantitative Concept]
   778   C1268822:Optical density [Clinical Attribute]
   748   C0178587:density [Quantitative Concept]

Phrase: "was"

Phrase: "quantitated by NIH image,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027468:NIH [Health Care Related Organization]
   770   C1704254:Image [Intellectual Product]
   770   C1704922:Image [Entity]
   770   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as the percentage of change"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0392747:Change [Functional Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0443172:change [Quantitative Concept]
   753   C0449450:Presented [Idea or Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
   753   C1705241:Change [Quantitative Concept]
   719 E C0150312:Present [Quantitative Concept]

Phrase: "plus"

Phrase: "or"

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "the standard error"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1710181:Standard Error [Quantitative Concept]
   861   C0743559:error [Qualitative Concept]
   861   C1442989:Standard [Qualitative Concept]
   861   C1608199:Error [Functional Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "or"

Phrase: "the mean"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444504:Mean [Quantitative Concept]
  1000   C2347634:Mean [Quantitative Concept]
  1000   C2348143:Mean [Quantitative Concept]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.116: (D) The secreted A140 peptides were measured by using a sandwich ELISA kit (Biosource International). 

Phrase: "("

Phrase: "D)"

Phrase: "The secreted A140 peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "measured by"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C0444706:Measured [Qualitative Concept]
   833   C3541902:MEASURED [Diagnostic Procedure]
   799 E C0079809:Measure [Quantitative Concept]
   799 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a sandwich ELISA kit (Biosource"

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.117: Data from four separate experiments were combined and are presented as mean  SEM pgm of A per mg cellular protein (n = 16/condition).  

Phrase: "Data from four separate experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "are"

Phrase: "presented as mean  SEM pgm of A"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0444504:Mean [Quantitative Concept]
   744   C0449450:Presented [Idea or Concept]
   744   C1150365:PGM [Molecular Function]
   744   C2347634:Mean [Quantitative Concept]
   744   C2348143:Mean [Quantitative Concept]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   711 E C0150312:Present [Quantitative Concept]

Phrase: "per mg cellular protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(n = 16/condition"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   755 E C0009647:Conditioned [Mental Process]
   755 E C1701901:Conditional [Qualitative Concept]
   755 E C1963686:Conditional [Functional Concept]
   727 E C1519605:Conditionality [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.118: Reduced APP secretion is due to APP degradation The decreased secretion of APP caused by MOCA may be due to a blockage of the secretion pathway, which will cause an intracellular accumulation of APP, a decrease in its rate of synthesis, or an increase in the rate of APP degradation. 

Phrase: "Reduced APP secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1159339:Protein Secretion [Cell Function]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "is due to APP degradation"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   853   C1327161:amyloid precursor protein degradation [Molecular Function]
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0597297:Protein Degradation [Molecular Function]
   778   C0597304:Protein Degradation [Molecular Function]
   778   C0678226:Due to [Functional Concept]
           due
   778   C1623036:Protein Degradation [Molecular Function]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0243125:degradation [Functional Concept]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0699900:Degradation [Organism Function]
   748   C1709634:Precursor [Idea or Concept]
   748   C3146286:Due [Idea or Concept]

Phrase: "The decreased secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1159339:Protein Secretion [Cell Function]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]

Phrase: "caused by MOCA"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "may"

Phrase: "be due to a blockage of the secretion pathway,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0678226:Due to [Functional Concept]
           due
   764   C1159342:Secretion Pathway [Cell Function]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C1704259:Pathway [Molecular Function]
   742   C1705987:Pathway [Conceptual Entity]
   742   C1706968:Blockage [Finding]
   742   C1879887:Blockage [Phenomenon or Process]
   742   C2987476:Be [Conceptual Entity]
   742   C3146286:Due [Idea or Concept]

Phrase: "which"

Phrase: "will"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an intracellular accumulation of APP,"

Phrase: "a decrease in its rate of synthesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "or"

Phrase: "an increase in the rate of APP degradation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]
Processing 00000000.tx.119: To distinguish between these alternatives, we first examined the intracellular levels of APP. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "distinguish between these alternatives,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1523987:Alternative [Conceptual Entity]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the intracellular levels of APP."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.120: Full-length APP was reduced in B103 cells containing APP695/MOCA relative to APP695 cells as defined by two antibodies, 6E10 and 22C11 (Fig. 4, A and B). 

Phrase: "Full-length APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "reduced in B103 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0392756:Reduced [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "APP695/MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "relative to APP695 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "as"

Phrase: "defined by two antibodies,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0205448:Two [Quantitative Concept]
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "6E10"

Phrase: "and"

Phrase: "22C11"

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.121: In addition, the level of expression of the COOH-terminal fragment of APP was diminished in cells stably transfected with MOCA as determined by immunoprecipitation with the CT-15 antibody, which recognizes the last 15 COOH-terminal amino acid residues of APP695 (Fig. 4 C). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the level of expression of the COOH-terminal fragment of APP"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   749   C0428479:Protein level [Laboratory or Test Result]
   749   C3244092:expression level [Idea or Concept]
   735   C0441889:Level [Qualitative Concept]
   735   C0456079:Level [Classification]
   735   C1547707:Level [Geographic Area]
   735   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "diminished in cells stably"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0205216:Diminished [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "transfected with MOCA"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "as"

Phrase: "determined by immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with the CT-15 antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which"

Phrase: "recognizes"

Phrase: "the last 15 COOH-terminal amino acid residues of APP695"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(Fig. 4 C)."
Processing 00000000.tx.122: These data rule out the possibility that MOCA expression is enhancing the intracellular accumulation of APP and suggest that the decreased APP secretion caused by MOCA expression is not due to a direct blockage of the secretion pathways. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that MOCA expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205349:Modifier [Qualitative Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "is"

Phrase: "enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "the intracellular accumulation of APP"

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the decreased APP secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1159339:Protein Secretion [Cell Function]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "caused by MOCA expression"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0007577:Cell Adhesion [Cell Function]
   770   C1171362:protein expression [Genetic Function]
   744   C0001511:Adhesion [Pathologic Function]
   744   C0007634:Cell [Cell]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0175633:Adhesion [Natural Phenomenon or Process]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205349:Modifier [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1514623:Modifier [Conceptual Entity]
   744   C1516451:Modifier [Chemical Viewed Functionally]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C3542952:Modifier [Intellectual Product]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]

Phrase: "is"

Phrase: "not due to a direct blockage of the secretion pathways."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0678226:Due to [Functional Concept]
           due
   760   C1159342:Secretion Pathways [Cell Function]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C0439851:Direct [Qualitative Concept]
   739   C1518422:Not [Functional Concept]
   739   C1704259:Pathways [Molecular Function]
   739   C1705987:Pathways [Conceptual Entity]
   739   C1706968:Blockage [Finding]
   739   C1879887:Blockage [Phenomenon or Process]
   739   C1947931:Direct [Qualitative Concept]
   739   C3146286:Due [Idea or Concept]
Processing 00000000.tx.123: View larger version (32K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(32K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.124: APP is not accumulated intracellularly in cells expressing MOCA. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accumulated"

Phrase: "intracellularly in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.125: The intracellular levels of APP were detected in whole cell lysates by antibodies 6E10 (A) and 22C11 (B). 

Phrase: "The intracellular levels of APP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "detected in whole cell lysates"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1881488:Cell Lysate [Physical Object]
           Lysate
   760   C0007634:Cell [Cell]
   760   C0442726:Detected [Finding]
   760   C0444667:Whole [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "by antibodies 6E10 (A)"

Phrase: "and"

Phrase: "22C11"

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.126: (C) The cell lysates from the corresponding cells were immunoprecipitated with the antibody CT-15 and visualized by Western blot analysis. 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "The cell lysates from the corresponding cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "immunoprecipitated with the antibody CT-15"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C3540513:CT [Gene or Genome]
   719   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "visualized by Western blot analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0234621:Visualized [Functional Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.127: (D) Actin controls for protein loading.  

Phrase: "("

Phrase: "D)"

Phrase: "Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "controls for protein loading."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1708715:Loading [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.128: Because there is no increased intracellular accumulation of APP in cells expressing MOCA, we investigated the effect of MOCA on the turnover of APP by pulsechase experiments. 

Phrase: "Because"

Phrase: "there"

Phrase: "is"

Phrase: "no increased intracellular accumulation of APP"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on the turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031227:turnover [Quantitative Concept]
  1000   C0243127:turnover [Functional Concept]
  1000   C0443331:Turnover [Health Care Activity]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "by pulsechase experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.129: Antibodies 6E10 and CT-15 specifically immunoprecipitate the intracellular APP holoprotein, whereas antibodies GID and 22C11 performed less well (Fig. 5 A). 

Phrase: "Antibodies 6E10"

Phrase: "and"

Phrase: "CT-15 specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3540513:CT [Gene or Genome]

Phrase: "immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "the intracellular APP holoprotein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "whereas"

Phrase: "antibodies GID"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009225:Gid [Disease or Syndrome]

Phrase: "and"

Phrase: "22C11"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "less well"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "(Fig. 5 A"

Phrase: ")."
Processing 00000000.tx.130: 6E10 was used in the following experiments. 

Phrase: "6E10"

Phrase: "was"

Phrase: "used in the following experiments."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0681814:Experiments [Research Activity]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726   C0332283:follow [Temporal Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726   C1719822:Follow [Intellectual Product]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.131: B103 cells expressing either APP695/vector or APP695/MOCA were labeled for 10 min in [35S]methionine-containing media and chased for 15, 30, 45, and 60 min in "cold," serum-free conditioned media. 

Phrase: "B103 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "either APP695/vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0442335:Vector [Spatial Concept]
   827   C1705099:Vector [Idea or Concept]

Phrase: "or"

Phrase: "APP695/MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "were"

Phrase: "labeled for 10 min in [35S"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0456692:/10 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "]methionine-containing media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0009458:Media [Intellectual Product]
   827   C0162867:Media [Tissue]
   827   C1254021:Media [Tissue]
   793 E C0439536:Medium [Quantitative Concept]
   793 E C1705217:Medium [Substance]
   793 E C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "chased for 15,"

Phrase: "30,"

Phrase: "45,"

Phrase: "and"

Phrase: "60 min in ""cold,"" serum-free conditioned media."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   842   C0085414:Serum-Free Media [Indicator, Reagent, or Diagnostic Aid]
   834   C0456913:Cold medium [Finding]
   812   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   793   C0009458:Media [Intellectual Product]
   793   C0162867:Media [Tissue]
   793   C1254021:Media [Tissue]
   760 E C0439536:Medium [Quantitative Concept]
   760 E C1705217:Medium [Substance]
   760 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.132: In control B103 (APP695/vector) cells, the APP protein level decreased gradually (Fig. 5 B). 

Phrase: "In control B103"

Phrase: "(APP695/vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "the APP protein level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   853   C0428479:Protein level [Laboratory or Test Result]
   804   C0441889:Level [Qualitative Concept]
   804   C0456079:Level [Classification]
   804   C1547707:Level [Geographic Area]
   804   C2946261:Level [Pharmacologic Substance]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "gradually"

Phrase: "(Fig. 5 B"

Phrase: ")."
Processing 00000000.tx.133: In contrast, the intracellular APP protein level in B103 (APP695/MOCA) cells rapidly decreased. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the intracellular APP protein level in B103"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C0428479:Protein level [Laboratory or Test Result]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "(APP695/MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: ")"

Phrase: "cells rapidly"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "decreased."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.134: The initial levels after the 10-min labeling period were also lower than controls in cells expressing MOCA, a result which would be predicted for nascent proteins can be very rapidly degraded after synthesis (Schubert et al., 2000). 

Phrase: "The initial levels after the 10-min labeling period"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0441889:Levels [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "controls in cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0007634:Cells [Cell]
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "which"

Phrase: "would"

Phrase: "be"

Phrase: "predicted for nascent proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0681842:Predicted [Idea or Concept]
   770   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "very rapidly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442824:Very [Qualitative Concept]
   861   C1637379:Rapidly [Qualitative Concept]

Phrase: "degraded after synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0220781:synthesis [Biologic Function]
   790   C1881707:DEGRADED [Phenomenon or Process]
   790   C1883254:Synthesis [Activity]

Phrase: "(Schubert et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.135: There was a temporal increase in the amount of APP protein in the medium of both cell types (Fig. 5 B), but the overall level of APP accumulation in the medium is decreased by the expression of MOCA (Figs. 13). 

Phrase: "There"

Phrase: "was"

Phrase: "a temporal increase in the amount of APP protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0442805:Increase [Functional Concept]

Phrase: "in the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "of both cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "(Fig. 5 B"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "the overall level of APP accumulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0428479:Protein level [Laboratory or Test Result]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "is"

Phrase: "decreased by the expression of MOCA"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   782   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0007577:Cell Adhesion [Cell Function]
   757   C1171362:expression protein [Genetic Function]
   739   C0001511:Adhesion [Pathologic Function]
   739   C0007634:Cell [Cell]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0175633:Adhesion [Natural Phenomenon or Process]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
   739   C0205216:Decreased [Quantitative Concept]
   739   C0205349:Modifier [Qualitative Concept]
   739   C0392756:Decreased [Qualitative Concept]
   739   C0442797:decreased [Qualitative Concept]
   739   C1269647:Cell [Cell]
   739   C1514623:Modifier [Conceptual Entity]
   739   C1516451:Modifier [Chemical Viewed Functionally]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   739   C3542952:Modifier [Intellectual Product]
   706 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Figs. 13"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.136: Therefore, it is likely that MOCA facilitates the degradation of APP. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "facilitates"

Phrase: "the degradation of APP."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   864   C1327161:amyloid precursor protein degradation [Molecular Function]
   783   C0597297:Protein Degradation [Molecular Function]
   783   C0597304:Protein Degradation [Molecular Function]
   783   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.137: Finally, the data in the following paragraphs rule out the remaining alternative that MOCA expression down-regulates APP synthesis, since in the presence of proteasome inhibitors the levels of extracellular APP are similar in cells expressing MOCA and controls. 

Phrase: "Finally,"

Phrase: "the data in the following paragraphs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the remaining alternative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1523987:Alternative [Conceptual Entity]

Phrase: "that MOCA expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205349:Modifier [Qualitative Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "down-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "APP synthesis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1327111:amyloid precursor protein synthesis [Molecular Function]
   861   C0597295:Protein Synthesis [Molecular Function]
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "since in the presence of proteasome inhibitors"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   778   C2266856:Proteasome Inhibitors [Molecular Function]
   748   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1325620:proteasome [Cell Component]
   748   C1711239:Since [Temporal Concept]
   748   C1752727:Proteasome [Molecular Function]
   745 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "the levels of extracellular APP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "similar in cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.138: View larger version (39K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.139: MOCA alters the rate of intracellular APP protein degradation. 

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the rate of intracellular APP protein degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.140: (A) Antibody specificity was tested by immunoprecipitation of [35S]methionine-labeled protein using various antibodies including 6E10 (lane 1), 22C11 (lane 2), GID (lane 3), and CT-15 (lane 4). 

Phrase: "(A"

Phrase: ")"

Phrase: "Antibody specificity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0003264:Antibody Specificity [Molecular Function]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "tested by immunoprecipitation of [35S"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "]methionine-labeled protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "various antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "6E10"

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "22C11"

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "GID (lane 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0009225:Gid [Disease or Syndrome]
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "CT-15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "(lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.141: Both the APP695 holoprotein in transfected B103 cells bearing the APP695 gene and the endogenous APP751 protein in HEK293 cells were immunoprecipitated by 6E10 and CT-15. 

Phrase: "Both"

Phrase: "the APP695 holoprotein in transfected B103 cells"

Phrase: "bearing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704689:Bearing [Medical Device]
   966 E C0004897:Bear [Mammal]

Phrase: "the APP695 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "the endogenous APP751 protein in HEK293 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "immunoprecipitated by 6E10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "and"

Phrase: "CT-15."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]
Processing 00000000.tx.142: (B) The turnover rate for intracellular APP holoprotein in APP695/vector and APP695/MOCA (clone 8) cells was determined. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The turnover rate for intracellular APP holoprotein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: "in APP695/vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "and"

Phrase: "APP695/MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "(clone 8"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.143: The cells were labeled for 10 min with [35S]methionine and chased for the indicated time periods with cold medium. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled for 10 min"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "chased for the indicated time periods"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0439582:Time periods [Temporal Concept]
   762 E C0585019:Temporal periods [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C1444656:Indicated [Finding]
   753   C3541383:Time [Temporal Concept]
   719   C0439531:/period [Temporal Concept]
   719   C1948053:Period [Temporal Concept]

Phrase: "with cold medium."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0456913:Cold medium [Finding]
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.144: The cell lysates were collected and immunoprecipitated with antibody 6E10 (arrow is APP). 

Phrase: "The cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "immunoprecipitated with antibody 6E10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "is"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.145: The level of APP secretion was also determined at the same time. 

Phrase: "The level of APP secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "also"

Phrase: "determined at the same time."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0040223:Time [Temporal Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.146: The optical density of APP expression was quantitated by NIH image, and the data are presented as the percentage change after normalization to the initial levels of APP (intracellular) or to the highest levels of APPs (n = 3). 

Phrase: "The optical density of APP expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439164:Optical density [Quantitative Concept]
   770   C1268822:Optical density [Clinical Attribute]
   744   C0178587:density [Quantitative Concept]

Phrase: "was"

Phrase: "quantitated by NIH image,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027468:NIH [Health Care Related Organization]
   770   C1704254:Image [Intellectual Product]
   770   C1704922:Image [Entity]
   770   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as the percentage change"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   760   C0392747:Change [Functional Concept]
   760   C0439165:Percentage [Quantitative Concept]
   760   C0443172:change [Quantitative Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]
   760   C1705241:Change [Quantitative Concept]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "after normalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalization [Research Activity]

Phrase: "to the initial levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(intracellular"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175996:intracellular [Cell Component]
  1000   C0178719:Intracellular [Spatial Concept]

Phrase: ")"

Phrase: "or to the highest levels of APPs"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   748   C0441889:Levels [Qualitative Concept]
   748   C1522410:Highest [Qualitative Concept]
   714 E C0205250:High [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1299351:High [Qualitative Concept]
   714 E C1547707:Level [Geographic Area]
   714 E C2700149:HIGH [Intellectual Product]
   714 E C2946261:Level [Pharmacologic Substance]
   714   C3538722:APP [Laboratory Procedure]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.147: (C) The effects of the protease inhibitor MG132 on the secretion of APP. 

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "The effects of the protease inhibitor MG132"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on the secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "of APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.148: Cells were incubated in the presence and absence of MG132 (10 M) for the indicated time periods. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in the presence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "absence of MG132"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(10"

Phrase: "M) for the indicated time periods."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0439582:Time periods [Temporal Concept]
   762 E C0585019:Temporal periods [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1444656:Indicated [Finding]
   753   C3541383:Time [Temporal Concept]
   719   C0439531:/period [Temporal Concept]
   719   C1948053:Period [Temporal Concept]
Processing 00000000.tx.149: The identical amount of protein collected from the serum-free condition medium was subjected to SDS-PAGE analysis, and the APP levels were determined by Western blot analysis. 

Phrase: "The identical amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "collected from the serum-free condition medium"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   748   C0009458:Medium [Intellectual Product]
   748   C0012634:condition [Disease or Syndrome]
   748   C0229671:Serum [Body Substance]
   748   C0332296:free [Functional Concept]
   748   C0348080:Condition [Qualitative Concept]
   748   C0439536:Medium [Quantitative Concept]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
   748   C1546774:Serum [Intellectual Product]
   748   C1550100:Serum [Body Substance]
   748   C1705217:Medium [Substance]
   748   C1705253:Condition [Conceptual Entity]
   748   C1880497:Free [Qualitative Concept]
   748   C1996904:Free [Qualitative Concept]
   748   C3244283:medium [Intellectual Product]
   743   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "subjected to SDS-PAGE analysis,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1704732:Page [Intellectual Product]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "the APP levels"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0428479:Protein level [Laboratory or Test Result]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "were"

Phrase: "determined by Western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
Processing 00000000.tx.150: The secretion of APP was increased in APP695/MOCA (clone 8) cells treated by MG132 as a function of time. 

Phrase: "The secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "increased in APP695/MOCA"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   800   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0007577:Cell Adhesion [Cell Function]
   744   C0001511:Adhesion [Pathologic Function]
   744   C0007634:Cell [Cell]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0175633:Adhesion [Natural Phenomenon or Process]
   744   C0205217:Increased [Quantitative Concept]
   744   C0205349:Modifier [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1269647:Cell [Cell]
   744   C1514623:Modifier [Conceptual Entity]
   744   C1516451:Modifier [Chemical Viewed Functionally]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C3542952:Modifier [Intellectual Product]

Phrase: "(clone 8"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated by MG132"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0332293:treated [Therapeutic or Preventive Procedure]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "as a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of time."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.151: The optical density of APP secretion was quantitated from lower exposure images by NIH image, and the data are presented as the percentage increase in APP, plus or minus the standard error of the mean (n = 3).  

Phrase: "The optical density of APP secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439164:Optical density [Quantitative Concept]
   770   C1268822:Optical density [Clinical Attribute]
   744   C0178587:density [Quantitative Concept]

Phrase: "was"

Phrase: "quantitated from lower exposure images"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0274281:Exposure, NOS [Injury or Poisoning]
   760   C0332157:Exposure [Clinical Attribute]
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "by NIH image,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as the percentage increase"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0439165:Percentage [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0449450:Presented [Idea or Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]
   726 E C0150312:Present [Quantitative Concept]

Phrase: "in APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "plus"

Phrase: "or"

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "the standard error of the mean"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   895   C1710181:Standard Error of the Mean [Quantitative Concept]
           Standard Error
   753   C0743559:error [Qualitative Concept]
   753   C1442989:Standard [Qualitative Concept]
   753   C1608199:Error [Functional Concept]
   753   C2828392:Standard [Intellectual Product]

Phrase: "(n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.152: Proteasomes mediate APP degradation To independently verify the data on APP degradation, we studied the effect of protease inhibitors on the secretion and the intracellular accumulation of APP. 

Phrase: "Proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1325620:proteasome [Cell Component]
   966 E C1752727:Proteasome [Molecular Function]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "APP degradation To independently"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   882   C1327161:amyloid precursor protein degradation [Molecular Function]
   790   C0597297:Protein Degradation [Molecular Function]
   790   C0597304:Protein Degradation [Molecular Function]
   790   C1623036:Protein Degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "the data on APP degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effect of protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "the intracellular accumulation of APP."
Processing 00000000.tx.153: Leupeptin inhibits lysosomal proteases, whereas MG132 inhibits membrane protein degradation through the ubiquitin-proteasome pathway (Soriano et al., 1999). 

Phrase: "Leupeptin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "lysosomal proteases,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "whereas"

Phrase: "MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "membrane protein degradation through the ubiquitin-proteasome pathway"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0597297:Protein Degradation [Molecular Function]
   770   C0597304:Protein Degradation [Molecular Function]
   770   C1623036:Protein Degradation [Molecular Function]
   767   C1156182:membrane degradation [Cell Function]
   767   C1511758:Degradation Pathway [Conceptual Entity]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: "(Soriano et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.154: Both APP secretion and the intracellular accumulation of APP were significantly increased in the APP695/MOCA cells by 10 M MG132; 

Phrase: "Both APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "the intracellular accumulation of APP"

Phrase: "were"

Phrase: "significantly"

Phrase: "increased in the APP695/MOCA cells"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   782   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1154382:cell-cell adhesion [Cell Function]
   760   C0007577:Cell Adhesion [Cell Function]
   739   C0001511:Adhesion [Pathologic Function]
   739   C0007634:Cell [Cell]
           Cells
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0175633:Adhesion [Natural Phenomenon or Process]
   739   C0205217:Increased [Quantitative Concept]
   739   C0205349:Modifier [Qualitative Concept]
   739   C0442805:Increased [Functional Concept]
   739   C1269647:Cell [Cell]
   739   C1514623:Modifier [Conceptual Entity]
   739   C1516451:Modifier [Chemical Viewed Functionally]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   739   C3282337:Cells [Cell]
   739   C3542952:Modifier [Intellectual Product]

Phrase: "by 10 M MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.155: no effect was observed in cells treated with 100 M leupeptin (unpublished data). 

Phrase: "no effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 100 M leupeptin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.156: More strikingly, the secretion of APP in cells expressing MOCA was enhanced in concert with the increasing duration of MG132 treatment and was nearly restored to control levels after 16 h (Fig. 5 C). 

Phrase: "More strikingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "the secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "was"

Phrase: "enhanced in concert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2349975:Enhanced [Activity]

Phrase: "with the increasing duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449238:Duration [Temporal Concept]
   861   C2926735:Duration [Pharmacologic Substance]

Phrase: "of MG132 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "was"

Phrase: "nearly"

Phrase: "restored"

Phrase: "to control levels after 16 h (Fig. 5 C)."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   745   C0456951:Level 5 [Qualitative Concept]
   742   C0243148:control [Qualitative Concept]
   742   C0441889:Levels [Qualitative Concept]
   742   C1550141:Control [Substance]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.157: These data again show that the APP degradation is affected by MOCA. 

Phrase: "These data again"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the APP degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "affected by MOCA."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0392760:Affected [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1314939:Affected [Functional Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714 E C0001721:Affect [Mental Process]
Processing 00000000.tx.158: They also confirm the Northern and RT-PCR data, showing no effect of MOCA on APP transcription, and rule out the possibility that the expression of MOCA reduces APP synthesis. 

Phrase: "They also"

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the Northern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709269:Northern [Spatial Concept]

Phrase: "and"

Phrase: "RT-PCR data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1511726:Data [Idea or Concept]
   812   C3245479:data [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no effect of MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1301751:No effect [Qualitative Concept]
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on APP transcription,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0040649:Transcription [Genetic Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the expression of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "reduces"

Phrase: "APP synthesis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1327111:amyloid precursor protein synthesis [Molecular Function]
   861   C0597295:Protein Synthesis [Molecular Function]
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.159: To confirm the above data on protein degradation and identify the mechanism which might be involved in the MOCA regulation of APP degradation, the effects of additional protease inhibitors were tested. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the above data on protein degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "identify"

Phrase: "the mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "which"

Phrase: "might"

Phrase: "be"

Phrase: "involved in the MOCA regulation"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   810   C1154398:regulation of cell adhesion [Cell Function]
   790   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0007577:Cell Adhesion [Cell Function]
   742   C0001511:Adhesion [Pathologic Function]
   742   C0007634:Cell [Cell]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0175633:Adhesion [Natural Phenomenon or Process]
   742   C0205349:Modifier [Qualitative Concept]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1269647:Cell [Cell]
   742   C1314939:Involved [Functional Concept]
   742   C1327622:Regulation [Biologic Function]
   742   C1514623:Modifier [Conceptual Entity]
   742   C1516451:Modifier [Chemical Viewed Functionally]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C3542952:Modifier [Intellectual Product]

Phrase: "of APP degradation,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "the effects of additional protease inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.160: Cells were treated with chloroquine (50 M), NH4Cl (5 mM), phosphoramidon (2 M), N-acetyl-leucyl-norleucinal (ALLN) (27 M), N-Ac-Leu-Leu-methioninal (ALLM) (27 M), lactacystin (20 M), clasto-lactacystin -lactone (20 M), or epoxomicin (10 M) for 4 and 16 h, and the secretion and the intracellular levels of APP were measured by Western blotting. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with chloroquine"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]

Phrase: "(50"

Phrase: "M)"

Phrase: ","

Phrase: "NH4Cl (5 mM"

Phrase: ")"

Phrase: ","

Phrase: "phosphoramidon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "M)"

Phrase: ","

Phrase: "N-acetyl-leucyl-norleucinal (ALLN)"

Phrase: "(27"

Phrase: "M)"

Phrase: ","

Phrase: "N-Ac-Leu-Leu-methioninal (ALLM)"

Phrase: "(27"

Phrase: "M)"

Phrase: ","

Phrase: "lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "(20"

Phrase: "M)"

Phrase: ","

Phrase: "clasto-lactacystin -lactone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022947:Lactone [Organic Chemical]

Phrase: "(20"

Phrase: "M)"

Phrase: ","

Phrase: "or"

Phrase: "epoxomicin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(10"

Phrase: "M) for 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "16 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "the secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "the intracellular levels of APP"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured by Western blotting."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C1705493:Western [Spatial Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.161: Lactacystin, -lactone, and epoxomicin, which specifically target the proteasome and do not inhibit lysosomal protein degradation (Craiu et al., 1997; Fenteany and Schreiber, 1998; Meng et al., 1999), effectively restored the level of APP secretion in MOCA-containing cells (Fig. 6 A). 

Phrase: "Lactacystin, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "lactone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022947:Lactone [Organic Chemical]

Phrase: "and"

Phrase: "epoxomicin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "which specifically"

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "lysosomal protein degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0597297:Protein Degradation [Molecular Function]
   901   C0597304:Protein Degradation [Molecular Function]
   901   C1623036:Protein Degradation [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "(Craiu et al.,"

Phrase: "1997"

Phrase: "; Fenteany"

Phrase: "and"

Phrase: "Schreiber,"

Phrase: "1998"

Phrase: "; Meng et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: ","

Phrase: "effectively"

Phrase: "restored"

Phrase: "the level of APP secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "in MOCA-containing cells"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   835   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007577:Cell Adhesion [Cell Function]
   793   C0001511:Adhesion [Pathologic Function]
   793   C0007634:Cell [Cell]
           Cells
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0150312:In [Quantitative Concept]
   793   C0175633:Adhesion [Natural Phenomenon or Process]
   793   C0205349:Modifier [Qualitative Concept]
   793   C0332256:Containing [Functional Concept]
   793   C0332285:In [Spatial Concept]
   793   C1269647:Cell [Cell]
   793   C1514623:Modifier [Conceptual Entity]
   793   C1516451:Modifier [Chemical Viewed Functionally]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]
   793   C2700400:Containing [Activity]
   793   C3282337:Cells [Cell]
   793   C3542952:Modifier [Intellectual Product]

Phrase: "(Fig. 6 A"

Phrase: ")."
Processing 00000000.tx.162: Similar effects were also observed in cells treated with the peptide aldehydes, ALLN and ALLM, which inhibit proteasomes but also inhibit lysosomal cysteine proteases and calpains (Sherwood et al., 1993; Zhang et al., 1999). 

Phrase: "Similar effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "observed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1441672:Observed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "treated with the peptide aldehydes,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0001992:Aldehydes [Organic Chemical]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "ALLN"

Phrase: "and"

Phrase: "ALLM,"

Phrase: "which"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1325620:proteasome [Cell Component]
   966 E C1752727:Proteasome [Molecular Function]

Phrase: "but"

Phrase: "also"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "lysosomal cysteine proteases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C2717970:Cysteine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   884 E C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   884 E C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Proteases [Enzyme]

Phrase: "and"

Phrase: "calpains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0006784:Calpain [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Sherwood et al.,"

Phrase: "1993"

Phrase: "; Zhang et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.163: In contrast, two lysosomal protease inhibitors, chloroquine and ammonium chloride (Caporaso et al., 1992), did not reverse the MOCA effects on APP secretion. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "two lysosomal protease inhibitors,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   827 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   812   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   812   C1947941:Protease [Enzyme]
   779 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "chloroquine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   944 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "ammonium chloride"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002615:Ammonium Chloride [Inorganic Chemical,Pharmacologic Substance]
   861   C0002611:Ammonium [Inorganic Chemical]
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "(Caporaso et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "the MOCA effects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0681891:effect modifier [Functional Concept]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "on APP secretion."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.164: As another negative control, phosphoramidon, a metalloprotease inhibitor, did not affect APP secretion, consistent with the previous reports (Parvathy et al., 1998). 

Phrase: "As another negative control,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1639518:% negative control [Quantitative Concept]
  1000   C1947986:Negative Control [Conceptual Entity]
   861   C0205160:Negative [Qualitative Concept]
   861   C0243148:control [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "a metalloprotease inhibitor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1152589:metalloprotease inhibitor [Molecular Function]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "APP secretion,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "consistent with the previous reports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Parvathy et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.165: The effects of these inhibitors on the intracellular levels of APP were also tested and were comparable to the corresponding effects on APP secretion (Fig. 6 B). 

Phrase: "The effects of these inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the intracellular levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "also"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "were"

Phrase: "comparable to the corresponding effects"

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Fig. 6 B"

Phrase: ")."
Processing 00000000.tx.166: These data were confirmed by a kinetic pulsechase analysis. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "confirmed by a kinetic pulsechase analysis."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0022702:kinetic [Natural Phenomenon or Process]
   753   C0750484:Confirmed [Idea or Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   719 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.167: Cells with and without MOCA were labeled for 10 min with [35S]methionine and chased in complete medium in the presence of 10 M MG132. 

Phrase: "Cells with"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C0007634:Cells [Cell]
   833   C3282337:Cells [Cell]
   799 E C1269647:Cell [Cell]
   799 E C1704653:Cell [Medical Device]
   799 E C1948049:Cell [Spatial Concept]

Phrase: "and without MOCA"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1515981:And [Idea or Concept]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "were"

Phrase: "labeled for 10 min"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "chased in complete medium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0009458:Medium [Intellectual Product]
   770   C0205197:Complete [Qualitative Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0725685:COMPLEAT [Food]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 10 M MG132."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.168: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.169: 7 A shows that nascent APP molecules are stabilized by proteasome inhibition and that the rate of loss of intracellular APP in cells expressing MOCA becomes similar to that of MOCA-deficient cells. 

Phrase: "7 A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that nascent APP molecules"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0567416:molecules [Substance]
   721 E C1521991:Molecular [Qualitative Concept]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "are"

Phrase: "stabilized by proteasome inhibition"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0184512:Stabilized [Qualitative Concept]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C1752727:Proteasome [Molecular Function]
   770   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "that"

Phrase: "the rate of loss of intracellular APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0871208:Rate [Activity]
   742   C1521828:Rate [Quantitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "becomes"

Phrase: "similar to that of MOCA-deficient cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.170: These data strongly support the involvement of proteasomes in the regulation of APP degradation by MOCA. 

Phrase: "These data strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the involvement of proteasomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of APP degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "by MOCA."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   861   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007577:Cell Adhesion [Cell Function]
   799   C0001511:Adhesion [Pathologic Function]
   799   C0006539:BY [Geographic Area]
   799   C0007634:Cell [Cell]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0175633:Adhesion [Natural Phenomenon or Process]
   799   C0205349:Modifier [Qualitative Concept]
   799   C1269647:Cell [Cell]
   799   C1514623:Modifier [Conceptual Entity]
   799   C1516451:Modifier [Chemical Viewed Functionally]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.171: View larger version (50K): [in this window] [in a new window]  Figure 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(50K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.172: Effects of different protease inhibitors on the secretion of APP. 

Phrase: "Effects of different protease inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "of APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.173: (A) Equal numbers of cells were incubated in the presence of various protease inhibitors including chloroquine (Chl) (50 M, lane 2), NH4Cl (5 mM, lane 3), phosphoramidon (PAD) (2 M, lane 4), ALLN (27 M, lane 5), ALLM (27 M, lane 6), lactacystin (Lact) (20 M, lane 7), clasto-lactacystin -lactone (Lactone) (20 M, lane 8), epoxomicin (Epo) (10 M, lane 9), and MG132 (10 M, lane 10) for 4 and 16 h. 

Phrase: "(A"

Phrase: ")"

Phrase: "Equal numbers of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007584:Cell Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "incubated in the presence of various protease inhibitors"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   744   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   744   C1439852:Incubated [Laboratory Procedure]
   744   C1947941:Protease [Enzyme]
   737 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   711 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "chloroquine (Chl)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   944 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]

Phrase: "(50 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "NH4Cl (5 mM,"

Phrase: "lane 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "phosphoramidon (PAD)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(2 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "lane 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "ALLN"

Phrase: "(27 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "lane 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "ALLM"

Phrase: "(27 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "lane 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "(Lact"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: ")"

Phrase: "(20 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "clasto-lactacystin -lactone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022947:Lactone [Organic Chemical]

Phrase: "(Lactone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022947:Lactone [Organic Chemical]

Phrase: ")"

Phrase: "(20 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "lane 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "epoxomicin (Epo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(10 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "lane 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(10 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "lane 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "for 4"

Phrase: "and"

Phrase: "16 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.174: The secretion of APP was increased in APP695/MOCA (clone 8) cells treated by ALLN, ALLM, lactacystin, clasto-lactacystin -lactone, or epoxomicin. 

Phrase: "The secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "was"

Phrase: "increased in APP695/MOCA"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   800   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0007577:Cell Adhesion [Cell Function]
   744   C0001511:Adhesion [Pathologic Function]
   744   C0007634:Cell [Cell]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0175633:Adhesion [Natural Phenomenon or Process]
   744   C0205217:Increased [Quantitative Concept]
   744   C0205349:Modifier [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1269647:Cell [Cell]
   744   C1514623:Modifier [Conceptual Entity]
   744   C1516451:Modifier [Chemical Viewed Functionally]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C3542952:Modifier [Intellectual Product]

Phrase: "(clone 8"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated by ALLN,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "ALLM,"

Phrase: "lactacystin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "clasto-lactacystin -lactone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022947:Lactone [Organic Chemical]

Phrase: "or"

Phrase: "epoxomicin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.175: In contrast, the effect of MOCA on APP secretion was not reversed in cells treated with chloroquine, NH4Cl, or phosphoramidon. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reversed in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756   C1555029:Reverse [Idea or Concept]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "treated with chloroquine,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]

Phrase: "NH4Cl,"

Phrase: "or"

Phrase: "phosphoramidon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.176: (B) Effects of different protease inhibitors on the intracellular levels of APP were assayed as well, and the experiments were performed as described in A except that the cell lysates were used. 

Phrase: "(B) Effects of different protease inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on the intracellular levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "were"

Phrase: "assayed as well,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205170:Well [Qualitative Concept]
   790   C3146287:Well [Manufactured Object]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in A"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C1552738:described [Idea or Concept]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332300:except [Functional Concept]

Phrase: "that"

Phrase: "the cell lysates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.177: Actin was used as loading control (unpublished data).  

Phrase: "Actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "was"

Phrase: "used as loading control"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C1273517:used [Finding]
   770   C1550141:Control [Substance]
   770   C1708715:Loading [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(unpublished data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: ")."
Processing 00000000.tx.178: View larger version (25K): [in this window] [in a new window]  Figure 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 7."
Processing 00000000.tx.179: Proteasome inhibitors block the degradation of nascent APP. 

Phrase: "Proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "the degradation of nascent APP."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C1327161:amyloid precursor protein degradation [Molecular Function]
   774   C0597297:Protein Degradation [Molecular Function]
   774   C0597304:Protein Degradation [Molecular Function]
   774   C1623036:Protein Degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
Processing 00000000.tx.180: (A) Pulsechase analysis of intracellular APP in cells expressing MOCA or no MOCA in the presence of MG132 (10 M). 

Phrase: "(A"

Phrase: ")"

Phrase: "Pulsechase analysis of intracellular APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1514534:Protein Analysis [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "or"

Phrase: "no MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(10"

Phrase: "M)."
Processing 00000000.tx.181: Cells were labeled for 10 min with [35S]methionine and then chased with normal medium. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled for 10 min"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "with"

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "chased with normal medium."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C2347086:% Normal [Quantitative Concept]
   770   C3244283:medium [Intellectual Product]
Processing 00000000.tx.182: The rate of intracellular decline was determined relative to the initial level of APP in each cell type. 

Phrase: "The rate of intracellular decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "relative to the initial level of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0080103:Relative [Family Group]
   742   C0205345:Relative [Qualitative Concept]
   742   C1547039:*Relative [Quantitative Concept]

Phrase: "in each cell type."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007634:Cell Type [Cell]
           Cell
  1000   C0449475:cell type [Intellectual Product]
   861   C0332307:Type [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1547052:*Type [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.183: The data are the mean of triplicate determinations plus or minus the standard error of the mean. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "the mean of triplicate determinations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444504:Mean [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]

Phrase: "plus"

Phrase: "or"

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "the standard error of the mean."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   895   C1710181:Standard Error of the Mean [Quantitative Concept]
           Standard Error
   753   C0743559:error [Qualitative Concept]
   753   C1442989:Standard [Qualitative Concept]
   753   C1608199:Error [Functional Concept]
   753   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.184: (B) Western blotting of MOCA in the presence of MG132 (10 M) at indicated times. 

Phrase: "(B) Western blotting of MOCA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   764   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
           protein blotting
   748 E C0949466:Western Blot [Laboratory Procedure]
   742   C1705493:Western [Spatial Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(10"

Phrase: "M) at indicated times."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0040223:times [Temporal Concept]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1444656:Indicated [Finding]
   770   C1632851:Times [Quantitative Concept]
   737 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.185: (C) Confocal images of cells show an increase in MOCA accumulation in B103 (APP695/MOCA) cells. 

Phrase: "(C) Confocal images of cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C3542466:Image [Intellectual Product]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "an increase in MOCA accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "in B103"

Phrase: "(APP695/MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: ")"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.186: The expression of MOCA was analyzed with a MOCA antibody and visualized by staining with Texas redconjugated secondary antibodies. 

Phrase: "The expression of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "analyzed with a MOCA antibody"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   790   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0007577:Cell Adhesion [Cell Function]
   764   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   742   C0001511:Adhesion [Pathologic Function]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0007634:Cell [Cell]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0175633:Adhesion [Natural Phenomenon or Process]
   742   C0205349:Modifier [Qualitative Concept]
   742   C0936012:Analyzed [Research Activity]
   742   C1269647:Cell [Cell]
   742   C1514623:Modifier [Conceptual Entity]
   742   C1516451:Modifier [Chemical Viewed Functionally]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C3542952:Modifier [Intellectual Product]

Phrase: "and"

Phrase: "visualized by staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0234621:Visualized [Functional Concept]
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]

Phrase: "with Texas redconjugated secondary antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.187: Control, secondary Texas Redconjugated antibody stain only (C-1); 

Phrase: "Control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "secondary Texas Redconjugated antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "stain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "(C-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418485:C-1 [Gene or Genome]
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.188: no MG132 (C-2); 

Phrase: "no MG132"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(C-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050322:c 2 [Lipid]
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.189: MG132-treated cells (4 h) (C-3) ; MG132-treated cells (8 h) (C-4); 

Phrase: "MG132-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(4 h) (C-3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0041119:h 3 [Element, Ion, or Isotope]
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "; MG132-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(8 h) (C-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.190: MG132-treated cells (16 h) (C5).  

Phrase: "MG132-treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(16 h) (C5"

Phrase: ")."
Processing 00000000.tx.191: To determine if MOCA itself is affected by proteasome inhibition, MOCA expression patterns were studied as a function of time by Western blotting and confocal microscopy in the presence of MG132. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "itself"

Phrase: "is"

Phrase: "affected by proteasome inhibition,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   833   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   770   C1325620:proteasome [Cell Component]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C1752727:Proteasome [Molecular Function]
   770   C3463820:Inhibition [Activity]
   737 E C0001721:Affect [Mental Process]

Phrase: "MOCA expression patterns"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205349:Modifier [Qualitative Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "were"

Phrase: "studied as a function of time"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C0040227:Time Study [Intellectual Product]
   767   C2349982:Study Time [Temporal Concept]
   753   C0031843:function [Physiologic Function]
   753   C0040223:Time [Temporal Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   753   C3541383:Time [Temporal Concept]
   719   C0557651:Study [Manufactured Object]
   719   C2603343:Study [Research Activity]

Phrase: "by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "and"

Phrase: "confocal microscopy in the presence of MG132."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0242842:Microscopy, Confocal [Laboratory Procedure]
   748   C0026018:Microscopy [Laboratory Procedure]
Processing 00000000.tx.192: The accumulation of intracellular MOCA increased after MG132 treatment (Fig. 7 B). 

Phrase: "The accumulation of intracellular MOCA"

Phrase: "increased after MG132 treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205217:Increased [Quantitative Concept]
   770   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0442805:Increased [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 7 B"

Phrase: ")."
Processing 00000000.tx.193: Confocal images showed that under normal conditions MOCA is widely dispersed in the cytoplasm of B103 nerve cells (Fig. 7, C-2). 

Phrase: "Confocal images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that under normal conditions MOCA"
Meta Candidates (Total=23; Excluded=0; Pruned=0; Remaining=23)
   790   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0007577:Cell Adhesion [Cell Function]
   762   C0007634:Normal cell [Cell]
           Cell
   762   C0860902:normal protein [Finding]
   762   C1268443:Normal cell [Cell]
   748   C0231162:Normal condition [Finding]
   742   C0001511:Adhesion [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0175633:Adhesion [Natural Phenomenon or Process]
   742   C0205307:Normal [Qualitative Concept]
   742   C0205349:Modifier [Qualitative Concept]
   742   C0439166:% normal [Quantitative Concept]
   742   C1269647:Cell [Cell]
   742   C1514623:Modifier [Conceptual Entity]
   742   C1516451:Modifier [Chemical Viewed Functionally]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C2347086:% Normal [Quantitative Concept]
   742   C3542952:Modifier [Intellectual Product]
   708   C0012634:condition [Disease or Syndrome]
   708   C0348080:Condition [Qualitative Concept]
   708   C1705253:Condition [Conceptual Entity]

Phrase: "is"

Phrase: "widely"

Phrase: "dispersed in the cytoplasm of B103 nerve cells"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   797   C2324611:Cytoplasm of neural cell [Cell Component]
   770   C0027882:Nerve Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0010834:Cytoplasm [Cell Component]
   744   C0027740:Nerve [Tissue]
   744   C0027757:NERVE [Tissue]
   744   C0332624:Dispersed [Spatial Concept]
   744   C1280541:Nerve [Body Part, Organ, or Organ Component]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0050322:c 2 [Lipid]
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.194: MG132 treatment caused an increase in MOCA accumulation in the cytoplasm, and after 16 h treatment with MG132, there was MOCA accumulation in the perinuclear areas (Fig. 7, C-5). 

Phrase: "MG132 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "an increase in MOCA accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "in the cytoplasm,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "and after 16 h treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with MG132,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "there"

Phrase: "was"

Phrase: "MOCA accumulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "in the perinuclear areas"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0205146:areas [Spatial Concept]
   827 E C0017446:Area [Geographic Area]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C-5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.195: These data suggest that like many other proteins MOCA metabolism is regulated by the proteasome pathway. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that like many"

Phrase: "other proteins MOCA metabolism"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205349:Modifier [Qualitative Concept]
   744   C1514623:Modifier [Conceptual Entity]
   744   C1516451:Modifier [Chemical Viewed Functionally]
   744   C3542952:Modifier [Intellectual Product]

Phrase: "is"

Phrase: "regulated by the proteasome pathway."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C1752727:Proteasome Pathway [Molecular Function]
           Proteasome
   770 E C1523807:proteasomal pathway [Molecular Function]
   760   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1325620:proteasome [Cell Component]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.196: MOCA reduces cell-substratum adhesion The profound decrease in APP secretion caused by MOCA should have biological consequences. 

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "reduces"

Phrase: "cell-substratum adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "The profound decrease in APP secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "caused by MOCA"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "should"

Phrase: "have"

Phrase: "biological consequences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0686907:consequences [Functional Concept]
Processing 00000000.tx.197: APP has multiple functions, but its ability to mediate cell-substratum adhesion has been well-documented (Schubert et al., 1989; Chen and Yankner, 1991; Schubert and Behl, 1993; Jin et al., 1994; Beher et al., 1996; Coulson et al., 1997). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "has"

Phrase: "multiple functions,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0542341:Functions [Functional Concept]
   827 E C0031843:function [Physiologic Function]
   827 E C0700205:FUNCTION [Classification]
   827 E C1705273:Function [Intellectual Product]
   777 E C0205245:Functional [Functional Concept]
   777 E C2700217:Functional [Conceptual Entity]

Phrase: "but"

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cell-substratum adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "has"

Phrase: "been"

Phrase: "well-documented"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C1301725:Documented [Health Care Activity]
   861   C1609436:documented [Idea or Concept]
   861   C3146287:Well [Manufactured Object]
   827 E C1301746:document [Intellectual Product]
   827 E C1547673:Document [Intellectual Product]

Phrase: "(Schubert et al.,"

Phrase: "1989"

Phrase: "; Chen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "and"

Phrase: "Yankner,"

Phrase: "1991"

Phrase: "; Schubert"

Phrase: "and"

Phrase: "Behl,"

Phrase: "1993"

Phrase: "; Jin et al.,"

Phrase: "1994"

Phrase: "; Beher et al.,"

Phrase: "1996"

Phrase: "; Coulson et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.198: Because the inhibition of APP synthesis by antisense nucleotides blocks cell-substratum adhesion (Coulson et al., 1997), it would be predicted that the expression of MOCA has a similar effect and that this phenotype would be reversed by proteasome inhibitors, which restore APP accumulation and secretion. 

Phrase: "Because"

Phrase: "the inhibition of APP synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1519619:Protein Synthesis Inhibition [Genetic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by antisense nucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "cell-substratum adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "(Coulson et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "would"

Phrase: "be"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "that"

Phrase: "the expression of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "a similar effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "would"

Phrase: "be"

Phrase: "reversed by proteasome inhibitors,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   833   C2266856:Proteasome Inhibitors [Molecular Function]
   799 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   737   C1555029:Reverse [Idea or Concept]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "restore"

Phrase: "APP accumulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]
Processing 00000000.tx.199: This is indeed the case when the ability of B103 nerve cells, expressing APP, MOCA, or both, to adhere to the extracellular matrix protein laminin are compared. 

Phrase: "This"

Phrase: "is"

Phrase: "indeed"

Phrase: "the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "when"

Phrase: "the ability of B103 nerve cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "expressing"

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "MOCA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "or"

Phrase: "both,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "adhere to the extracellular matrix protein laminin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0079323:Extracellular Matrix Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0015350:Extracellular Matrix [Tissue]
   774   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0231441:Adhere [Finding]
   748   C0521119:Extracellular [Cell Component]
   748   C1704640:Matrix [Spatial Concept]
   748   C1706515:Matrix [Body Substance]

Phrase: "are"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.200: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.201: 8 A shows that the expression of APP695 in B103 cells, which normally lack APP, increases the rate of cell-substratum adhesion to laminin. 

Phrase: "8 A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the expression of APP695"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in B103 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "which normally"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the rate of cell-substratum adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "to laminin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.202: The expression of MOCA alone in B103 cells lacking APP695 has no effect on adhesion. 

Phrase: "The expression of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "alone in B103 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Alone [Quantitative Concept]
   770   C0439044:alone [Finding]
   770   C0679994:alone [Group Attribute]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "APP695"

Phrase: "has"

Phrase: "no effect on adhesion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.203: In contrast, cells expressing both APP and MOCA adhere to laminin at a rate which is indistinguishable from cells expressing no APP. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "both APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "adhere to laminin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0231441:Adhere [Finding]

Phrase: "at a rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "indistinguishable from cells"

Phrase: "expressing"

Phrase: "no APP."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.204: However, when cells expressing APP and MOCA are exposed to the proteasome inhibitor lactacystin for 5 h before the adhesion assay there is an increase in the rate of adhesion to a level indistinguishable from cells expressing APP but no MOCA (Fig. 8 B). 

Phrase: "However,"

Phrase: "when"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "are"

Phrase: "exposed to the proteasome inhibitor lactacystin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   790   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   790   C2266856:Proteasome Inhibitor [Molecular Function]
   790   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   753   C0125179:lactacystin [Antibiotic,Organic Chemical]
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1325620:proteasome [Cell Component]
   753   C1752727:Proteasome [Molecular Function]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "for 5 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "before the adhesion assay there"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "an increase in the rate of adhesion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "to a level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "indistinguishable from cells"

Phrase: "expressing"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "but"

Phrase: "no MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "(Fig. 8 B"

Phrase: ")."
Processing 00000000.tx.205: Lactacystin does not alter the rate of adhesion of cells which do not express MOCA or wild-type B103 cells. 

Phrase: "Lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the rate of adhesion of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "which"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "or"

Phrase: "wild-type B103 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0449475:type cell [Intellectual Product]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.206: The adhesion data are in agreement with those which show that MOCA expression increases APP breakdown and decreases its secretion (Figs. 1, 2, and 5) and that APP accumulation and secretion can be restored by proteasome inhibitors (Figs. 5 and 6). 

Phrase: "The adhesion data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with those"

Phrase: "which"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that MOCA expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205349:Modifier [Qualitative Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "APP breakdown"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1327161:amyloid precursor protein breakdown [Molecular Function]
   861   C1623036:protein breakdown [Molecular Function]
   812   C0443161:break down [Qualitative Concept]
   812   C0699900:breakdown [Organism Function]
   812   C1265875:breakdown [Acquired Abnormality]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "its secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "(Figs. 1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "that APP accumulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "can"

Phrase: "be"

Phrase: "restored by proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   833   C2266856:Proteasome Inhibitors [Molecular Function]
   799 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Figs. 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.207: View larger version (17K): [in this window] [in a new window]  Figure 8. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 8."
Processing 00000000.tx.208: The expression of MOCA decreases cell-substratum adhesion. 

Phrase: "The expression of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "cell-substratum adhesion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.209: Exponentially growing cells were labeled with 3H-leucine overnight, and their rate of adhesion to laminin was determined as a function of time as described in Materials and methods. 

Phrase: "Exponentially growing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled with 3H-leucine overnight,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0439583:Overnight [Temporal Concept]
   760   C1442460:3H [Temporal Concept]
   760   C1708632:Labeled [Qualitative Concept]
   726 E C0181496:Label [Manufactured Object]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "their rate of adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "to laminin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "determined as a function of time"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0031843:function [Physiologic Function]
   753   C0040223:Time [Temporal Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   753   C3541383:Time [Temporal Concept]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.210: (A) O, B103; 

Phrase: "(A"

Phrase: ")"

Phrase: "O,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "B103"

Phrase: ";"
Processing 00000000.tx.211: x, B103 APP695; 

Phrase: "x,"

Phrase: "B103 APP695"

Phrase: ";"
Processing 00000000.tx.212: , B103 MOCA Cl 3; 

Phrase: ", B103 MOCA Cl 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205349:Modifier [Qualitative Concept]
   744   C1514623:Modifier [Conceptual Entity]
   744   C1516451:Modifier [Chemical Viewed Functionally]
   744   C3542952:Modifier [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.213: , B103 APP695/MOCA Cl 8. 

Phrase: ", B103 APP695/MOCA Cl 8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205349:Modifier [Qualitative Concept]
   742   C1514623:Modifier [Conceptual Entity]
   742   C1516451:Modifier [Chemical Viewed Functionally]
   742   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.214: (B) O, B103/APP695Cl 1 with empty vector; 

Phrase: "(B) O,"

Phrase: "B103/APP695Cl 1 with empty vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0442335:Vector [Spatial Concept]
   753   C1705099:Vector [Idea or Concept]
   753   C1880497:Empty [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.215: x-B103/APP695 with empty vector plus LC; 

Phrase: "x-B103/APP695 with empty vector plus LC"

Phrase: ";"
Processing 00000000.tx.216: -B103/APP695/MOCA Cl 8 plus LC; 

Phrase: "-B103/APP695/MOCA Cl 8 plus LC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0205349:Modifier [Qualitative Concept]
   738   C1514623:Modifier [Conceptual Entity]
   738   C1516451:Modifier [Chemical Viewed Functionally]
   738   C3542952:Modifier [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.217: -B103/APP695/MOCA. 

Phrase: "-B103/APP695/MOCA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205349:Modifier [Qualitative Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.218: In some cells, 25 M lactacystin (LC) was added to the cultures 5 h before the adhesion assay. 

Phrase: "In some cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "25 M lactacystin (LC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "was"

Phrase: "added to the cultures 5 h"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0010453:Cultures [Idea or Concept]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1524062:Added [Functional Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C1883712:Add [Functional Concept]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "before the adhesion assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.219: The data are presented as the mean plus or minus the standard error of the mean for triplicate determinations. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as the mean"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0444504:Mean [Quantitative Concept]
   770   C0449450:Presented [Idea or Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "plus"

Phrase: "or"

Phrase: "minus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332288:Minus [Qualitative Concept]

Phrase: "the standard error of the mean"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   895   C1710181:Standard Error of the Mean [Quantitative Concept]
           Standard Error
   753   C0743559:error [Qualitative Concept]
   753   C1442989:Standard [Qualitative Concept]
   753   C1608199:Error [Functional Concept]
   753   C2828392:Standard [Intellectual Product]

Phrase: "for triplicate determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.220: The experiment was repeated three times with similar results.   

Phrase: "The experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "three times with similar results."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.221: Discussion Top Abstract Introduction Results Discussion Materials and methods References  The above data show that MOCA decreases the secretion of APP and A and also reduces the rate of cell adhesion. 

Phrase: "Discussion Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The above data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "A"

Phrase: "and"

Phrase: "also"

Phrase: "reduces"

Phrase: "the rate of cell adhesion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.222: These results reflect the acceleration of intracellular APP degradation for the following reasons. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the acceleration of intracellular APP degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0000894:Acceleration [Phenomenon or Process]

Phrase: "for the following reasons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.223: (a) There is no accumulation of intracellular APP nor is there a decrease in APP mRNA in cells expressing MOCA. 

Phrase: "(a) There"

Phrase: "is"

Phrase: "no accumulation of intracellular APP"

Phrase: "nor"

Phrase: "is"

Phrase: "there"

Phrase: "a decrease in APP mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "MOCA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.224: (b) In pulsechase experiments, the intracellular APP protein level is rapidly reduced in cells expressing physiological levels of MOCA relative to cells not expressing MOCA. 

Phrase: "(b) In pulsechase experiments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347469:/B [Quantitative Concept]

Phrase: "the intracellular APP protein level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   839   C0428479:Protein level [Laboratory or Test Result]
   799   C0441889:Level [Qualitative Concept]
   799   C0456079:Level [Classification]
   799   C1547707:Level [Geographic Area]
   799   C2946261:Level [Pharmacologic Substance]

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "reduced in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0392756:Reduced [Qualitative Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "physiological levels of MOCA"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   750   C0428479:Protein level [Laboratory or Test Result]
   744   C0205463:Physiological [Functional Concept]
   744   C0441889:Levels [Qualitative Concept]
   731   C0007613:Cell physiology [Cell Function]
   731   C1325880:cell physiology [Cell Function]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "relative to cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0080103:Relative [Family Group]
   790   C0205345:Relative [Qualitative Concept]
   790   C1547039:*Relative [Quantitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expressing"

Phrase: "MOCA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.225: (c) The level of APP secretion and the remaining COOH-terminal fragments of APP are decreased by MOCA to a similar extent. 

Phrase: "(c)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "The level of APP secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0428479:Protein level [Laboratory or Test Result]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the remaining COOH-terminal fragments of APP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   745   C1335533:Protein Fragment [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   742   C0332255:fragments [Functional Concept]
   742   C0486805:Fragments [Body Substance]
   708 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "decreased by MOCA"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "to a similar extent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]
Processing 00000000.tx.226: (d) Several proteasome inhibitors increase the accumulation of intracellular APP and reverse the effect of MOCA on APP secretion and cell adhesion; 

Phrase: "("

Phrase: "d)"

Phrase: "Several proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   901   C2266856:Proteasome Inhibitors [Molecular Function]
   867 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1325620:proteasome [Cell Component]
   827   C1752727:Proteasome [Molecular Function]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the accumulation of intracellular APP"

Phrase: "and"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "the effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "cell adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: ";"
Processing 00000000.tx.227: lysosomal protease inhibitors are ineffective. 

Phrase: "lysosomal protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "are"

Phrase: "ineffective."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3242229:ineffective [Idea or Concept]
Processing 00000000.tx.228: (e) Pulse-labeled APP is also stabilized by proteasome inhibitors in MOCA-expressing cells, and unlike in the absence of proteasome inhibitors, its rate of intracellular decline is indistinguishable from that in cells not expressing MOCA. 

Phrase: "(e) Pulse-labeled APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   895   C0599561:E protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "also"

Phrase: "stabilized by proteasome inhibitors"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   833   C2266856:Proteasome Inhibitors [Molecular Function]
   799 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   770   C0184512:Stabilized [Qualitative Concept]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "in MOCA-expressing cells,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   835   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007577:Cell Adhesion [Cell Function]
   793   C0001511:Adhesion [Pathologic Function]
   793   C0007634:Cell [Cell]
           Cells
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0150312:In [Quantitative Concept]
   793   C0175633:Adhesion [Natural Phenomenon or Process]
   793   C0205349:Modifier [Qualitative Concept]
   793   C0332285:In [Spatial Concept]
   793   C1269647:Cell [Cell]
   793   C1514623:Modifier [Conceptual Entity]
   793   C1516451:Modifier [Chemical Viewed Functionally]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]
   793   C3282337:Cells [Cell]
   793   C3542952:Modifier [Intellectual Product]

Phrase: "and unlike"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of proteasome inhibitors,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "its rate of intracellular decline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "is"

Phrase: "indistinguishable from that"

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expressing"

Phrase: "MOCA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.229: APP is a type I membrane-spanning protein whose secretion is regulated by a variety of factors including growth factors, neurotransmitters, phorbol esters, extracellular matrix molecules, and stress (Schubert et al., 1989; Mills and Reiner, 1999; De Strooper and Annaert, 2000). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "a type I membrane-spanning protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "whose secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "regulated by a variety of factors"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0960756:factor A [Organic Chemical]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "growth factors,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "neurotransmitters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027908:Neurotransmitters [Neuroreactive Substance or Biogenic Amine]

Phrase: "phorbol esters,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031586:Phorbol Esters [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0014898:Esters [Organic Chemical]
   861   C0031588:phorbol [Organic Chemical]
   861   C0070750:Phorbol [Organic Chemical]

Phrase: "extracellular matrix molecules,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "and"

Phrase: "stress"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038435:Stress [Finding]
   928 E C0231297:Stressful [Functional Concept]

Phrase: "(Schubert et al.,"

Phrase: "1989"

Phrase: "; Mills"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599997:mills [Manufactured Object]

Phrase: "and"

Phrase: "Reiner,"

Phrase: "1999"

Phrase: "; De Strooper"

Phrase: "and"

Phrase: "Annaert,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.230: The mechanisms involved in the regulation of APP secretion include alternations in APP phosphorylation (Caporaso et al., 1992), the modification of protein glycosylation (Galbete et al., 2000), alternative in gene splicing (Shepherd et al., 2000) and transcription (Ciallella et al., 1994), and also changes in protein degradation (Checler et al., 2000). 

Phrase: "The mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in the regulation of APP secretion"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   807   C1327618:regulation of protein secretion [Cell Function]
   790   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   790   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   784   C1523071:regulation of secretion [Cell Function]
   764   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1159339:Protein Secretion [Cell Function]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0851285:Regulation [Governmental or Regulatory Activity]
   742   C1314939:Involved [Functional Concept]
   742   C1327622:Regulation [Biologic Function]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "alternations in APP phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0919661:alternation [Pathologic Function]

Phrase: "(Caporaso et al.,"

Phrase: "1992"

Phrase: ")"

Phrase: ","

Phrase: "the modification of protein glycosylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0033666:Protein Modification [Molecular Function]
   797   C2263112:protein modification [Molecular Function]
   760   C0392747:Modification [Functional Concept]
   760   C1554963:modification [Qualitative Concept]

Phrase: "(Galbete et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "alternative in gene splicing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0002345:Alternative Splicing [Genetic Function]
   770   C1523987:Alternative [Conceptual Entity]

Phrase: "(Shepherd et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "and"

Phrase: "transcription"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040649:Transcription [Genetic Function]

Phrase: "(Ciallella et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "also"

Phrase: "changes in protein degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0597297:Protein Degradation [Molecular Function]
   833   C0597304:Protein Degradation [Molecular Function]
   833   C1623036:Protein Degradation [Molecular Function]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243125:degradation [Functional Concept]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C0699900:Degradation [Organism Function]
   770   C1705241:Change [Quantitative Concept]

Phrase: "(Checler et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.231: Although these mechanisms are diverse, it is likely that they are shared with many type I membrane proteins. 

Phrase: "Although"

Phrase: "these mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "diverse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880371:Diverse [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "they"

Phrase: "are"

Phrase: "shared with many type I membrane proteins."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0441729:Type I [Classification]
   757   C0087044:i protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0103404:Protein I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0021966:I- [Inorganic Chemical]
   748   C0025255:Membrane [Tissue]
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0237876:shared [Social Behavior]
   748   C0332307:Type [Qualitative Concept]
   748   C0596901:Membrane [Cell Component]
   748   C1522138:Shared [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]
   748   C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.232: APP is probably the most studied molecule of this class because of its medical importance. 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "the most studied molecule of this class"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0567416:Molecule [Substance]

Phrase: "because of its medical importance."
Processing 00000000.tx.233: The intracellular sites of APP metabolism still remain controversial with -secretase cleavage described at the plasma membrane, in the Golgi, or in the post-Golgi secretory vesicles (Mills and Reiner, 1999). 

Phrase: "The intracellular sites of APP metabolism still"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   773   C1373176:Site of Metabolism [Spatial Concept]
   748   C2945843:Site of [Qualitative Concept]
   742   C0205145:Sites [Spatial Concept]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "remain"

Phrase: "controversial with -secretase cleavage"

Phrase: "described at the plasma membrane,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0596901:Membrane [Cell Component]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1552738:described [Idea or Concept]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "in the Golgi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018042:Golgi [Cell Component]

Phrase: "or in the post-Golgi secretory vesicles"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0886515:Secretory Vesicles [Cell Component]
   757   C0230767:Golgi vesicle [Cell Component]
   748   C0018042:Golgi [Cell Component]
   748   C0333262:VESICLES [Acquired Abnormality]
   748   C0687676:Post [Temporal Concept]
   748   C1327616:Secretory [Cell Function]
   748   C1704687:Post [Manufactured Object]
   714 E C1622418:vesicle [Cell Component]

Phrase: "(Mills"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599997:mills [Manufactured Object]

Phrase: "and"

Phrase: "Reiner,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.234: Similarly, - and -secretase activities have been identified in the trans-Golgi network (Xu et al., 1997), the endoplasmic reticulum/intermediate compartment (Cook et al., 1997), and the endosome/lysosome system (Haass et al., 1992). 

Phrase: "Similarly,"

Phrase: "-"

Phrase: "and -"

Phrase: "secretase activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified in the trans-Golgi network"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0887838:trans-Golgi Network [Cell Component]
   790   C1179875:Golgi network [Cell Component]
   753   C0018042:Golgi [Cell Component]
   753   C0205396:Identified [Qualitative Concept]
   753   C1513822:Network [Professional or Occupational Group]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1705739:Network [Manufactured Object]
   753   C1882071:Network [Conceptual Entity]
   753   C2826298:TRANS [Idea or Concept]

Phrase: "(Xu et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "the endoplasmic reticulum/intermediate compartment"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205103:Intermediate [Spatial Concept]
   812   C1185625:Compartment [Body Space or Junction]
   812   C1550465:intermediate [Idea or Concept]
   812   C2827755:INTERMEDIATE [Laboratory or Test Result]
   812   C2986730:Compartment [Spatial Concept]

Phrase: "(Cook et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the endosome/lysosome system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Haass et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.235: Our data do not distinguish between these alternatives but show that secretion of APP and A are both reduced in the presence of MOCA. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "distinguish between these alternatives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1523987:Alternative [Conceptual Entity]

Phrase: "but"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "and"

Phrase: "A"

Phrase: "are"

Phrase: "both"

Phrase: "reduced in the presence of MOCA."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   782   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0007577:Cell Adhesion [Cell Function]
   739   C0001511:Adhesion [Pathologic Function]
   739   C0007634:Cell [Cell]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0175633:Adhesion [Natural Phenomenon or Process]
   739   C0205349:Modifier [Qualitative Concept]
   739   C0392148:Presence [Therapeutic or Preventive Procedure]
   739   C0392756:Reduced [Qualitative Concept]
   739   C1269647:Cell [Cell]
   739   C1514623:Modifier [Conceptual Entity]
   739   C1516451:Modifier [Chemical Viewed Functionally]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   739   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.236: Because we do not observe an intracellular accumulation of APP or intermediate breakdown products of APP, the effect of MOCA on APP processing most likely occurs before APP reaches the cell surface. 

Phrase: "Because"

Phrase: "we"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "an intracellular accumulation of APP"

Phrase: "or"

Phrase: "intermediate breakdown products of APP,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "the effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on APP processing most likely"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033666:protein processing [Molecular Function]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332148:Likely [Qualitative Concept]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0750492:Likely [Idea or Concept]
   799   C1709634:Precursor [Idea or Concept]
   799   C1709694:Processing [Activity]

Phrase: "occurs before APP"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1709305:Occur [Activity]
   760   C1709634:Precursor [Idea or Concept]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "reaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596012:Reaches [Finding]
  1000   C2584321:Reach [Organism Function]

Phrase: "the cell surface."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.237: The pleotropic effects of MOCA on APP degradation may occur in the ER, which is consistent with the subcellular localization of both PS1 and MOCA (Doan et al., 1996; 

Phrase: "The pleotropic effects of MOCA"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   745   C0681891:effect modifier [Functional Concept]
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "on APP degradation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C1327161:amyloid precursor protein degradation [Molecular Function]
   861   C0597297:Protein Degradation [Molecular Function]
   861   C0597304:Protein Degradation [Molecular Function]
   861   C1623036:Protein Degradation [Molecular Function]
   812   C0243125:degradation [Functional Concept]
   812   C0699900:Degradation [Organism Function]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "may"

Phrase: "occur in the ER,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "which"

Phrase: "is"

Phrase: "consistent with the subcellular localization of both PS1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "and"

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "(Doan et al.,"

Phrase: "1996"

Phrase: ";"
Processing 00000000.tx.238: Kashiwa et al., 2000; 

Phrase: "Kashiwa et al.,"

Phrase: "2000"

Phrase: ";"
Processing 00000000.tx.239: Xia et al., 2000. 

Phrase: "Xia et al.,"

Phrase: "2000."
Processing 00000000.tx.240: Proteins destined for membranes or secretion are translocated into the ER, folded, assembled, and transported to a cellular destination or secreted (Hurtley and Helenius, 1989). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "destined for membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0025255:Membranes [Tissue]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "or"

Phrase: "secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "are"

Phrase: "translocated into the ER,"

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: ","

Phrase: "assembled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706853:Assemble [Activity]

Phrase: ","

Phrase: "and"

Phrase: "transported to a cellular destination"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1550030:Transport To [Idea or Concept]
   760   C0007634:Cellular [Cell]
   760   C0079220:Destination [Spatial Concept]
   760   C0178539:Cellular [Functional Concept]
   760   C1521840:Destination [Functional Concept]
   726   C0005528:Transport, NOS [Cell Function]
   726   C1317949:Transport [Manufactured Object]
   726   C3495449:transport [Medical Device]

Phrase: "or"

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "(Hurtley"

Phrase: "and"

Phrase: "Helenius,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.241: Incorrectly folded proteins, unassembled subunits of multisubunit complexes, and mutated proteins are rapidly eliminated from the cell; 

Phrase: "Incorrectly folded proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "unassembled subunits of multisubunit complexes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "mutated proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "eliminated from the cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0007634:Cell [Cell]
   770   C0849355:Eliminated [Qualitative Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.242: misfolded proteins are translocated to proteasomes and degraded (Suzuki et al., 1998). 

Phrase: "misfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "translocated to proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   756 E C1325620:proteasome [Cell Component]
   756 E C1752727:Proteasome [Molecular Function]

Phrase: "and"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(Suzuki et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.243: However, in the case of unfolded proteins the conventional route may not be taken because excessive accumulation of these macromolecules within the ER lumen might lead to their aggregation and precipitation, thereby blocking the secretory pathway (Klausner and Sitia, 1990). 

Phrase: "However,"

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of unfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the conventional route"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0013153:ROUTE [Functional Concept]
   861   C0449444:Route [Spatial Concept]
   861   C1879941:ROUTE [Intellectual Product]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "because"

Phrase: "excessive accumulation of these macromolecules"

Phrase: "within the ER lumen"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C1166837:ER lumen [Cell Component]
   861   C0524461:Lumen [Body Space or Junction]
   861   C1282864:Lumen [Body Space or Junction]
   861   C1301906:Lumen [Qualitative Concept]
   861   C1551056:Lumen [Quantitative Concept]
   789 E C0524462:Luminal [Spatial Concept]

Phrase: "might"

Phrase: "lead to their aggregation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0332621:Aggregation [Functional Concept]
   770   C0439168:% aggregation [Quantitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "precipitation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032931:Precipitation [Natural Phenomenon or Process]
  1000   C0032932:Precipitation [Molecular Function]
  1000   C1642401:% precipitation [Quantitative Concept]
  1000   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "thereby"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "the secretory pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159342:Secretory Pathway [Cell Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "(Klausner"

Phrase: "and"

Phrase: "Sitia,"

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.244: Because APP binds to the molecular chaperones Bip/G-RP78 and HSC73 and misfolded proteins bound to Bip/GRP78 are degraded, it has been suggested that APP can be retained in the ER as a nascent polypeptide and degraded (Yang et al., 1998; Kouchi et al., 1999). 

Phrase: "Because"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "binds to the molecular chaperones Bip/G-RP78"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   782   C0063423:BiP molecular chaperone [Amino Acid, Peptide, or Protein,Enzyme]
           BiP
   770   C0243041:Molecular Chaperones [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone
   744   C0439267:g% [Quantitative Concept]
   744   C1145667:Bind [Activity]
   744   C1167622:bind [Molecular Function]
   744   C1415761:BIP [Gene or Genome]
   744   C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "HSC73"

Phrase: "and"

Phrase: "misfolded proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "bound to Bip/GRP78"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0063423:BiP [Amino Acid, Peptide, or Protein,Enzyme]
           GRP78
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1415761:BIP [Gene or Genome]
           GRP78
   770   C1689898:% bound [Quantitative Concept]
   770   C1708295:GRP78 [Gene or Genome]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "are"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: ","

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "retained in the ER"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333118:Retained [Functional Concept]

Phrase: "as a nascent polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(Yang et al.,"

Phrase: "1998"

Phrase: "; Kouchi et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.245: This idea is consistent with data suggesting that the degradation pathway for APP in the ER participates in APP secretion and is distinct from -secretase cleavage (Bunnell et al., 1998) and that the proteasome is involved in APP processing (Hare, 2001). 

Phrase: "This idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "is"

Phrase: "consistent with data"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the degradation pathway for APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1511758:Degradation Pathway [Conceptual Entity]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "in the ER"

Phrase: "participates in APP secretion"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1159339:Protein Secretion [Cell Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "is"

Phrase: "distinct from -secretase cleavage"

Phrase: "(Bunnell et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: "and"

Phrase: "that"

Phrase: "the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "is"

Phrase: "involved in APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033666:protein processing [Molecular Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1709634:Precursor [Idea or Concept]
   753   C1709694:Processing [Activity]

Phrase: "(Hare,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242372:Hare [Mammal]
  1000   C1425660:HARE [Gene or Genome]

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.246: Because APP secretion is restored by proteasome inhibitors and intracellular accumulation of APP is not observed in the absence of proteasome inhibitors, the secretion pathway is not blocked by MOCA. 

Phrase: "Because"

Phrase: "APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "restored by proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   833   C2266856:Proteasome Inhibitors [Molecular Function]
   799 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   737 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "intracellular accumulation of APP"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in the absence of proteasome inhibitors,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   778   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   778   C2266856:Proteasome Inhibitors [Molecular Function]
   748   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0332197:absence [Quantitative Concept]
   748   C1325620:proteasome [Cell Component]
   748   C1441672:Observed [Functional Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1752727:Proteasome [Molecular Function]
   745 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "the secretion pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159342:Secretion Pathway [Cell Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "blocked by MOCA."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0028778:Blocked [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0332206:Blocked [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C2983591:BLOCKED [Research Activity]
   748   C3542952:Modifier [Intellectual Product]
   714 E C1533157:Block [Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.247: Consistent with previous data (Bunnell et al., 1998), we were unable to isolate a ubiquitin-conjugated APP complex even after the treatment with proteasome inhibitors, and we did not observe any APP intermediates caused by MOCA expression. 

Phrase: "Consistent with previous data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Bunnell et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "a ubiquitin-conjugated APP complex even after the treatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1523872:protein complex [Cell Component]
   738   C0439855:Complex [Qualitative Concept]
   738   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with proteasome inhibitors,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "any APP intermediates"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   779   C0205103:Intermediate [Spatial Concept]
   779   C1550465:intermediate [Idea or Concept]
   779   C2827755:INTERMEDIATE [Laboratory or Test Result]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "caused by MOCA expression."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   800   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0007577:Cell Adhesion [Cell Function]
   770   C1171362:protein expression [Genetic Function]
   744   C0001511:Adhesion [Pathologic Function]
   744   C0007634:Cell [Cell]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0175633:Adhesion [Natural Phenomenon or Process]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205349:Modifier [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1514623:Modifier [Conceptual Entity]
   744   C1516451:Modifier [Chemical Viewed Functionally]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C3542952:Modifier [Intellectual Product]
   711   C0015127:cause [Functional Concept]
   711   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.248: Proteasome inhibitors increase the stability of both total and pulse-labeled APP in cells (Figs. 6 and 7) and restore the secretion rate to near control levels in MOCA-expressing cells (Fig. 5 C and Fig. 6). 

Phrase: "Proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the stability of both total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205360:Stability [Qualitative Concept]
   760   C2347098:Stability [Qualitative Concept]

Phrase: "and"

Phrase: "pulse-labeled APP in cells"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0018956:cells precursor [Cell]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]

Phrase: "(Figs. 6"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "7"

Phrase: ")"

Phrase: "and"

Phrase: "restore"

Phrase: "the secretion rate to near control levels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0489879:Rate control [Functional Concept]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "in MOCA-expressing cells"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   835   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007577:Cell Adhesion [Cell Function]
   793   C0001511:Adhesion [Pathologic Function]
   793   C0007634:Cell [Cell]
           Cells
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0150312:In [Quantitative Concept]
   793   C0175633:Adhesion [Natural Phenomenon or Process]
   793   C0205349:Modifier [Qualitative Concept]
   793   C0332285:In [Spatial Concept]
   793   C1269647:Cell [Cell]
   793   C1514623:Modifier [Conceptual Entity]
   793   C1516451:Modifier [Chemical Viewed Functionally]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]
   793   C3282337:Cells [Cell]
   793   C3542952:Modifier [Intellectual Product]

Phrase: "(Fig. 5 C"

Phrase: "and"

Phrase: "Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.249: They also increase the intracellular accumulation of MOCA over long periods of time (Fig. 7). 

Phrase: "They also"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the intracellular accumulation of MOCA"

Phrase: "over long periods"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "of time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.250: Although it cannot be formally ruled out in any studies that proteasome inhibitors block an unknown function to generate the resultant phenotype, we feel that this is unlikely in the experiments described here for two reasons. 

Phrase: "Although"

Phrase: "it"

Phrase: "cannot"

Phrase: "be"

Phrase: "formally"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out in any"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "that proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "an unknown function to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "generate"

Phrase: "the resultant phenotype,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "we"

Phrase: "feel"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013987:feel [Mental Process]
   916 E C1527305:Feeling, NOS [Mental Process]

Phrase: "that"

Phrase: "this"

Phrase: "is"

Phrase: "unlikely in the experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0750558:Unlikely [Conceptual Entity]
   770   C1710571:Unlikely [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here for two reasons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205448:Two [Quantitative Concept]
   770   C0392360:reasons [Idea or Concept]
Processing 00000000.tx.251: First, in an experiment where cells are pulse labeled for 10 min and chased in the presence of a proteasome inhibitor there was a rapid inhibition of APP breakdown, bringing it up to the rate of loss of intracellular APP in non-MOCA cells due to secretion (Fig. 7). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "in an experiment where cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0232117:PULSE [Clinical Attribute]
  1000   C0391850:Pulse [Physiologic Function]
  1000   C1947910:Pulse [Phenomenon or Process]
   916 E C0034107:Pulses [Health Care Activity]

Phrase: "labeled for 10 min"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "chased in the presence of a proteasome inhibitor there"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   764   C2266856:Proteasome Inhibitor [Molecular Function]
   764   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   742   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C1325620:proteasome [Cell Component]
   742   C1752727:Proteasome [Molecular Function]
   742   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "a rapid inhibition of APP breakdown,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "bringing"

Phrase: "it up to the rate of loss of intracellular APP"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   770   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   753   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0175996:intracellular [Cell Component]
   736   C0178719:Intracellular [Spatial Concept]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0871208:Rate [Activity]
   736   C1517945:Loss [Quantitative Concept]
   736   C1521828:Rate [Quantitative Concept]
   736   C1709634:Precursor [Idea or Concept]

Phrase: "in non-MOCA cells"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   835   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007577:Cell Adhesion [Cell Function]
   793   C0001511:Adhesion [Pathologic Function]
   793   C0007634:Cell [Cell]
           Cells
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0150312:In [Quantitative Concept]
   793   C0175633:Adhesion [Natural Phenomenon or Process]
   793   C0205349:Modifier [Qualitative Concept]
   793   C0332285:In [Spatial Concept]
   793   C1269647:Cell [Cell]
   793   C1514623:Modifier [Conceptual Entity]
   793   C1516451:Modifier [Chemical Viewed Functionally]
   793   C1518422:Non [Functional Concept]
   793   C1704653:Cell [Medical Device]
   793   C1948049:Cell [Spatial Concept]
   793   C3282337:Cells [Cell]
   793   C3542952:Modifier [Intellectual Product]

Phrase: "due to secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.252: The effect occurred well before any significant accumulation of other proteins like MOCA. 

Phrase: "The effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "well before any significant accumulation of other proteins"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C0682323:Significant other [Family Group]
   767   C1553704:significant other [Intellectual Product]
   744   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205170:Well [Qualitative Concept]
   744   C0237881:significant [Quantitative Concept]
   744   C0750502:Significant [Idea or Concept]
   744   C1546944:Significant [Qualitative Concept]
   744   C3146287:Well [Manufactured Object]

Phrase: "like MOCA."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   861   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007577:Cell Adhesion [Cell Function]
   799   C0001511:Adhesion [Pathologic Function]
   799   C0007634:Cell [Cell]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0175633:Adhesion [Natural Phenomenon or Process]
   799   C0205349:Modifier [Qualitative Concept]
   799   C0870814:Like [Mental Process]
   799   C1269647:Cell [Cell]
   799   C1514623:Modifier [Conceptual Entity]
   799   C1516451:Modifier [Chemical Viewed Functionally]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.253: The accumulation in proteins in the ER in the presence of proteasome inhibitors can sometimes indirectly inhibit the secretory pathway; 

Phrase: "The accumulation in proteins"

Phrase: "in the ER"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "can"

Phrase: "sometimes indirectly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1998882:Sometimes [Temporal Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the secretory pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159342:Secretory Pathway [Cell Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.254: in our case, APP secretion is enhanced. 

Phrase: "in our case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "enhanced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]
Processing 00000000.tx.255: Second, a variety of structurally diverse proteasome inhibitors reversed the effect of MOCA on APP secretion, whereas -secretase inhibitors, lysosomal protease inhibitors, and a metalloprotease inhibitor have no effect. 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "a variety of structurally diverse proteasome inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]

Phrase: "reversed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555029:Reverse [Idea or Concept]

Phrase: "the effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on APP secretion,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "whereas -"

Phrase: "secretase inhibitors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "lysosomal protease inhibitors,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "a metalloprotease inhibitor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1152589:metalloprotease inhibitor [Molecular Function]
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: "have"

Phrase: "no effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.256: These results strongly suggest that proteasomes are involved in MOCA-induced APP degradation. 

Phrase: "These results strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1325620:proteasome [Cell Component]
   966 E C1752727:Proteasome [Molecular Function]

Phrase: "are"

Phrase: "involved in MOCA-induced APP degradation."
Meta Candidates (Total=31; Excluded=0; Pruned=0; Remaining=31)
   790   C1327161:amyloid precursor protein degradation [Molecular Function]
   770   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
           Amyloid Protein Precursor
   770   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   753   C0007577:Cell Adhesion [Cell Function]
   751   C0018956:precursor cell [Cell]
   751   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   751   C0597297:Protein Degradation [Molecular Function]
   751   C0597304:Protein Degradation [Molecular Function]
   751   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   751   C1623036:Protein Degradation [Molecular Function]
   736   C0001511:Adhesion [Pathologic Function]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0007634:Cell [Cell]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0175633:Adhesion [Natural Phenomenon or Process]
   736   C0205263:Induced [Functional Concept]
   736   C0205349:Modifier [Qualitative Concept]
   736   C0243125:degradation [Functional Concept]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0699900:Degradation [Organism Function]
   736   C1269647:Cell [Cell]
   736   C1314939:Involved [Functional Concept]
   736   C1514623:Modifier [Conceptual Entity]
   736   C1516451:Modifier [Chemical Viewed Functionally]
   736   C1704653:Cell [Medical Device]
   736   C1709634:Precursor [Idea or Concept]
   736   C1948049:Cell [Spatial Concept]
   736   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.257: These data also suggest that nascent APP may pass through an ER environment in which complexes for both protein degradation and protein assembly coexist. 

Phrase: "These data also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that nascent APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "may"

Phrase: "pass through an ER environment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014406:Environment [Spatial Concept]
   760   C2828386:Pass [Finding]

Phrase: "in which complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704241:Complexes [Chemical Viewed Structurally]
   966 E C0439855:Complex [Qualitative Concept]

Phrase: "for both protein degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0597297:Protein Degradation [Molecular Function]
  1000   C0597304:Protein Degradation [Molecular Function]
  1000   C1623036:Protein Degradation [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "protein assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "coexist."
Processing 00000000.tx.258: In the absence of MOCA, the precursor protein follows the secretory pathway, whereas the expression of MOCA directs a significant fraction of APP to proteasomes where it is degraded. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of MOCA,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   861   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007577:Cell Adhesion [Cell Function]
   799   C0001511:Adhesion [Pathologic Function]
   799   C0007634:Cell [Cell]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0175633:Adhesion [Natural Phenomenon or Process]
   799   C0205349:Modifier [Qualitative Concept]
   799   C0332285:Of [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1514623:Modifier [Conceptual Entity]
   799   C1516451:Modifier [Chemical Viewed Functionally]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3542952:Modifier [Intellectual Product]

Phrase: "the precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "the secretory pathway,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1159342:Secretory Pathway [Cell Function]
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "whereas"

Phrase: "the expression of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "directs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "a significant fraction of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   748   C1554103:Fraction [Idea or Concept]

Phrase: "to proteasomes where"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C1325620:proteasome [Cell Component]
   827 E C1752727:Proteasome [Molecular Function]

Phrase: "it"

Phrase: "is"

Phrase: "degraded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.259: This novel MOCA-mediated pathway presents yet another way in which the expression of specific proteins may be controlled. 

Phrase: "This novel MOCA-mediated pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205349:Modifier [Qualitative Concept]
   742   C1514623:Modifier [Conceptual Entity]
   742   C1516451:Modifier [Chemical Viewed Functionally]
   742   C3542952:Modifier [Intellectual Product]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "yet"

Phrase: "another way in which"

Phrase: "the expression of specific proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "controlled."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.260: A amyloid peptides are also generated from various cellular compartments, including the ER, the Golgi apparatus, the trans-Golgi networks, lysosomes, and endosomes, through either a constitutive secretion pathway or through an endocytotic pathway in which cell surface APP moves to the lysosomes or endosomes where A is produced (Mills and Reiner, 1999; De Strooper and Annaert, 2000). 

Phrase: "A amyloid peptides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "also"

Phrase: "generated from various cellular compartments,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0007634:Cellular [Cell]
   760   C0178539:Cellular [Functional Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1185625:Compartments [Body Space or Junction]
   760   C1382196:Compartments [Natural Phenomenon or Process]
   760   C3146294:Generated [Activity]
   726 E C2986730:Compartment [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the ER,"

Phrase: "the Golgi apparatus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018042:Golgi Apparatus [Cell Component]
           Golgi
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]

Phrase: "the trans-Golgi networks,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   988   C0887838:trans-Golgi Network [Cell Component]
   884   C1179875:Golgi network [Cell Component]
   827   C1882071:networks [Conceptual Entity]
   793 E C1513822:Network [Professional or Occupational Group]
   793 E C1705739:Network [Manufactured Object]

Phrase: "lysosomes,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "through either"

Phrase: "a constitutive secretion pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1159342:Secretion Pathway [Cell Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "or through an endocytotic pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2984285:Endocytosis Pathway [Functional Concept]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "in which cell surface APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C0025252:surface protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "moves to the lysosomes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0024369:Lysosomes [Cell Component]
   770   C0560560:move [Organism Function]
   770   C0578671:Moves [Finding]
   770   C1269909:move [Functional Concept]
   770   C1299988:move [Functional Concept]
   770   C2699029:Move [Activity]
   737 E C2984253:Lysosome [Functional Concept]

Phrase: "or"

Phrase: "endosomes where A"

Phrase: "is"

Phrase: "produced"

Phrase: "(Mills"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599997:mills [Manufactured Object]

Phrase: "and"

Phrase: "Reiner,"

Phrase: "1999"

Phrase: "; De Strooper"

Phrase: "and"

Phrase: "Annaert,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.261: A secretion is decreased by MOCA in our studies, probably because of the rapid degradation of APP, therefore reducing the APP source for the generation of A. 

Phrase: "A secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C1327439:antibody secretion [Cell Function]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "decreased by MOCA"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "in our studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "probably because of the rapid degradation of APP,"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   799   C1327161:amyloid precursor protein degradation [Molecular Function]
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0597297:Protein Degradation [Molecular Function]
   757   C0597304:Protein Degradation [Molecular Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1623036:Protein Degradation [Molecular Function]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0243125:degradation [Functional Concept]
   739   C0439831:Rapid [Qualitative Concept]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0699900:Degradation [Organism Function]
   739   C0750492:Probably [Idea or Concept]
   739   C1709634:Precursor [Idea or Concept]

Phrase: "therefore"

Phrase: "reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the APP source for the generation of A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   761   C0449424:Source of antibody [Finding]
   738   C0449416:Source [Finding]
   738   C1705919:Source [Idea or Concept]
Processing 00000000.tx.262: Because the overall production of A is reduced by MOCA, MOCA expression may help to reduce A production in the central nervous system. 

Phrase: "Because"

Phrase: "the overall production of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0003261:antibodies production [Biologic Function]
   753   C0033268:production [Occupational Activity]

Phrase: "is"

Phrase: "reduced by MOCA,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "MOCA expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "may"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "A production in the central nervous system."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0003261:antibodies production [Biologic Function]
   744   C0033268:production [Occupational Activity]
Processing 00000000.tx.263: It follows that the loss of MOCA function could lead to AD. 

Phrase: "It"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "that"

Phrase: "the loss of MOCA function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1517945:Loss [Quantitative Concept]

Phrase: "could"

Phrase: "lead to AD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.264: PS1 controls several aspects of APP metabolism (Sisodia, 2000) and protein breakdown (Niwa et al., 1999; Katayama et al., 2000). 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "several aspects of APP metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1547011:Aspect [Quantitative Concept]
   714   C1879746:Aspect [Qualitative Concept]

Phrase: "(Sisodia,"

Phrase: "2000"

Phrase: ")"

Phrase: "and"

Phrase: "protein breakdown"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1623036:protein breakdown [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0443161:break down [Qualitative Concept]
   861   C0699900:breakdown [Organism Function]
   861   C1265875:breakdown [Acquired Abnormality]

Phrase: "(Niwa et al.,"

Phrase: "1999"

Phrase: "; Katayama et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.265: PS1 is also required for "-secretase" cleavage of Notch-1. 

Phrase: "PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "required for ""-secretase"" cleavage of Notch-1."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1334889:notch 1 [Gene or Genome]
   748   C0010813:cleavage [Cell Function]
   748   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1235660:Notch [Body Space or Junction]
   748   C1330957:cleavage [Cell Function]
   748   C1514873:Required [Functional Concept]
Processing 00000000.tx.266: However, the proteolytic cleavage of APP and Notch are differentially facilitated (Capell et al., 2000). 

Phrase: "However,"

Phrase: "the proteolytic cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "Notch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1235660:Notch [Body Space or Junction]

Phrase: "are"

Phrase: "differentially"

Phrase: "facilitated"

Phrase: "(Capell et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.267: The PS1-dependent -secretase processing of APP appears to be nonselective and occurs at multiple sites within the APP transmembrane domain. 

Phrase: "The PS1-dependent -secretase processing of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0033666:protein processing [Molecular Function]
   742   C1709694:Processing [Activity]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "nonselective"

Phrase: "and"

Phrase: "occurs at multiple sites"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205145:Sites [Spatial Concept]
   770   C0439064:Multiple [Quantitative Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "within the APP transmembrane domain."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   853   C0162808:Protein Domain [Spatial Concept]
   853   C1514562:Protein Domain [Amino Acid Sequence]
   840   C1519623:Transmembrane Domain [Amino Acid Sequence]
   804   C1167322:transmembrane [Cell Component]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C2752508:transmembrane [Cell Component]
   804   C3541951:Domain [Intellectual Product]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
Processing 00000000.tx.268: This is in contrast to the highly selective PS1-dependent processing of Notch (Yu et al., 2001). 

Phrase: "This"

Phrase: "is in contrast to the highly selective PS1-dependent processing of Notch"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   736   C0205250:Highly [Qualitative Concept]
   736   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0851827:Dependent [Qualitative Concept]
   736   C1235660:Notch [Body Space or Junction]
   736   C1418985:PS1 [Gene or Genome]
   736   C1701901:Dependent [Qualitative Concept]
   736   C1709694:Processing [Activity]
   736   C1979874:Contrast [Qualitative Concept]
   736   C2986918:PS1 [Gene or Genome]
   736   C3244310:dependent [Functional Concept]

Phrase: "(Yu et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.269: Our data show that, unlike PS1, MOCA has a minimal effect on Notch-1 degradation and that of five additional membrane proteins (Fig. 1). 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that,"

Phrase: "unlike PS1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "has"

Phrase: "a minimal effect on Notch-1 degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "that of five additional membrane proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0025255:Membrane [Tissue]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205451:Five [Quantitative Concept]
   753   C0596901:Membrane [Cell Component]
   753   C1524062:Additional [Functional Concept]
   753   C1706182:Membrane [Manufactured Object]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.270: We also studied the effects of several selective -secretase inhibitors on APP secretion modulated by MOCA (Fig. 2 B). 

Phrase: "We also"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the effects of several selective -secretase inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "modulated by MOCA"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0443264:Modulated [Spatial Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "(Fig. 2 B"

Phrase: ")."
Processing 00000000.tx.271: Consistent with previous observations, there was little effect of these -secretase inhibitors on APP secretion in the absence of MOCA. 

Phrase: "Consistent with previous observations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "there"

Phrase: "was"

Phrase: "little effect of these -secretase inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of MOCA."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   861   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007577:Cell Adhesion [Cell Function]
   799   C0001511:Adhesion [Pathologic Function]
   799   C0007634:Cell [Cell]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0175633:Adhesion [Natural Phenomenon or Process]
   799   C0205349:Modifier [Qualitative Concept]
   799   C0332285:Of [Spatial Concept]
   799   C1269647:Cell [Cell]
   799   C1514623:Modifier [Conceptual Entity]
   799   C1516451:Modifier [Chemical Viewed Functionally]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   799   C3542952:Modifier [Intellectual Product]
Processing 00000000.tx.272: In contrast to the proteasome inhibitors, among the -secretase inhibitors tested, only -secretase inhibitors III and IV and Calp III partially revert the effect of MOCA effect on APP secretion. 

Phrase: "In contrast to the proteasome inhibitors,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "among the -secretase inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "only -secretase inhibitors III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "IV"

Phrase: "and"

Phrase: "Calp III partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "revert"

Phrase: "the effect of MOCA effect"

Phrase: "on APP secretion."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.273: -Secretase inhibitor II, which has no effect, is thought to be an aspartyl protease inhibitor, which selectively inhibits the -secretase cleavage of APP and Notch-1 proteolysis (Wolfe et al., 1998; 1999; De Strooper et al., 1999; Berezovska et al., 2000; Esler et al., 2000). 

Phrase: "-Secretase inhibitor II,"

Phrase: "which"

Phrase: "has"

Phrase: "no effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an aspartyl protease inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   901   C0078989:aspartyl protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2717969:Aspartyl Protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "which selectively"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the -secretase cleavage of APP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "Notch-1 proteolysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0597304:Proteolysis [Molecular Function]
   755 E C1947941:proteolytic [Enzyme]
   734   C1334889:notch 1 [Gene or Genome]

Phrase: "(Wolfe et al.,"

Phrase: "1998"

Phrase: "; 1999"

Phrase: "; De Strooper et al.,"

Phrase: "1999"

Phrase: "; Berezovska et al.,"

Phrase: "2000"

Phrase: "; Esler et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.274: The other -secretase inhibitors including III, IV, V, and the potent calpain inhibitor III are dipeptidyl aldehydes targeting cysteine proteases and may block proteasome enzymes, accounting for the inconsistency of their effects on APP secretion affected by MOCA. 

Phrase: "The"

Phrase: "other -secretase inhibitors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "IV,"

Phrase: "V,"

Phrase: "and"

Phrase: "the potent calpain inhibitor III"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C1700414:calpain inhibitor III [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]

Phrase: "are"

Phrase: "dipeptidyl aldehydes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001992:Aldehydes [Organic Chemical]

Phrase: "targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521840:Targeting [Functional Concept]
   966 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "cysteine proteases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C2717970:Cysteine Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]

Phrase: "and"

Phrase: "may"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "proteasome enzymes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "accounting for the inconsistency of their effects"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   748   C0000938:Accounting [Occupational Activity]
   748   C1280500:effects [Qualitative Concept]
   714 E C1551359:account [Idea or Concept]
   714 E C2348382:Effect [Qualitative Concept]
   714 E C2741673:Account # [Clinical Attribute]
   714 E C2981730:Account [Classification]

Phrase: "on APP secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1159339:Protein Secretion [Cell Function]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "affected by MOCA."
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C0392760:Affected [Functional Concept]
   748   C1269647:Cell [Cell]
   748   C1314939:Affected [Functional Concept]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714 E C0001721:Affect [Mental Process]
Processing 00000000.tx.275: Finally, the additive effect of PS1 on MOCA-decreased APP secretion was demonstrated (Fig. 2 C). 

Phrase: "Finally,"

Phrase: "the additive effect of PS1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0442796:Additive [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C1550602:Additive [Substance]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on MOCA-decreased APP secretion"
Meta Candidates (Total=29; Excluded=1; Pruned=0; Remaining=28)
   860   C1327616:Cell secretion [Cell Function]
   840   C1159339:Protein Secretion [Cell Function]
   816   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   816   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   816   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   801   C0007577:Cell Adhesion [Cell Function]
   788   C0001511:Adhesion [Pathologic Function]
   788   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0007634:Cell [Cell]
   788   C0011560:Amyloid [Pathologic Function]
   788   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0036536:secretion [Biologic Function]
   788   C0036537:Secretion [Body Substance]
   788   C0175633:Adhesion [Natural Phenomenon or Process]
   788   C0205216:Decreased [Quantitative Concept]
   788   C0205349:Modifier [Qualitative Concept]
   788   C0392756:Decreased [Qualitative Concept]
   788   C0442797:decreased [Qualitative Concept]
   788   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C1269647:Cell [Cell]
   788   C1514623:Modifier [Conceptual Entity]
   788   C1516451:Modifier [Chemical Viewed Functionally]
   788   C1704653:Cell [Medical Device]
   788   C1709634:Precursor [Idea or Concept]
   788   C1720176:On [Functional Concept]
   788   C1720294:On [Intellectual Product]
   788   C1948049:Cell [Spatial Concept]
   788   C3542952:Modifier [Intellectual Product]
   755 E C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "demonstrated"

Phrase: "(Fig. 2 C)."
Processing 00000000.tx.276: This observation is consistent with the fact that PS1 lowers the secretion of APP in yeast (Evin et al., 2000). 

Phrase: "This observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is"

Phrase: "consistent with the fact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that PS1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PS1 [Gene or Genome]
  1000   C2986918:PS1 [Gene or Genome]

Phrase: "lowers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "the secretion of APP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "in yeast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0036025:yeast [Fungus]
  1000   C0043392:Yeast [Food]
  1000   C0043393:Yeast [Fungus]
  1000   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]

Phrase: "(Evin et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.277: MOCA also functions effectively in the presence of mutant PS1. 

Phrase: "MOCA also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: "functions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "effectively in the presence of mutant PS1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C1418985:PS1 [Gene or Genome]
   748   C2986918:PS1 [Gene or Genome]
Processing 00000000.tx.278: Together, the above data show that the effect of MOCA is very different from that of the PS1-associated -secretase activity. 

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the above data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "very different from that of the PS1-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "associated -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "secretase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.279: MOCA contains an SH3 domain, interacts with the Crk adaptor protein, and shares a 40% homology with DOCK180 (Kashiwa et al., 2000). 

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an SH3 domain,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0282535:SH3 Domain [Amino Acid Sequence]
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: "interacts with the Crk adaptor protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1135629:Adaptor Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C1451465:CRK Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1706710:Adaptor [Manufactured Object]

Phrase: "and"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "a 40% homology with DOCK180"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1334043:Homology [Gene or Genome]
   760   C2697616:Homology [Qualitative Concept]

Phrase: "(Kashiwa et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.280: Because DOCK180 interacts with Rac and other small G-proteins, MOCA may also interact with small G-proteins involved in protein breakdown or mediate phosphorylation events between proteins involved in APP trafficking and metabolism. 

Phrase: "Because"

Phrase: "DOCK180"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1333245:DOCK180 [Gene or Genome]
  1000   C1333263:DOCK180 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interacts with Rac"

Phrase: "and"

Phrase: "other small G-proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0751984:Small G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "may"

Phrase: "also"

Phrase: "interact with small G-proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   862   C0751984:Small G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   781 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439267:g% [Quantitative Concept]
   760   C0700321:Small [Quantitative Concept]

Phrase: "involved in protein breakdown"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1623036:protein breakdown [Molecular Function]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0443161:break down [Qualitative Concept]
   770   C0699900:breakdown [Organism Function]
   770   C1265875:breakdown [Acquired Abnormality]
   770   C1314939:Involved [Functional Concept]

Phrase: "or"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "phosphorylation events between proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441471:Events [Event]
   770   C3541888:Events [Classification]

Phrase: "involved in APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1314939:Involved [Functional Concept]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "trafficking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599896:trafficking [Cell Function]

Phrase: "and"

Phrase: "metabolism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.281: APP is a potent cell adhesion molecule which binds to both heparin and other extracellular matrix molecules (Schubert et al., 1989; Beher et al., 1996; Wu et al., 1997). 

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "is"

Phrase: "a potent cell adhesion molecule"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   923   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   861   C0007577:Cell Adhesion [Cell Function]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0007634:Cell [Cell]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0567416:Molecule [Substance]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   741 E C1521991:Molecular [Qualitative Concept]

Phrase: "which"

Phrase: "binds to both heparin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "other extracellular matrix molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0015350:Extracellular Matrix [Tissue]

Phrase: "(Schubert et al.,"

Phrase: "1989"

Phrase: "; Beher et al.,"

Phrase: "1996"

Phrase: "; Wu et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.282: Cells which express APP adhere more rapidly to extracellular matrix proteins than cells which do not (Fig. 8) (Schubert and Behl, 1993). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "express"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "adhere"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231441:Adhere [Finding]

Phrase: "more rapidly to extracellular matrix proteins"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0079323:Extracellular Matrix Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0015350:Extracellular Matrix [Tissue]
   767   C1333498:Extracellular Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205172:More [Functional Concept]
   753   C0521119:Extracellular [Cell Component]
   753   C1637379:Rapidly [Qualitative Concept]
   753   C1704640:Matrix [Spatial Concept]
   753   C1706515:Matrix [Body Substance]

Phrase: "than cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "do"

Phrase: "not (Fig. 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]
   827   C1518422:Not [Functional Concept]

Phrase: ")"

Phrase: "(Schubert"

Phrase: "and"

Phrase: "Behl,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.283: Conversely, the inhibition of APP synthesis by antisense techniques blocks cell-substratum adhesion (Coulson et al., 1997). 

Phrase: "Conversely,"

Phrase: "the inhibition of APP synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1519619:Protein Synthesis Inhibition [Genetic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by antisense techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "cell-substratum adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "(Coulson et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.284: The expression of MOCA in B103 nerve cells, which do not make APP, has no effect on cellular adhesion to laminin, but reduces the rate of adhesion of cells which express APP (Fig. 8). 

Phrase: "The expression of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in B103 nerve cells,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0027882:Nerve Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "which"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "APP,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "has"

Phrase: "no effect on cellular adhesion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "to laminin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "reduces"

Phrase: "the rate of adhesion of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "which"

Phrase: "express"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.285: Therefore, the effect of MOCA on cell-substratum is tightly coupled to APP expression. 

Phrase: "Therefore,"

Phrase: "the effect of MOCA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0681891:effect modifier [Functional Concept]
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on cell-substratum"

Phrase: "is"

Phrase: "tightly"

Phrase: "coupled to APP expression."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1171362:protein expression [Genetic Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1709634:Precursor [Idea or Concept]
   753   C1948027:Coupled [Functional Concept]
   719 E C0010222:couple [Family Group]
Processing 00000000.tx.286: When the rapid breakdown of APP caused by MOCA is blocked by proteasome inhibitors, there is a return to the normal rate of adhesion for B103 cells expressing APP (Fig. 8 B). 

Phrase: "When"

Phrase: "the rapid breakdown of APP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C1327161:amyloid precursor protein breakdown [Molecular Function]
   774   C1623036:protein breakdown [Molecular Function]
   748   C0443161:break down [Qualitative Concept]
   748   C0699900:breakdown [Organism Function]
   748   C1265875:breakdown [Acquired Abnormality]

Phrase: "caused by MOCA"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]
   714   C0015127:cause [Functional Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "is"

Phrase: "blocked by proteasome inhibitors,"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   833   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
   833   C2266856:Proteasome Inhibitors [Molecular Function]
   799 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   770   C0028778:Blocked [Pathologic Function]
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0243077:inhibitors [Chemical Viewed Functionally]
   770   C0332206:Blocked [Functional Concept]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C1999216:Inhibitor [Qualitative Concept]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "there"

Phrase: "is"

Phrase: "a return to the normal rate of adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332156:Return to [Qualitative Concept]
           Return

Phrase: "for B103 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "(Fig. 8 B"

Phrase: ")."
Processing 00000000.tx.287: The simplest explanation for these results is that in the presence of MOCA newly synthesized APP is degraded at such a rapid rate that very little reaches the cell surface so that it is unable to participate in adhesive interactions. 

Phrase: "The simplest explanation for these results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanation [Intellectual Product]

Phrase: "is"

Phrase: "that in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "of MOCA newly synthesized APP"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   816   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   816   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   816   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   801   C0007577:Cell Adhesion [Cell Function]
   788   C0001511:Adhesion [Pathologic Function]
   788   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0007634:Cell [Cell]
   788   C0011560:Amyloid [Pathologic Function]
   788   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0175633:Adhesion [Natural Phenomenon or Process]
   788   C0205349:Modifier [Qualitative Concept]
   788   C0332285:Of [Spatial Concept]
   788   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0750546:newly [Idea or Concept]
   788   C1269647:Cell [Cell]
   788   C1514623:Modifier [Conceptual Entity]
   788   C1516451:Modifier [Chemical Viewed Functionally]
   788   C1704653:Cell [Medical Device]
   788   C1709634:Precursor [Idea or Concept]
   788   C1883254:Synthesized [Activity]
   788   C1948049:Cell [Spatial Concept]
   788   C3542952:Modifier [Intellectual Product]

Phrase: "is"

Phrase: "degraded at such"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "a rapid rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]

Phrase: "that very little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]

Phrase: "reaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596012:Reaches [Finding]
  1000   C2584321:Reach [Organism Function]

Phrase: "the cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "participate in adhesive interactions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001516:Adhesive [Manufactured Object]
   770   C2982905:Adhesive [Manufactured Object]
   737   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.288: Because one adhesion-dependent biological activity of APP is the regulation of neurite outgrowth (Jin et al., 1994), the expression of MOCA during development could regulate cell migration and axon pathfinding. 

Phrase: "Because"

Phrase: "one adhesion-dependent biological activity of APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   781   C1325278:amyloid protein activity [Molecular Function]
   762   C1537044:protein activity [Molecular Function]
   762   C1818642:biological adhesion [Biologic Function]
   742   C0005532:Biological [Biomedical Occupation or Discipline]
   742   C0205177:Activity [Functional Concept]
   742   C0205460:biological [Qualitative Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "the regulation of neurite outgrowth"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "(Jin et al.,"

Phrase: "1994"

Phrase: ")"

Phrase: ","

Phrase: "the expression of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "could"

Phrase: "regulate"

Phrase: "cell migration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1622501:Migration, Cell [Cell Function]
   861   C0600210:Migration [Social Behavior]
   861   C1533574:Migration [Physiologic Function]
   861   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "and"

Phrase: "axon pathfinding."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2984268:axon pathfinding [Cell Function]
   964 E C0598950:axonal pathfinding [Cell Function]
Processing 00000000.tx.289: Therefore, the aberrant expression of MOCA or its loss could have pathological consequences in addition to those caused by altered A secretion.  

Phrase: "Therefore,"

Phrase: "the aberrant expression of MOCA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "its loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "could"

Phrase: "have"

Phrase: "pathological consequences in addition to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0686907:consequences [Functional Concept]

Phrase: "caused by altered A secretion."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   767   C1327439:antibody secretion [Cell Function]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0392747:Altered [Functional Concept]
   719   C0015127:cause [Functional Concept]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719   C1524003:Cause [Conceptual Entity]
Processing 00000000.tx.290: Materials and methods Top Abstract Introduction Results Discussion Materials and methods References  Antibodies and chemicals Monoclonal antibody 22C11, which recognizes amino acid residues 6681 of APP695, was purchased from Roche. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "chemicals Monoclonal antibody 22C11,"

Phrase: "which"

Phrase: "recognizes"

Phrase: "amino acid residues 6681 of APP695,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "was"

Phrase: "purchased from Roche."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0331965:Roche [Health Care Related Organization]
   790   C0869011:purchased [Activity]
Processing 00000000.tx.291: Anti-GID, a rabbit polyclonal antibody against amino acid residues 175186 of APP695, was provided by Dr. 

Phrase: "Anti-GID,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009225:Gid [Disease or Syndrome]

Phrase: "a rabbit polyclonal antibody against amino acid residues 175186 of APP695,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   738   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.292: Greg Cole (University of California, Los Angeles, CA) and has been well characterized (Schubert et al., 1989). 

Phrase: "Greg Cole"

Phrase: "(University of California,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006754:California [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C3146274:California [Plant]

Phrase: "Los Angeles,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024015:Los Angeles [Geographic Area]

Phrase: "CA)"

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "well characterized"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C1880022:Characterized [Activity]
   861   C3146287:Well [Manufactured Object]

Phrase: "(Schubert et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.293: CT-15, a rabbit polyclonal antibody against the last 15 COOH-terminal amino acid residues of APP695, was provided by Dr. 

Phrase: "CT-15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "a rabbit polyclonal antibody against the last 15 COOH-terminal amino acid residues"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   749   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   749   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   735   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   735   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "of APP695,"

Phrase: "was"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.294: Edward Koo (University of California, San Diego, CA). 

Phrase: "Edward Koo"

Phrase: "(University of California,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006754:California [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C3146274:California [Plant]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.295: Monoclonal antibody 6E10, which recognizes amino acid residues 117 of human A, was obtained from Dr. 

Phrase: "Monoclonal antibody 6E10,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which"

Phrase: "recognizes"

Phrase: "amino acid residues 117 of human A,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C2917660:Amino Acid [Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0086418:Human [Human]
   744   C0202406:Acid [Laboratory Procedure]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "was"

Phrase: "obtained from Dr."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.296: Richard Kiscsak (New York State Institute for Basic Research, Staten Island, NY) or purchased from Senetek. 

Phrase: "Richard Kiscsak"

Phrase: "(New York State Institute for Basic Research,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0035172:Research Institute [Organization]
   748   C0021622:institute [Organization]
   748   C1272753:Institute [Idea or Concept]

Phrase: "Staten Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "purchased from Senetek."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.297: An affinity purified polyclonal antibody, which recognizes amino acid residues 2,0122,027 of MOCA, was generated in rabbits (Kashiwa et al., 2000). 

Phrase: "An affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "polyclonal antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which"

Phrase: "recognizes"

Phrase: "amino acid residues 2,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "0122,"

Phrase: "027 of MOCA,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   814   C0007578:cell adhesion protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0007577:Cell Adhesion [Cell Function]
   748   C0001511:Adhesion [Pathologic Function]
   748   C0007634:Cell [Cell]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0175633:Adhesion [Natural Phenomenon or Process]
   748   C0205349:Modifier [Qualitative Concept]
   748   C1269647:Cell [Cell]
   748   C1514623:Modifier [Conceptual Entity]
   748   C1516451:Modifier [Chemical Viewed Functionally]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3542952:Modifier [Intellectual Product]

Phrase: "was"

Phrase: "generated in rabbits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034493:Rabbit [Mammal]
   790   C3146294:Generated [Activity]

Phrase: "(Kashiwa et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.298: A monoclonal antibody, recognizing the NH2-terminal amino acid residues 2180 of human PS1, and a polyclonal antibody, recognizing the amino acid residues 303316 of mouse PS1, were purchased from Chemicon and Oncogene, respectively. 

Phrase: "A monoclonal antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0746619:monoclonal [Finding]

Phrase: "recognizing"

Phrase: "the NH2-terminal amino acid residues 2180 of human PS1,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   760   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C2917660:Amino Acid [Pharmacologic Substance]
   739   C0001128:Acid [Chemical]
   739   C0002508:NH2 [Organic Chemical]
   739   C0025033:NH2 [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   739   C0086418:Human [Human]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0205088:Terminal [Temporal Concept]
   739   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1418985:PS1 [Gene or Genome]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   739   C2986918:PS1 [Gene or Genome]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "a polyclonal antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "recognizing"

Phrase: "the amino acid residues 303316 of mouse PS1,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C2917660:Amino Acid [Pharmacologic Substance]
   744   C0001128:Acid [Chemical]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1418985:PS1 [Gene or Genome]
   744   C2986918:PS1 [Gene or Genome]
   711   C1709915:Residue [Conceptual Entity]
   711   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "were"

Phrase: "purchased from Chemicon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "and"

Phrase: "Oncogene,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]

Phrase: "respectively."
Processing 00000000.tx.299: -Laminin antibody (sc-6018), N-CAM antibody (sc-1507), N- and E-cadherin antibody from Transduction Laboratories, Notch antibody (sc-6014) were purchased from Santa Cruz Biotechnology, Inc., and APLP was from Dr. 

Phrase: "-Laminin antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(sc-6018"

Phrase: ")"

Phrase: ","

Phrase: "N-CAM antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   870   C0443887:Nerve antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   771   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   771   C1413393:neural cell adhesion molecule [Gene or Genome]
   722   C1413564:neural adhesion molecule [Gene or Genome]
   717   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(sc-1507"

Phrase: ")"

Phrase: ","

Phrase: "N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "E-cadherin antibody from Transduction Laboratories,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0313106:antibody e [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0947659:E Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Notch antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(sc-6014"

Phrase: ")"

Phrase: "were"

Phrase: "purchased from Santa Cruz Biotechnology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0869011:purchased [Activity]

Phrase: "Inc.,"

Phrase: "and"

Phrase: "APLP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN [Gene or Genome]
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   875   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "was from Dr."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0031831:DR [Professional or Occupational Group]
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.300: Gopal Thinakaran (University of Chicago, Chicago, IL). 

Phrase: "Gopal Thinakaran"

Phrase: "(University of Chicago,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008044:Chicago [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.301: The following chemical reagents were bought from Sigma-Aldrich: chloroquine, NH4Cl, phosphoramidon, ALLN, ALLM, lactacystin, clasto-lactacystin -lactone, leupeptin, and MG132. 

Phrase: "The following chemical reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0462885:Chemical reagents [Indicator, Reagent, or Diagnostic Aid]
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "bought from Sigma-Aldrich"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1719918:Sigma [Intellectual Product]

Phrase: ":"

Phrase: "chloroquine,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   944 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]

Phrase: "NH4Cl,"

Phrase: "phosphoramidon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070915:phosphoramidon [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "ALLN,"

Phrase: "ALLM,"

Phrase: "lactacystin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "clasto-lactacystin -lactone,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022947:Lactone [Organic Chemical]

Phrase: "leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "MG132."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.302: Epoxomicin was bought from Biomol. 

Phrase: "Epoxomicin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0656383:epoxomicin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "bought from Biomol."
Processing 00000000.tx.303: -Secretase inhibitors II, III, IV, and V and calpain inhibitor III were purchased from Calbiochem. 

Phrase: "-Secretase inhibitors II,"

Phrase: "III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: "IV,"

Phrase: "and"

Phrase: "V"

Phrase: "and"

Phrase: "calpain inhibitor III"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1700414:calpain inhibitor III [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]
   734   C0054533:calpain inhibitor [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "purchased from Calbiochem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]
Processing 00000000.tx.304: Cells and transfection The neuronal cell line B103 (Schubert et al., 1974) was grown in DME supplemented with 10% heat-inactivated FBS. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "The neuronal cell line B103"

Phrase: "(Schubert et al.,"

Phrase: "1974"

Phrase: ")"

Phrase: "was"

Phrase: "grown in DME"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "supplemented with 10% heat-inactivated FBS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0018837:Heat [Natural Phenomenon or Process]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.305: B103 cells were stably transfected with APP695 using G418 selection (Schubert et al., 1989) and with various plasmids by Lipofectamine 2000 (Invitrogen) using puromycin selection for MOCA or hygromycin for PS1. 

Phrase: "B103 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stably"

Phrase: "transfected with APP695"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "G418 selection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036576:selection [Genetic Function]

Phrase: "(Schubert et al.,"

Phrase: "1989"

Phrase: ")"

Phrase: "and with various plasmids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1515981:And [Idea or Concept]

Phrase: "by Lipofectamine 2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1312445:lipofectamine 2000 [Organic Chemical]
   861   C0253711:Lipofectamine [Indicator, Reagent, or Diagnostic Aid,Lipid]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "puromycin selection for MOCA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0036576:selection [Genetic Function]

Phrase: "or"

Phrase: "hygromycin for PS1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0063201:hygromycin [Organic Chemical]
Processing 00000000.tx.306: The stably transfected cells were subsequently cloned and screened for protein expression by Western blot analysis. 

Phrase: "The stably transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "subsequently"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "screened for protein expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1171362:protein expression [Genetic Function]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]

Phrase: "by Western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]
Processing 00000000.tx.307: Western blotting, metabolic labeling, immunoprecipitation, and ELISA For Western blotting, cells were washed twice with ice-cold PBS and lysed in lysis buffer (1% Triton, 50 mM Hepes, pH 7.5, 50 mM NaCl, 5 mM EDTA, 1 mM Na3VO4, 50 mM NaF, 10 mM Na4P2O7, plus a mixture of protease inhibitors [Complete Mini; Roche]). 

Phrase: "Western blotting,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "metabolic labeling,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "immunoprecipitation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "ELISA For Western blotting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0014441:ELISA [Laboratory Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with ice-cold PBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1720725:Twice [Intellectual Product]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   760   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "lysed in lysis buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0024348:Lysis [Pathologic Function]
           lysed
   770   C1536403:lysis [Cell Function]

Phrase: "(1% Triton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242759:Triton [Geographic Area]

Phrase: "50 mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "50 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "5 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM Na3VO4,"

Phrase: "50 mM NaF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037508:NaF [Biomedical or Dental Material,Inorganic Chemical]
   827   C1366571:NAF [Gene or Genome]
   827   C1705592:NAF [Gene or Genome]

Phrase: "10 mM Na4P2O7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0663811:Na4P2O7 [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "a mixture of protease inhibitors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:Mixture [Substance]

Phrase: "[Complete Mini"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445542:Mini [Organism Attribute]

Phrase: "; Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.308: For secreted protein analysis, semiconfluent cultures (106 cells in 100-mm tissue culture dishes) were washed twice with serum-free medium and incubated for 20 h in 4 ml serum-free medium. 

Phrase: "For secreted protein analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1514534:Protein Analysis [Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "semiconfluent cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "(106 cells in 100-mm tissue culture dishes"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   778   C1331092:tissue/cell culture [Laboratory Procedure]
   776 E C0040284:cell tissue culture [Laboratory Procedure]
   767   C0007585:cells culture [Laboratory Procedure]
   767   C1441340:100 cells [Cell]
   750   C2347576:Cells/dish [Quantitative Concept]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with serum-free medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   760   C0009458:Medium [Intellectual Product]
   760   C0229671:Serum [Body Substance]
   760   C0332296:free [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C1546774:Serum [Intellectual Product]
   760   C1550100:Serum [Body Substance]
   760   C1705217:Medium [Substance]
   760   C1720725:Twice [Intellectual Product]
   760   C1880497:Free [Qualitative Concept]
   760   C1948050:Twice [Quantitative Concept]
   760   C1996904:Free [Qualitative Concept]
   760   C3244283:medium [Intellectual Product]

Phrase: "and"

Phrase: "incubated for 20 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 4 ml serum-free medium."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C0009458:Medium [Intellectual Product]
   804   C0229671:Serum [Body Substance]
   804   C0332296:free [Functional Concept]
   804   C0439536:Medium [Quantitative Concept]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]
   804   C1705217:Medium [Substance]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]
   804   C3244283:medium [Intellectual Product]
Processing 00000000.tx.309: The growth conditioned medium was then desalted by passage through a Sephadex G25 column, and 10% of the material was used to determine protein content. 

Phrase: "The growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018270:'growth' NOS [Organism Function]
  1000   C0220844:growth [Physiologic Function]
  1000   C1621966:Growth [Organ or Tissue Function]
  1000   C2911660:Growth [Activity]

Phrase: "conditioned"
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
  1000   C0009647:Conditioned [Mental Process]
   966 E C0012634:condition [Disease or Syndrome]
   966 E C0348080:Condition [Qualitative Concept]
   966 E C1705253:Condition [Conceptual Entity]
   928 E C0040607:Training [Educational Activity]
   928 E C0220931:Training [Educational Activity]
   928 E C0336809:Train [Manufactured Object]
   928 E C1552514:Train [Manufactured Object]
   928 E C2673163:training [Qualitative Concept]

Phrase: "medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "desalted by passage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439799:Passage [Spatial Concept]

Phrase: "through a Sephadex G25 column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "and"

Phrase: "10% of the material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0520510:Material [Substance]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "protein content."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.310: For a given experiment, equal amounts of protein (usually 15 g) were lyophilized and resuspended in 50 l of sample buffer. 

Phrase: "For a given experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0681814:Experiment [Research Activity]
   861   C1706386:Experiment [Conceptual Entity]
   789 E C1517586:Experimental [Qualitative Concept]

Phrase: "equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "(usually 15 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "lyophilized"

Phrase: "and"

Phrase: "resuspended in 50 l of sample buffer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0370003:Sample [Substance]
   748   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.311: Protein concentrations were determined by Coomassie Plus (Pierce Chemical Co.). 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined by Coomassie"

Phrase: "Plus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332287:Plus [Qualitative Concept]

Phrase: "(Pierce Chemical Co."

Phrase: ")."
Processing 00000000.tx.312: The same amount of protein from each sample was separated on Novex precast 10% polyacrylamide gels (Invitrogen) and transferred to Immobulin membranes (Millipore). 

Phrase: "The same amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "from each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "separated on Novex precast 10% polyacrylamide gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   714 E C1382104:Gel [Substance]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "and"

Phrase: "transferred to Immobulin membranes"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0025255:Membranes [Tissue]
   770   C0348011:transferred [Functional Concept]
   737 E C0040671:Transfer [Mental Process]
   737 E C0596901:Membrane [Cell Component]
   737 E C1705822:Transfer [Activity]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "(Millipore"

Phrase: ")."
Processing 00000000.tx.313: The membranes were blocked with 5% nonfat milk in Tris-buffered saline for 1 h at room temperature. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "blocked with 5% nonfat milk"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0026131:Milk [Body Substance]
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C0349374:Milk [Food]
   760   C0444318:Milk [Substance]
   760   C2825079:Milk [Food]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
   704 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   704 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "in Tris-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0036082:Saline [Substance]
   827   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   827   C0814229:TRI [Intellectual Product]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.314: After overnight incubation at 4C with primary antibodies, the antigens were detected with HRP-conjugated secondary antibodies (Bio-Rad Laboratories) using an ECL kit (Amersham Pharmacia) and exposed to film. 

Phrase: "After overnight incubation"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with primary antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "the antigens"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "were"

Phrase: "detected with HRP-conjugated secondary antibodies"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0019941:HRP [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0442726:Detected [Finding]
   753   C0522529:Conjugated [Spatial Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Bio-Rad Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ECL kit (Amersham Pharmacia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")"

Phrase: "and"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "film."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086296:Film [Manufactured Object]
  1000   C1561571:film [Biomedical or Dental Material]
  1000   C1561572:film [Substance]
Processing 00000000.tx.315: For pulsechase experiments, cells were grown to 80% confluency and incubated in methionine-free DME for 90 min. 

Phrase: "For pulsechase experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown to 80% confluency"

Phrase: "and"

Phrase: "incubated in methionine-free DME"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   760   C0332296:free [Functional Concept]
   760   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1880497:Free [Qualitative Concept]
   760   C1996904:Free [Qualitative Concept]

Phrase: "for 90 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.316: Cells were labeled with [35S]methionine (400 Ci/ml in methionine-free DME plus 5% dialyzed FBS) for 10 min at 37C, and the medium was replaced with serum-free DME medium plus N1 supplement (Sigma-Aldrich). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[35S"

Phrase: "]methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(400 Ci/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2348025:Ci/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "in methionine-free DME plus 5% dialyzed FBS)"

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 37C,"

Phrase: "and"

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "replaced with serum-free DME medium plus N1 supplement"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   742   C0009458:Medium [Intellectual Product]
   742   C0058217:DME [Hazardous or Poisonous Substance,Organic Chemical]
   742   C0229671:Serum [Body Substance]
   742   C0242295:Supplement [Food]
   742   C0332287:Plus [Qualitative Concept]
   742   C0332296:free [Functional Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C0441962:N1 [Finding]
   742   C0559956:Replaced [Functional Concept]
   742   C0641456:dme [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C1299987:replaced [Functional Concept]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C1705217:Medium [Substance]
   742   C1880497:Free [Qualitative Concept]
   742   C1947943:Supplement [Intellectual Product]
   742   C1996904:Free [Qualitative Concept]
   742   C2348609:Supplement [Functional Concept]
   742   C3244283:medium [Intellectual Product]
   708 E C1554078:Replace [Idea or Concept]

Phrase: "(Sigma-Aldrich"

Phrase: ")."
Processing 00000000.tx.317: The media were collected, and cells were lysed after different time periods. 

Phrase: "The media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed after different time periods."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0439582:Time periods [Temporal Concept]
   778 E C0585019:Temporal periods [Temporal Concept]
   762   C1442103:Time Difference [Temporal Concept]
   762   C1547049:*Time Difference [Quantitative Concept]
   760   C0024348:lysed [Pathologic Function]
   760   C0040223:Time [Temporal Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   726   C0439531:/period [Temporal Concept]
   726   C1948053:Period [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.318: Protein concentrations were determined, and the same amounts of protein were immunoprecipitated with antibodies at 4C overnight. 

Phrase: "Protein concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427716:Protein concentration [Laboratory Procedure]
   983   C1304757:Protein concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "determined"

Phrase: ","

Phrase: "and"

Phrase: "the same amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:amounts [Quantitative Concept]

Phrase: "were"

Phrase: "immunoprecipitated with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   756   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "at 4C overnight."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]
Processing 00000000.tx.319: 25 l of antimouse IgG agarose (Roche) were then added to each sample and incubated at 4C for 2 h on a rocker platform. 

Phrase: "25 l of antimouse IgG agarose"

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added to each sample"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0370003:Sample [Substance]
   770   C1524062:Added [Functional Concept]
   770   C2347026:Sample [Conceptual Entity]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "on a rocker platform."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710360:Platform [Research Device]
Processing 00000000.tx.320: The immunoprecipitates were collected by centrifugation and washed four times with the washing buffer (0.1% Triton, 20 mM Hepes, 150 mM NaCl, 10% glycerol). 

Phrase: "The immunoprecipitates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "were"

Phrase: "collected by centrifugation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "washed four times with the washing buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "(0.1% Triton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242759:Triton [Geographic Area]

Phrase: "20 mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "10% glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.321: The agarose beads were resuspended in 30 l SDS-PAGE sample buffer and boiled for 3 min to release the proteins. 

Phrase: "The agarose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in 30 l SDS-PAGE sample buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   744   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0370003:Sample [Substance]
   744   C1704732:Page [Intellectual Product]
   744   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "boiled for 3 min to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0242301:Boil [Disease or Syndrome]
   726   C1546559:Boil [Intellectual Product]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.322: After 2 min of centrifugation, the supernatants were separated on 10% Tris-glycine gels. 

Phrase: "After 2 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "of centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "separated on 10% Tris-glycine gels."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   753   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0522461:Glycine [Plant]
   753   C0687118:Separated [Functional Concept]
   753   C0814229:TRI [Intellectual Product]
   719 E C1382104:Gel [Substance]
Processing 00000000.tx.323: For A analysis, 1020% acrylamide Tricine gels and longer incubation times were used. 

Phrase: "For A analysis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "1020% acrylamide Tricine gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "longer incubation times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0040223:times [Temporal Concept]
   827   C1632851:Times [Quantitative Concept]
   793 E C3541383:Time [Temporal Concept]
   755 E C0442043:Temporal [Spatial Concept]
   755 E C2362314:Temporal [Temporal Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.324: The gels were dried and subjected to autoradiography and quantitated by NIH image. 

Phrase: "The gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "subjected to autoradiography"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0004400:Autoradiography [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "quantitated by NIH image."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027468:NIH [Health Care Related Organization]
   770   C1704254:Image [Intellectual Product]
   770   C1704922:Image [Entity]
   770   C3542466:Image [Intellectual Product]
Processing 00000000.tx.325: A production was also measured by a sensitive fluorescence-based sandwich ELISA assay using a kit from Biosource International according to the manufacturer's instructions. 

Phrase: "A production"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0003261:antibodies production [Biologic Function]
   827   C0033268:production [Occupational Activity]

Phrase: "was"

Phrase: "also"

Phrase: "measured by a sensitive fluorescence-based sandwich ELISA assay"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   764   C0014441:ELISA assay [Laboratory Procedure]
           ELISA
   742   C0005507:Assay [Laboratory Procedure]
   742   C0016315:Fluorescence [Natural Phenomenon or Process]
   742   C0243073:assay [Qualitative Concept]
   742   C0332324:Sensitive [Functional Concept]
   742   C0444706:Measured [Qualitative Concept]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1527178:Based [Functional Concept]
   742   C1550474:sensitive [Idea or Concept]
   742   C1705938:Based [Idea or Concept]
   742   C3541902:MEASURED [Diagnostic Procedure]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0079809:Measure [Quantitative Concept]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C0242485:Measure [Functional Concept]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a kit from Biosource"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0812225:KIT [Medical Device]
   770   C1150635:KIT [Molecular Function]
   770   C1705212:Kit [Medical Device]
   770   C1705213:KIT [Medical Device]
   770   C3273202:Kit [Manufactured Object]

Phrase: "International according to the manufacturer's instructions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512888:International [Idea or Concept]
Processing 00000000.tx.326: Northern hybridization and RT-PCR Total RNA was isolated from the cells and brain tissues using Trizol reagents (Invitrogen), and mRNA was purified using a mRNA purification kit (Amersham Pharmacia Biotech). 

Phrase: "Northern hybridization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599862:northern hybridization [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0020202:Hybridisation [Genetic Function]
   861   C1300517:Hybridization [Laboratory Procedure]

Phrase: "and"

Phrase: "RT-PCR Total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from the cells"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0370215:Isolate [Substance]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "brain tissues"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0440746:brain tissues [Tissue]
   966 E C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0040300:Tissues [Tissue]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Trizol reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mRNA purification kit (Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.327: 2 g of mRNAs from each sample were separated on 1% agarose gels and transferred onto Zeta membranes (Bio-Rad Laboratories, Inc.). 

Phrase: "2 g of mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439267:g% [Quantitative Concept]

Phrase: "from each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "separated on 1% agarose gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1706746:Agarose Gel [Research Device]
   760   C0017243:Gels [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C0086972:Separated [Finding]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   726 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "transferred onto Zeta membranes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0025255:Membranes [Tissue]
   770   C0348011:transferred [Functional Concept]
   770   C1719914:Zeta [Intellectual Product]
   770   C2828406:Zeta [Eukaryote]
   737 E C0040671:Transfer [Mental Process]
   737 E C0596901:Membrane [Cell Component]
   737 E C1705822:Transfer [Activity]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "(Bio-Rad Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022877:Laboratories [Manufactured Object,Organization]
   827   C1619828:Laboratories [Intellectual Product]
   793 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.328: Northern hybridization was performed in a UltraHyb buffer (Ambion) with an APP cDNA fragment probe labeled with 32P-dCTP using a rediprime kit (Amersham Pharmacia Biotech). 

Phrase: "Northern hybridization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599862:northern hybridization [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0020202:Hybridisation [Genetic Function]
   861   C1300517:Hybridization [Laboratory Procedure]

Phrase: "was"

Phrase: "performed in a UltraHyb buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Ambion"

Phrase: ")"

Phrase: "with an APP cDNA fragment probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0182400:Probe [Medical Device]
   799   C1704681:Probe [Gene or Genome]
   799   C2347609:Probe [Chemical Viewed Functionally]
   799   C3536729:Probe [Manufactured Object]

Phrase: "labeled with 32P-dCTP"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1553631:32p [Medical Device]
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a rediprime kit (Amersham Pharmacia Biotech"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0331955:Pharmacia [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.329: RT reactions were performed for each RNA sample using 1 g of total RNA in RT buffer composed of 10 mM DTT, 20 M each of dATP, dCTP, dGTP, and dTTP, and 1 M of oligo (dT). 

Phrase: "RT reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]
   734   C0035380:Reverse Transcription [Genetic Function]

Phrase: "were"

Phrase: "performed for each RNA sample"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0370003:Sample [Substance]
   760   C0884358:Performed [Functional Concept]
   760   C2347026:Sample [Conceptual Entity]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1 g of total RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   760   C0439267:g% [Quantitative Concept]

Phrase: "in RT buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   734   C0035380:Reverse Transcription [Genetic Function]

Phrase: "composed of 10 mM DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012789:DTT [Carbohydrate,Pharmacologic Substance]

Phrase: "20 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "each of dATP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0045186:dATP [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1457900:Each [Quantitative Concept]

Phrase: "dCTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0045191:dCTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "dGTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0057430:dGTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "dTTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076582:dTTP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "1 M of oligo (dT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.330: The solution was heated to 65C for 5 min and cooled to 37C for 10 min, and then incubated in the presence of 25 U of AMV RT at 42C for 1 h. 

Phrase: "The solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037633:Solution [Substance]
  1000   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "heated to 65C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "for 5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "cooled to 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1548792:Cool [Qualitative Concept]

Phrase: "for 10 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated in the presence of 25 U of AMV RT"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0035380:Reverse Transcription [Genetic Function]
   738   C0040649:Transcription [Genetic Function]
   738   C0280591:AMV [Therapeutic or Preventive Procedure]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1555029:Reverse [Idea or Concept]

Phrase: "at 42C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419782:42C [Gene or Genome]
  1000   C3538774:42C [Gene or Genome]

Phrase: "for 1 h."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.331: Master mixes for the PCR reactions were used for each sample. 

Phrase: "Master mixes for the PCR reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0205430:Mix [Functional Concept]
   719   C1421951:MIX [Gene or Genome]
   719   C1720722:Mix [Qualitative Concept]

Phrase: "were"

Phrase: "used for each sample."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0370003:Sample [Substance]
   770   C1273517:used [Finding]
   770   C2347026:Sample [Conceptual Entity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.332: The PCR reaction mixture contained forward and reverse primers (1020 pmol each), dNTPs (200 M each as final concentration), 1x PCR buffer, Taq DNA polymerase (0.5 U) (Roche), and 1 l of the RT mixture as the source of cDNA. 

Phrase: "The PCR reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439962:Mixture [Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "reverse primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1953384:Reverse primer [Amino Acid, Peptide, or Protein]
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(1020 pmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439192:pmol [Quantitative Concept]

Phrase: "each"

Phrase: ")"

Phrase: ","

Phrase: "dNTPs"

Phrase: "(200 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "each as final concentration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0086045:Concentration [Mental Process]
   770   C0205088:Final [Temporal Concept]
   770   C1446561:Concentration [Quantitative Concept]
   770   C1457900:Each [Quantitative Concept]
   770   C1546485:Final [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "1x PCR buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "Taq DNA polymerase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0075813:Taq DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Taq Polymerase
  1000   C2257065:Taq DNA polymerase [Genetic Function]
   901   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(0.5 U"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: ")"

Phrase: "(Roche"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331965:Roche [Health Care Related Organization]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "1 l of the RT mixture"

Phrase: "as the source"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449416:Source [Finding]
  1000   C1705919:Source [Idea or Concept]

Phrase: "of cDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.333: The primers used for PCR reaction were as follows: 5'-ATGGATGCAGAATTCCGACATGAC-3' (forward) (nt 1,9331,956) and 5'-CTAGTTCTGCATCTGCTCAAAGAA-3' (reverse) (nt 2,2352,212) for the APP gene (sequence data available from GenBank/EMBL/DDBJ under accession no. Y00264). 

Phrase: "The primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used for PCR reaction"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0443286:Reaction [Functional Concept]
   770   C0677874:pCR [Finding]
   770   C1114821:Reaction [Clinical Attribute]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "5'-ATGGATGCAGAATTCCGACATGAC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: ")"

Phrase: "(nt 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0128167:NT-1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: "9331,"

Phrase: "956"

Phrase: ")"

Phrase: "and"

Phrase: "5'-CTAGTTCTGCATCTGCTCAAAGAA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "(reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: ")"

Phrase: "(nt 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0128101:NT-2 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0332126:NT [Qualitative Concept]
   861   C1449832:NT [Diagnostic Procedure]

Phrase: "2352,"

Phrase: "212"

Phrase: ")"

Phrase: "for the APP gene (sequence data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1511726:Data [Idea or Concept]
   799   C3245479:data [Medical Device]

Phrase: "available from GenBank/EMBL/DDBJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]

Phrase: "under accession"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510755:Accession [Intellectual Product]
  1000   C1706078:Accession [Activity]

Phrase: "no. Y00264"

Phrase: ")."
Processing 00000000.tx.334: Amplification was performed at 94C for 40 s, 56C for 1 min, and 72C for 1 min, for 35 cycles. 

Phrase: "Amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "performed at 94C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "for 40 s,"

Phrase: "56C for 1 min,"

Phrase: "and"

Phrase: "72C for 1 min,"

Phrase: "for 35 cycles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.335: The PCR reactions with primers and RNAs but without the RT reaction were conducted as controls. 

Phrase: "The PCR reactions with primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0443286:Reaction [Functional Concept]
   726   C1114821:Reaction [Clinical Attribute]

Phrase: "and"

Phrase: "RNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:rnas [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but without the RT reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0035380:Reverse Transcription [Genetic Function]
   753   C0040649:Transcription [Genetic Function]
   753   C0233535:but [Mental or Behavioral Dysfunction]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1555029:Reverse [Idea or Concept]

Phrase: "were"

Phrase: "conducted as controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0004927:Conduct [Individual Behavior]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.336: After amplification, each sample was electrophoresed on a 1.5% agarose gel visualized by ethidium bromide staining. 

Phrase: "After amplification,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "each sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "was"

Phrase: "electrophoresed on a 1.5% agarose gel"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1706746:Agarose Gel [Research Device]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0036681:Agarose [Carbohydrate]
   748   C1382104:Gel [Substance]
   714   C0013855:electrophorese [Laboratory Procedure]

Phrase: "visualized by ethidium bromide staining."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   760   C0006222:Bromide [Inorganic Chemical]
   760   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
   760   C0234621:Visualized [Functional Concept]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
Processing 00000000.tx.337: Adhesion assay The cell adhesion assays were performed as described previously (Schubert et al., 1989). 

Phrase: "Adhesion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "The cell adhesion assays"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   901   C0007577:Cell Adhesion [Cell Function]
   827   C0001511:Adhesion [Pathologic Function]
   827   C0007634:Cell [Cell]
   827   C0175633:Adhesion [Natural Phenomenon or Process]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Schubert et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.338: Exponentially B103 (APP695/Vector) and B103 (APP695/MOCA) cells were labeled with [3H]leucine for 15 h. 

Phrase: "Exponentially B103"

Phrase: "(APP695/Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "B103"

Phrase: "(APP695/MOCA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205349:Modifier [Qualitative Concept]
   753   C1514623:Modifier [Conceptual Entity]
   753   C1516451:Modifier [Chemical Viewed Functionally]
   753   C3542952:Modifier [Intellectual Product]

Phrase: ")"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled with"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C1708632:Labeled [Qualitative Concept]
   799 E C0181496:Label [Manufactured Object]
   799 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]leucine for 15 h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.339: The cells were pipetted from the culture dishes and washed three times by centrifugation with Hepes buffered medium containing 0.4% BSA (Calbiochem). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pipetted from the culture dishes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C2242979:Culture [Laboratory Procedure]
   726   C0020498:DISH [Disease or Syndrome]
   726   C0182301:Pipette [Medical Device]
   726   C1706407:Pipette [Medical Device]

Phrase: "and"

Phrase: "washed three times by centrifugation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with Hepes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "buffered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "medium containing 0.4% BSA (Calbiochem"

Phrase: ")."
Processing 00000000.tx.340: No trypsin or chelating reagents were used. 

Phrase: "No trypsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "or"

Phrase: "chelating reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.341: Aliquots of 0.2 ml containing 5 x 104 cells were pipetted into 35-mm plastic Petri dishes coated with 5 g mouse laminin and 2 ml of the above medium. 

Phrase: "Aliquots of 0.2 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510844:Aliquot [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 x 104 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pipetted into 35-mm plastic Petri dishes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032167:Plastic [Substance]
   745   C1322960:Petri dish [Medical Device]
   714   C0020498:DISH [Disease or Syndrome]
   714   C0182301:Pipette [Medical Device]
   714   C1706407:Pipette [Medical Device]

Phrase: "coated with 5 g mouse laminin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   783   C0171955:laminin-5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0022984:Laminin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0439267:g% [Quantitative Concept]
   753   C1522408:Coated [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "2 ml of the above medium."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.342: The cells did not attach to uncoated dishes. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "attach to uncoated dishes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0231441:Attach [Finding]
   770   C1314972:ATTACH [Intellectual Product]
   770   C1519767:Uncoated [Qualitative Concept]
   737   C0020498:DISH [Disease or Syndrome]
Processing 00000000.tx.343: At the indicated times, the dishes were swirled 10 times, the medium was aspirated, the remaining attached cells were dissolved in 3% Triton X-100, and their isotope content was determined. 

Phrase: "At the indicated times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "the dishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0020498:DISH [Disease or Syndrome]

Phrase: "were"

Phrase: "swirled"

Phrase: "10 times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "aspirated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0700198:Aspirated [Pathologic Function]
   966 E C0370199:Aspirate [Body Substance]

Phrase: ","

Phrase: "the remaining attached cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "dissolved in 3% Triton X-100,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   790   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   753   C0242759:Triton [Geographic Area]
   719   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "their isotope content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "determined."
Processing 00000000.tx.344: The data are plotted as the percent of input cells (radioactivity) that adhered at the indicated time and are presented as the average of triplicate plates. 

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "plotted as the percent of input cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0007634:Cells [Cell]
   748   C0439165:Percent [Quantitative Concept]
   748   C1708517:Input [Conceptual Entity]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(radioactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: ")"

Phrase: "that"

Phrase: "adhered at the indicated time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0231441:Adhered [Finding]
   760   C1444656:Indicated [Finding]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "are"

Phrase: "presented as the average of triplicate plates."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0205174:Triplicate [Quantitative Concept]
   748   C0449450:Presented [Idea or Concept]
   748   C1139930:plates [Medical Device]
   748   C1510992:Average [Quantitative Concept]
   748   C2825518:AVERAGE [Quantitative Concept]
   714 E C0005971:Plate [Medical Device]
   714 E C0150312:Present [Quantitative Concept]
   714 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.345: Variation between duplicates was <5%. 

Phrase: "Variation between duplicates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205419:Variation [Qualitative Concept]

Phrase: "was <"

Phrase: "5%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.346: Immunostaining and laser confocal imaging Cultured cells were fixed in 4% paraformaldehyde for 20 min and permeabilized with 0.2% Triton X-100 for 30 min. 

Phrase: "Immunostaining"

Phrase: "and"

Phrase: "laser confocal imaging Cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   840   C0007600:cultured cells [Cell]
   840   C0007635:Cultured Cells [Cell]
   840   C3282338:Cells, Cultured [Cell]
   806 E C0007585:culture cell [Laboratory Procedure]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771   C0010453:Culture [Idea or Concept]
   771   C0220814:culture [Functional Concept]
   771   C0430400:Culture [Laboratory Procedure]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   771   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "fixed in 4% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "permeabilized with 0.2% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0242759:Triton [Geographic Area]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.347: The fixed cells were blocked in 2% BSA in PBS for 1 h and incubated with primary antibodies followed by fluorescent-conjugated secondary antibodies (Molecular Probes). 

Phrase: "The fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "blocked in 2% BSA"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "incubated with primary antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "followed by fluorescent-conjugated secondary antibodies"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0332283:Followed by [Temporal Concept]
           followed
   767   C0016318:fluorescent antibody [Laboratory Procedure]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0027627:secondary [Neoplastic Process]
   753   C0175668:Secondary [Temporal Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0522529:Conjugated [Spatial Concept]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.348: The cells were then mounted under glass coverslips with antifading media containing 4% N-propyl gallate (Sigma-Aldrich). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "mounted under glass coverslips"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017596:Glass [Manufactured Object]
   770   C0449878:mounted [Finding]
   770   C1947936:Glass [Medical Device]
   737 E C0181909:Mount [Medical Device]

Phrase: "with antifading media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "4% N-propyl gallate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033501:Propyl Gallate [Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma-Aldrich"

Phrase: ")."
Processing 00000000.tx.349: The cells were examined with a Carl Zeiss MicroImaging, Inc. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "examined with a Carl Zeiss MicroImaging,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332128:Examined [Finding]

Phrase: "Inc."
Processing 00000000.tx.350: LSM 5 PASCAL laser scanning microscope. 

Phrase: "LSM 5 PASCAL laser scanning microscope."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   799   C0023089:Laser [Manufactured Object]
   799   C0034606:Scanning [Diagnostic Procedure]
   799   C0181839:Microscope [Medical Device]
   799   C0441633:Scanning [Diagnostic Procedure]
   799   C0458142:Laser [Phenomenon or Process]
   799   C1023865:Laser [Plant]
   799   C1706315:Laser [Medical Device]
   799   C1706379:Microscope [Medical Device]
   766 E C2826292:SCAN [Finding]
Processing 00000000.tx.351: 0.5-M-thick serial optical sections of the cells were recorded using the Carl Zeiss MicroImaging, Inc. 

Phrase: "0.5-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "M-"

Phrase: "thick serial optical sections of the cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Carl Zeiss MicroImaging,"

Phrase: "Inc."
Processing 00000000.tx.352: LSM 5 Image Examiner software to obtain images with pixel intensity within a linear range.  

Phrase: "LSM 5 Image Examiner software to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "images with pixel intensity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1704254:Image [Intellectual Product]
   737   C1704922:Image [Entity]
   737   C3542466:Image [Intellectual Product]

Phrase: "within a linear range."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]
Processing 00000000.tx.353: Footnotes  * Abbreviations used in this paper: A, amyloid -peptide; 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "* Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used in this paper"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0030351:Paper [Manufactured Object]
   770   C1273517:used [Finding]
   770   C1547566:Paper [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "A,"

Phrase: "amyloid -peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.354: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.355: ALLM, N-Ac-Leu-Leu-methioninal; 

Phrase: "ALLM,"

Phrase: "N-Ac-Leu-Leu-methioninal"

Phrase: ";"
Processing 00000000.tx.356: ALLN, N-acetyl-leucyl-norleucinal; 

Phrase: "ALLN,"

Phrase: "N-acetyl-leucyl-norleucinal"

Phrase: ";"
Processing 00000000.tx.357: APLP, amyloid precursor-like protein; 

Phrase: "APLP,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN [Gene or Genome]
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   875   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor-like protein"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN [Gene or Genome]
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   875   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.358: APP, -amyloid precursor protein; 

Phrase: "APP, -"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.359: FAD, familial Alzheimer's disease; 

Phrase: "FAD,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "familial Alzheimer's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.360: MOCA, modifier of cell adhesion protein; 

Phrase: "MOCA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: "modifier of cell adhesion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205349:Modifier [Qualitative Concept]
   760   C1514623:Modifier [Conceptual Entity]
   760   C1516451:Modifier [Chemical Viewed Functionally]
   760   C3542952:Modifier [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.361: N-CAM, neural cell adhesion molecule; 

Phrase: "N-CAM,"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
  1000   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1413393:neural cell adhesion molecule [Gene or Genome]
   923   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   923   C1413564:neural adhesion molecule [Gene or Genome]
   861   C0007577:Cell Adhesion [Cell Function]
   861   C0027882:Neural cell [Cell]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0007634:Cell [Cell]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0567416:Molecule [Substance]
   812   C0599851:Neural [Functional Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   756 E C0027740:Nerve [Tissue]
   756 E C0027757:NERVE [Tissue]
   756 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   741 E C1521991:Molecular [Qualitative Concept]
   719 E C0027769:nervy [Sign or Symptom]

Phrase: "neural cell adhesion molecule"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
  1000   C0282587:Neural Cell Adhesion Molecule [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1413393:neural cell adhesion molecule [Gene or Genome]
   923   C0007578:Cell adhesion molecule [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Adhesion Molecule
   923   C1413564:neural adhesion molecule [Gene or Genome]
   861   C0007577:Cell Adhesion [Cell Function]
   861   C0027882:Neural cell [Cell]
   812   C0001511:Adhesion [Pathologic Function]
   812   C0007634:Cell [Cell]
   812   C0175633:Adhesion [Natural Phenomenon or Process]
   812   C0567416:Molecule [Substance]
   812   C0599851:Neural [Functional Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   756 E C0027740:Nerve [Tissue]
   756 E C0027757:NERVE [Tissue]
   756 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   741 E C1521991:Molecular [Qualitative Concept]
   719 E C0027769:nervy [Sign or Symptom]

Phrase: ";"
Processing 00000000.tx.362: PS, presenilin; 

Phrase: "PS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: ";"
Processing 00000000.tx.363: RT, reverse transcription.  

Phrase: "RT,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]

Phrase: "reverse transcription."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0035380:Reverse Transcription [Genetic Function]
   861   C0040649:Transcription [Genetic Function]
   861   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.364: Acknowledgments  We are grateful to Drs. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Drs."
Processing 00000000.tx.365: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.366: Maher, G. 

Phrase: "Maher,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.367: Cole, and E. 

Phrase: "Cole,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.368: Koo for critically reading the article, Dr. 

Phrase: "Koo for critically"

Phrase: "reading"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Reading [Daily or Recreational Activity]
  1000   C1705179:Reading [Finding]

Phrase: "the article,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.369: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.370: Mucke for the B103 APPsw clone and Dr. 

Phrase: "Mucke for the B103 APPsw clone"

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.371: Gopal Thinakaran for the APLP antibody, members of the laboratory for discussions, and B. 

Phrase: "Gopal Thinakaran for the APLP antibody,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   818   C1412466:AMYLOID PRECURSOR-LIKE PROTEIN [Gene or Genome]
   784   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   784   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   764   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0011560:Amyloid [Pathologic Function]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1709634:Precursor [Idea or Concept]

Phrase: "members of the laboratory"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0680022:members [Population Group]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "for discussions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557061:discussions [Therapeutic or Preventive Procedure]
   966 E C2584313:Discussion [Social Behavior]

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.372: Wamsley for article preparation. 

Phrase: "Wamsley for article preparation."
Processing 00000000.tx.373: This work was supported by a Bundy Foundation Fellowship to Q. 

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by a Bundy Foundation Fellowship"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0015770:Fellowship [Educational Activity]
   753   C0016617:Foundation [Organization]
   753   C1521721:Supported [Conceptual Entity]
   719 E C0183683:Support [Medical Device]

Phrase: "to Q."
Processing 00000000.tx.374: Chen, the Jacob Peter Hansen and Anna Charlotte Hansen Fund for Alzheimer's Research, the National Institutes of Health, and the Alzheimer's Association of America. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "the Jacob Peter Hansen"

Phrase: "and"

Phrase: "Anna Charlotte Hansen Fund for Alzheimer's Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0681805:research fund [Research Activity]
   748   C0016820:Fund [Quantitative Concept]

Phrase: "the National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "the Alzheimer's Association of America."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]
Processing 00000000.tx.375: Submitted: 30 October 2001 Revised: 21 May 2002 Accepted: 31 May 2002  References Top Abstract Introduction Results Discussion Materials and methods References  Beher, D., L. 

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: ":"

Phrase: "30 October 2001"

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: ":"

Phrase: "21 May 2002"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: ":"

Phrase: "31 May 2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450355:31 [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Results Discussion Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Beher,"

Phrase: "D."

Phrase: ","

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.376: Hesse, C.L. 

Phrase: "Hesse,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.377: Masters, and K. 

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.378: Beyreuther. 

Phrase: "Beyreuther."
Processing 00000000.tx.379: 1996. 

Phrase: "1996."
Processing 00000000.tx.380: Regulation of amyloid precursor protein (APP)-binding to collagen and mapping of the binding sites on APP and collagen type I. 

Phrase: "Regulation of amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "(APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ")"

Phrase: "-"

Phrase: "binding to collagen"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   858   C1149167:collagen binding [Molecular Function]
   790   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167364:collagen [Cell Component]
   790   C1167622:Binding [Molecular Function]
   718 E C0439689:Collagenous [Qualitative Concept]

Phrase: "and"

Phrase: "mapping of the binding sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1283195:Mapping [Activity]

Phrase: "on APP"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "collagen type I."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0041455:Collagen Type I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1167375:collagen type I [Cell Component]
   901   C0441729:Type I [Classification]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332307:Type [Qualitative Concept]
   827   C1167364:collagen [Cell Component]
   827   C1547052:*Type [Quantitative Concept]
   755 E C0439689:Collagenous [Qualitative Concept]
Processing 00000000.tx.381: J. 

Phrase: "J."
Processing 00000000.tx.382: Biol. 

Phrase: "Biol."
Processing 00000000.tx.383: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.384: 271:16131620.[Abstract/Free FullText] Borchelt, D.R., M.K. 

Phrase: "271"

Phrase: ":"

Phrase: "16131620."

Phrase: "[Abstract/Free FullText"

Phrase: "] Borchelt,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "M."

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.385: Lee, G. 

Phrase: "Lee,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.386: Thinakaran, T. 

Phrase: "Thinakaran,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.387: Ratovitsky, C.M. 

Phrase: "Ratovitsky,"

Phrase: "C.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.388: Prada, G. 

Phrase: "Prada,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.389: Kim, M. 

Phrase: "Kim,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.390: Seeger, A. 

Phrase: "Seeger,"

Phrase: "A."
Processing 00000000.tx.391: Levey, S. 

Phrase: "Levey,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.392: Gandy, N.G. 

Phrase: "Gandy,"

Phrase: "N.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.393: Copeland, et al. 

Phrase: "Copeland,"

Phrase: "et al."
Processing 00000000.tx.394: 1996. 

Phrase: "1996."
Processing 00000000.tx.395: Familial Alzheimer's disease-linked presenilin 1 variants elevate A1-42/1-40 ratio in vitro and in vivo. 

Phrase: "Familial Alzheimer's disease-linked presenilin 1 variants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0205419:variants [Qualitative Concept]
   701   C2931257:Alzheimer disease 1 [Disease or Syndrome]

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "A1-42/1-40 ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456603:Ratio [Quantitative Concept]
   804   C1547037:Ratio [Intellectual Product]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.396: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.397: 17:10051013.[Medline] Bunnell, W.L., H.V. 

Phrase: "17"

Phrase: ":"

Phrase: "10051013."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bunnell,"

Phrase: "W.L., H.V."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C0560267:%W/V [Quantitative Concept]
Processing 00000000.tx.398: Pham, and C.G. 

Phrase: "Pham,"

Phrase: "and"

Phrase: "C.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.399: Glabe. 

Phrase: "Glabe."
Processing 00000000.tx.400: 1998. 

Phrase: "1998."
Processing 00000000.tx.401: Gamma-secretase cleavage is distinct from endoplasmic reticulum degradation of the transmembrane domain of the amyloid precursor protein. 

Phrase: "Gamma-secretase cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]
   734   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "distinct from endoplasmic reticulum degradation of the transmembrane domain"

Phrase: "of the amyloid precursor protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.402: J. 

Phrase: "J."
Processing 00000000.tx.403: Biol. 

Phrase: "Biol."
Processing 00000000.tx.404: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.405: 273:3194731955.[Abstract/Free FullText] Caporaso, G.L., S.E. 

Phrase: "273"

Phrase: ":"

Phrase: "3194731955."

Phrase: "[Abstract/Free FullText"

Phrase: "] Caporaso,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "S."

Phrase: "E."
Processing 00000000.tx.406: Gandy, J.D. 

Phrase: "Gandy,"

Phrase: "J.D."
Processing 00000000.tx.407: Buxbaum, and P. 

Phrase: "Buxbaum,"

Phrase: "and"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.408: Greengard. 

Phrase: "Greengard."
Processing 00000000.tx.409: 1992. 

Phrase: "1992."
Processing 00000000.tx.410: Chloroquine inhibits intracellular degradation but not secretion of Alzheimer /A4 amyloid precursor protein. 

Phrase: "Chloroquine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008269:Chloroquine [Organic Chemical,Pharmacologic Substance]
   944 E C0699306:Aralen [Organic Chemical,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "intracellular degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "but"

Phrase: "not secretion of Alzheimer /A4 amyloid precursor protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C1159339:Protein Secretion [Cell Function]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
Processing 00000000.tx.411: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.412: Natl. 

Phrase: "Natl."
Processing 00000000.tx.413: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.414: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.415: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.416: 89:22522256.[Abstract] Chen, M., and B.A. 

Phrase: "89"

Phrase: ":"

Phrase: "22522256."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "B.A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0368720:B Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.417: Yankner. 

Phrase: "Yankner."
Processing 00000000.tx.418: 1991. 

Phrase: "1991."
Processing 00000000.tx.419: An antibody to  amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types. 

Phrase: "An antibody to  amyloid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "the amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cell-substratum adhesion in many mammalian cell types."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   789   C1154382:cell-cell adhesion [Cell Function]
   767   C0007577:Cell Adhesion [Cell Function]
   744   C0001511:Adhesion [Pathologic Function]
   744   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.420: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.421: Lett. 

Phrase: "Lett."
Processing 00000000.tx.422: 125:223226.[Medline] Chen, Q., H. 

Phrase: "125"

Phrase: ":"

Phrase: "223226."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Q.,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.423: Yoshida, D. 

Phrase: "Yoshida,"

Phrase: "D."
Processing 00000000.tx.424: Schubert, P. 

Phrase: "Schubert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.425: Maher, M. 

Phrase: "Maher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.426: Mallory, and E. 

Phrase: "Mallory,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.427: Masliah. 

Phrase: "Masliah."
Processing 00000000.tx.428: 2001. 

Phrase: "2001."
Processing 00000000.tx.429: Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation. 

Phrase: "Presenilin binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "associated with neurofibrillary alterations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   737 E C0750490:Associate [Idea or Concept]
   737   C1515926:Alteration [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "stimulates"

Phrase: "tau phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.430: Am. 

Phrase: "Am."
Processing 00000000.tx.431: J. 

Phrase: "J."
Processing 00000000.tx.432: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.433: 159:15971602.[Abstract/Free FullText] Cook, D.G., M.S. 

Phrase: "159"

Phrase: ":"

Phrase: "15971602."

Phrase: "[Abstract/Free FullText"

Phrase: "] Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "D."

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.434: Forman, J.C. 

Phrase: "Forman,"

Phrase: "J.C."
Processing 00000000.tx.435: Sung, S. 

Phrase: "Sung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0037173:SING [Geographic Area]
   966   C0234857:sing [Individual Behavior]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.436: Leight, D.L. 

Phrase: "Leight,"

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.437: Kolson, T. 

Phrase: "Kolson,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.438: Iwatsubo, V.M. 

Phrase: "Iwatsubo,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.439: Lee, and R.W. 

Phrase: "Lee,"

Phrase: "and"

Phrase: "R.W."
Processing 00000000.tx.440: Doms. 

Phrase: "Doms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3539821:DOM [Gene or Genome]
Processing 00000000.tx.441: 1997. 

Phrase: "1997."
Processing 00000000.tx.442: Alzheimer's A(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. 

Phrase: "Alzheimer's A"

Phrase: "(1-42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "is"

Phrase: "generated in the endoplasmic reticulum/intermediate compartment of NT2N cells."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   797   C2336015:Compartment of endoplasmic reticulum [Body Space or Junction]
   766   C2349967:Compartment of cell [Anatomical Structure]
           Cell compartment
   760   C0014239:Endoplasmic Reticulum [Cell Component]
   741   C0229606:Reticulum cell [Cell]
   741   C1948049:Cell (compartment) [Spatial Concept]
       E   Cell
   739   C0007634:Cells [Cell]
   739   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   739   C0205103:Intermediate [Spatial Concept]
   739   C1185625:Compartment [Body Space or Junction]
   739   C1550465:intermediate [Idea or Concept]
   739   C2827755:INTERMEDIATE [Laboratory or Test Result]
   739   C2986730:Compartment [Spatial Concept]
   739   C3146294:Generated [Activity]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
Processing 00000000.tx.443: Nat. 

Phrase: "Nat."
Processing 00000000.tx.444: Med. 

Phrase: "Med."
Processing 00000000.tx.445: 3:10211023.[Medline] Craiu, A., M. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "10211023."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Craiu,"

Phrase: "A.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.446: Gaczynska, T. 

Phrase: "Gaczynska,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.447: Akopian, C.F. 

Phrase: "Akopian,"

Phrase: "C.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.448: Gramm, G. 

Phrase: "Gramm,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.449: Fenteany, A.L. 

Phrase: "Fenteany,"

Phrase: "A.L."
Processing 00000000.tx.450: Goldberg, and K.L. 

Phrase: "Goldberg,"

Phrase: "and"

Phrase: "K.L."
Processing 00000000.tx.451: Rock. 

Phrase: "Rock."
Processing 00000000.tx.452: 1997. 

Phrase: "1997."
Processing 00000000.tx.453: Lactacystin and clasto-lactacystin -lactone modify multiple proteasome -subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. 

Phrase: "Lactacystin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "clasto-lactacystin -lactone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022947:Lactone [Organic Chemical]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "multiple proteasome -subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "intracellular protein degradation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0597297:Protein Degradation [Molecular Function]
   901   C0597304:Protein Degradation [Molecular Function]
   901   C1623036:Protein Degradation [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243125:degradation [Functional Concept]
   827   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "major histocompatibility complex class I antigen presentation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0019628:Histocompatibility Antigen [Immunologic Factor]
   818   C0206431:Antigen Presentation [Cell Function]
   818   C0212009:I-antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0443800:i antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003320:Antigen [Immunologic Factor]
   795   C0449450:Presentation [Idea or Concept]
Processing 00000000.tx.454: J. 

Phrase: "J."
Processing 00000000.tx.455: Biol. 

Phrase: "Biol."
Processing 00000000.tx.456: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.457: 272:1343713445.[Abstract/Free FullText] De Strooper, B., and W. 

Phrase: "272"

Phrase: ":"

Phrase: "1343713445."

Phrase: "[Abstract/Free FullText"

Phrase: "] De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "W."
Processing 00000000.tx.458: Annaert. 

Phrase: "Annaert."
Processing 00000000.tx.459: 2000. 

Phrase: "2000."
Processing 00000000.tx.460: Proteolytic processing and cell biological functions of the amyloid precursor protein. 

Phrase: "Proteolytic processing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514570:Proteolytic Processing [Molecular Function]
   861   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "cell biological functions of the amyloid precursor protein."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   767   C0007613:cell functions [Cell Function]
   750   C0815043:function protein [Amino Acid, Peptide, or Protein]
   750   C1527118:Protein Function [Molecular Function]
   744   C0005532:Biological [Biomedical Occupation or Discipline]
   744   C0205460:biological [Qualitative Concept]
   744   C0542341:Functions [Functional Concept]
   737   C0031845:Biological function, NOS [Physiologic Function]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.461: J. 

Phrase: "J."
Processing 00000000.tx.462: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.463: 113:18571870.[Abstract/Free FullText] Doan, A., G. 

Phrase: "113"

Phrase: ":"

Phrase: "18571870."

Phrase: "[Abstract/Free FullText"

Phrase: "] Doan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0591397:Doan's [Organic Chemical,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.464: Thinakaran, and D.R. 

Phrase: "Thinakaran,"

Phrase: "and"

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: Borchelt. 

Phrase: "Borchelt."
Processing 00000000.tx.466: 1996. 

Phrase: "1996."
Processing 00000000.tx.467: Protein topology of presenilin 1. 

Phrase: "Protein topology of presenilin 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002812:Topology [Biomedical Occupation or Discipline]
Processing 00000000.tx.468: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.469: 17:10231030.[Medline] Evin, G., D. 

Phrase: "17"

Phrase: ":"

Phrase: "10231030."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Evin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.470: Le Brocque, J.G. 

Phrase: "Le Brocque,"

Phrase: "J.G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.471: Culvenor, D. 

Phrase: "Culvenor,"

Phrase: "D."
Processing 00000000.tx.472: Galatis, A. 

Phrase: "Galatis,"

Phrase: "A."
Processing 00000000.tx.473: Weidemann, K. 

Phrase: "Weidemann,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.474: Beyreuther, C.L. 

Phrase: "Beyreuther,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.475: Masters, and R. 

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "and"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.476: Cappai. 

Phrase: "Cappai."
Processing 00000000.tx.477: 2000. 

Phrase: "2000."
Processing 00000000.tx.478: Presenilin I expression in yeast lowers secretion of the amyloid precursor protein. 

Phrase: "Presenilin I expression in yeast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "lowers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "secretion of the amyloid precursor protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1159339:Protein Secretion [Cell Function]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
Processing 00000000.tx.479: Neuroreport. 

Phrase: "Neuroreport."
Processing 00000000.tx.480: 11:405408.[Medline] Fenteany, G., and S.L. 

Phrase: "11"

Phrase: ":"

Phrase: "405408."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fenteany,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and S.L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.481: Schreiber. 

Phrase: "Schreiber."
Processing 00000000.tx.482: 1998. 

Phrase: "1998."
Processing 00000000.tx.483: Lactacystin, proteasome function, and cell fate. 

Phrase: "Lactacystin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0125179:lactacystin [Antibiotic,Organic Chemical]

Phrase: "proteasome function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "cell fate."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1540661:cell fate [Cell Function]
   861   C1539479:FATE [Gene or Genome]
   789 E C1302234:Fatal [Qualitative Concept]
   789 E C1705232:Fatal [Finding]
Processing 00000000.tx.484: J. 

Phrase: "J."
Processing 00000000.tx.485: Biol. 

Phrase: "Biol."
Processing 00000000.tx.486: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.487: 273:85458548.[Free FullText] Galbete, J.L., T.R. 

Phrase: "273"

Phrase: ":"

Phrase: "85458548."

Phrase: "[Free FullText"

Phrase: "] Galbete,"

Phrase: "J.L., T.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.488: Martin, E. 

Phrase: "Martin,"

Phrase: "E."
Processing 00000000.tx.489: Peressini, P. 

Phrase: "Peressini,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.490: Modena, R. 

Phrase: "Modena,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.491: Bianchi, and G. 

Phrase: "Bianchi,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.492: Forloni. 

Phrase: "Forloni."
Processing 00000000.tx.493: 2000. 

Phrase: "2000."
Processing 00000000.tx.494: Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway. 

Phrase: "Cholesterol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008377:Cholesterol [Biologically Active Substance,Steroid]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "secretion of the secreted form of amyloid precursor protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1159339:Protein Secretion [Cell Function]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]

Phrase: "by"

Phrase: "interfering with glycosylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017982:glycosylation [Natural Phenomenon or Process]
   790   C0376322:Glycosylation [Molecular Function]
   790   C0521102:interfering [Qualitative Concept]

Phrase: "in the protein secretory pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1159342:Secretory Pathway [Cell Function]
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.495: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.496: J. 

Phrase: "J."
Processing 00000000.tx.497: 348:307313.[CrossRef][Medline] Greenwald, I. 

Phrase: "348"

Phrase: ":"

Phrase: "307313."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Greenwald,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.498: 1998. 

Phrase: "1998."
Processing 00000000.tx.499: Lin-12/Notch signaling lessons from worms and flies. 

Phrase: "Lin-12/Notch signaling lessons from worms"

Phrase: "and"

Phrase: "flies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012578:Flies [Eukaryote]
   966 E C1704307:Fly [Eukaryote]
Processing 00000000.tx.500: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.501: 12:17511762.[Free FullText] Hare, J.F. 

Phrase: "12"

Phrase: ":"

Phrase: "17511762."

Phrase: "[Free FullText"

Phrase: "] Hare,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242372:Hare [Mammal]
  1000   C1425660:HARE [Gene or Genome]

Phrase: "J.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.502: 2001. 

Phrase: "2001."
Processing 00000000.tx.503: Protease inhibitors divert amyloid precursor protein to the secretory pathway. 

Phrase: "Protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "divert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0743226:divert [Functional Concept]

Phrase: "amyloid precursor protein to the secretory pathway."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   814   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   778   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0597427:secretory protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1709634:Precursor [Idea or Concept]
Processing 00000000.tx.504: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.505: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.506: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.507: Commun. 

Phrase: "Commun."
Processing 00000000.tx.508: 281:12981303.[CrossRef][Medline] Hurtley, S.M., and A. 

Phrase: "281"

Phrase: ":"

Phrase: "12981303."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hurtley,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.509: Helenius. 

Phrase: "Helenius."
Processing 00000000.tx.510: 1989. 

Phrase: "1989."
Processing 00000000.tx.511: Protein oligomerization in the endoplasmic reticulum. 

Phrase: "Protein oligomerization in the endoplasmic reticulum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1523273:protein oligomerization [Molecular Function]
Processing 00000000.tx.512: Annu. 

Phrase: "Annu."
Processing 00000000.tx.513: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.514: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.515: 5:277307.[CrossRef] Jin, L.-W., H. 

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ":"

Phrase: "277307."

Phrase: "[CrossRef"

Phrase: "] Jin,"

Phrase: "L.-W., H."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C2346686:L/h [Quantitative Concept]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.516: Ninomiya, J.-M. 

Phrase: "Ninomiya,"

Phrase: "J.-M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.517: Roch, D. 

Phrase: "Roch,"

Phrase: "D."
Processing 00000000.tx.518: Schubert, E. 

Phrase: "Schubert,"

Phrase: "E."
Processing 00000000.tx.519: Masliah, D.A.C. 

Phrase: "Masliah,"

Phrase: "D."

Phrase: "A.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0368815:antibodies c [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.520: Otero, and T. 

Phrase: "Otero,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.521: Saitoh. 

Phrase: "Saitoh."
Processing 00000000.tx.522: 1994. 

Phrase: "1994."
Processing 00000000.tx.523: Peptides containing RERMS sequence of amyloid /A4 protein precursor bind cell surface and promote neurite extension. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "RERMS sequence of amyloid /A4 protein precursor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0002518:Protein Sequence [Amino Acid Sequence]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "cell surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0699040:Cell surface [Cell Component]
   861   C0205148:Surface [Spatial Concept]

Phrase: "and"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "neurite extension."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231448:Extension [Functional Concept]
   861   C1880641:Extension [Conceptual Entity]
Processing 00000000.tx.524: J. 

Phrase: "J."
Processing 00000000.tx.525: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.526: 14:54615470.[Abstract] Katayama, T., K. 

Phrase: "14"

Phrase: ":"

Phrase: "54615470."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Katayama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.527: Imaizumi, N. 

Phrase: "Imaizumi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.528: Sato, K. 

Phrase: "Sato,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.529: Miyoshi, T. 

Phrase: "Miyoshi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.530: Kudo, J. 

Phrase: "Kudo,"

Phrase: "J."
Processing 00000000.tx.531: Hitomi, T. 

Phrase: "Hitomi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.532: Morihara, T. 

Phrase: "Morihara,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.533: Yoneda, and F. 

Phrase: "Yoneda,"

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.534: Gomi. 

Phrase: "Gomi."
Processing 00000000.tx.535: 2000. 

Phrase: "2000."
Processing 00000000.tx.536: Presenilin-1 mutations down-regulate the signalling pathway of the unfolded protein response. 

Phrase: "Presenilin-1 mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "down-regulate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "the signalling pathway of the unfolded protein response."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0037083:signalling pathway [Cell Function]
   754 E C0037080:Signal Pathway [Molecular Function]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.537: Nat. 

Phrase: "Nat."
Processing 00000000.tx.538: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.539: 1:479485.[CrossRef] Kim, K.S., G.Y. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "479485."

Phrase: "[CrossRef"

Phrase: "] Kim,"

Phrase: "K.S.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "G.Y."
Processing 00000000.tx.540: Wen, C. 

Phrase: "Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.541: Bancher, C.M.J. 

Phrase: "Bancher,"

Phrase: "C."

Phrase: "M."

Phrase: "J."
Processing 00000000.tx.542: Chen, V.J. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "V.J."
Processing 00000000.tx.543: Sapienza, H. 

Phrase: "Sapienza,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.544: Hong, and H.M. 

Phrase: "Hong,"

Phrase: "and"

Phrase: "H.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2348952:H/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.545: Wisniewski. 

Phrase: "Wisniewski."
Processing 00000000.tx.546: 1990. 

Phrase: "1990."
Processing 00000000.tx.547: Detection and quantitation of amyloid -peptide with 2 monoclonal antibodies. 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "quantitation of amyloid -peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantitation [Quantitative Concept]

Phrase: "with 2 monoclonal antibodies."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0746619:monoclonal [Finding]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.548: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.549: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.550: Comm. 

Phrase: "Comm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3639709:COMM [Intellectual Product]
Processing 00000000.tx.551: 7:113122. 

Phrase: "7"

Phrase: ":"

Phrase: "113122."
Processing 00000000.tx.552: Kouchi, Z., H. 

Phrase: "Kouchi,"

Phrase: "Z.,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.553: Sorimachi, K. 

Phrase: "Sorimachi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.554: Suzukui, and S. 

Phrase: "Suzukui,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.555: Ishiura. 

Phrase: "Ishiura."
Processing 00000000.tx.556: 1999. 

Phrase: "1999."
Processing 00000000.tx.557: Proteasome inhibitors induce the association of Alzheimer's amyloid precursor with Hsc73. 

Phrase: "Proteasome inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1443643:Proteasome Inhibitors [Pharmacologic Substance]
  1000   C2266856:Proteasome Inhibitors [Molecular Function]
   966 E C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   861   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1325620:proteasome [Cell Component]
   861   C1752727:Proteasome [Molecular Function]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the association of Alzheimer's amyloid precursor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004083:Association [Mental Process]
   753   C0439849:Association [Qualitative Concept]
   753   C0596306:Association [Phenomenon or Process]
   753   C0699792:association [Social Behavior]

Phrase: "with Hsc73."
Processing 00000000.tx.558: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.559: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.560: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.561: Commun. 

Phrase: "Commun."
Processing 00000000.tx.562: 254:804810.[CrossRef][Medline] Marambaud, P., J. 

Phrase: "254"

Phrase: ":"

Phrase: "804810."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marambaud,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "J."
Processing 00000000.tx.563: Shioi, A. 

Phrase: "Shioi,"

Phrase: "A."
Processing 00000000.tx.564: Georgakopoulos, S. 

Phrase: "Georgakopoulos,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.565: Sarner, V. 

Phrase: "Sarner,"

Phrase: "V."
Processing 00000000.tx.566: Nagy, L. 

Phrase: "Nagy,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.567: Baki, P. 

Phrase: "Baki,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.568: Wen, S. 

Phrase: "Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.569: Ethimiopoulos, Z. 

Phrase: "Ethimiopoulos,"

Phrase: "Z."
Processing 00000000.tx.570: Shao, T. 

Phrase: "Shao,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.571: Wishiewski. et al. 

Phrase: "Wishiewski. et al."
Processing 00000000.tx.572: 2002. 

Phrase: "2002."
Processing 00000000.tx.573: A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. 

Phrase: "A presenilin-1/gamma-secretase cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0010813:cleavage [Cell Function]
   795   C0596311:Cleavage [Phenomenon or Process]
   795   C1330957:cleavage [Cell Function]

Phrase: "releases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the E-cadherin intracellular domain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C1511474:Cadherin Domain [Amino Acid Sequence]
   812   C0175996:intracellular [Cell Component]
   812   C0178719:Intracellular [Spatial Concept]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "regulates"

Phrase: "disassembly of adherens junctions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1707798:Disassembly [Activity]
   770   C1880352:DISASSEMBLY [Phenomenon or Process]
Processing 00000000.tx.574: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.575: 21:19481956.[Abstract/Free FullText] Meng, L., R. 

Phrase: "21"

Phrase: ":"

Phrase: "19481956."

Phrase: "[Abstract/Free FullText"

Phrase: "] Meng,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.576: Mohan, B.H.B. 

Phrase: "Mohan,"

Phrase: "B.H.B."
Processing 00000000.tx.577: Kwok, M. 

Phrase: "Kwok,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.578: Elofsson, N. 

Phrase: "Elofsson,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.579: Sin, and C. 

Phrase: "Sin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0815304:sin [Idea or Concept]

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.580: Crews. 

Phrase: "Crews."
Processing 00000000.tx.581: 1999. 

Phrase: "1999."
Processing 00000000.tx.582: Expoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity. 

Phrase: "Expoxomicin,"

Phrase: "a potent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "selective proteasome inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1443643:Proteasome inhibitor [Pharmacologic Substance]
   901   C2266856:Proteasome Inhibitor [Molecular Function]
   901   C3537238:Proteasome Inhibitor [Pharmacologic Substance]
   827   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1325620:proteasome [Cell Component]
   827   C1752727:Proteasome [Molecular Function]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "in vivo anti-inflammatory activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.583: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.584: Natl. 

Phrase: "Natl."
Processing 00000000.tx.585: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.586: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.587: 96:1040310408.[Abstract/Free FullText] Naruse, S., G. 

Phrase: "96"

Phrase: ":"

Phrase: "1040310408."

Phrase: "[Abstract/Free FullText"

Phrase: "] Naruse,"

Phrase: "S."

Phrase: ","

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.588: Thinakaran, J.J. 

Phrase: "Thinakaran,"

Phrase: "J.J."
Processing 00000000.tx.589: Luo, J.W. 

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "J.W."
Processing 00000000.tx.590: Kusiak, T. 

Phrase: "Kusiak,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.591: Tomita, T. 

Phrase: "Tomita,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.592: Iwatsubo, X. 

Phrase: "Iwatsubo,"

Phrase: "X."
Processing 00000000.tx.593: Qian, D.D. 

Phrase: "Qian,"

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.594: Ginty, D.L. 

Phrase: "Ginty,"

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.595: Price, D.R. 

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D.R."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.596: Borchelt, et al. 

Phrase: "Borchelt,"

Phrase: "et al."
Processing 00000000.tx.597: 1998. 

Phrase: "1998."
Processing 00000000.tx.598: Effects of PS1 deficiency on membrane protein trafficking in neurons. 

Phrase: "Effects of PS1 deficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on membrane protein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0025255:Membrane [Tissue]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "trafficking in neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0599896:trafficking [Cell Function]
   706 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.599: Neuron. 

Phrase: "Neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.600: 21:12131221.[Medline] Parvathy, S., I. 

Phrase: "21"

Phrase: ":"

Phrase: "12131221."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Parvathy,"

Phrase: "S."

Phrase: ","

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.601: Hussain, E.H. 

Phrase: "Hussain,"

Phrase: "E.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.602: Karran, A.J. 

Phrase: "Karran,"

Phrase: "A.J."
Processing 00000000.tx.603: Turner, and N.M. 

Phrase: "Turner,"

Phrase: "and"

Phrase: "N.M."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2347350:N/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0441923:M+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.604: Hooper. 

Phrase: "Hooper."
Processing 00000000.tx.605: 1998. 

Phrase: "1998."
Processing 00000000.tx.606: Alzheimer's amyloid precursor protein -secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: Similarities to the angiotensin converting enzyme secretase. 

Phrase: "Alzheimer's amyloid precursor protein -secretase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   937   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
           secretase
   937   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   722   C1955168:Alzheimer precursor protein [Amino Acid, Peptide, or Protein]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]

Phrase: "is"

Phrase: "inhibited by hydroxamic acid-based zinc metalloprotease inhibitors"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   770   C0020314:Hydroxamic Acid [Organic Chemical]
   754   C1152589:metalloprotease inhibitor [Molecular Function]
   744   C0001128:Acid [Chemical]
   744   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0043481:Zinc [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0243077:inhibitors [Chemical Viewed Functionally]
   744   C0311403:Inhibited [Qualitative Concept]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   744   C2348288:Zinc [Element, Ion, or Isotope]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C1880279:Base [Biomedical or Dental Material]
   711 E C1999216:Inhibitor [Qualitative Concept]

Phrase: ":"

Phrase: "Similarities to the angiotensin converting enzyme secretase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C2348205:Similarity [Qualitative Concept]
Processing 00000000.tx.607: J. 

Phrase: "J."
Processing 00000000.tx.608: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.609: 37:16801685. 

Phrase: "37"

Phrase: ":"

Phrase: "16801685."
Processing 00000000.tx.610: Scheuner, D., C. 

Phrase: "Scheuner,"

Phrase: "D."

Phrase: ","

Phrase: "C."
Processing 00000000.tx.611: Eckman, M. 

Phrase: "Eckman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.612: Jensen, X. 

Phrase: "Jensen,"

Phrase: "X."
Processing 00000000.tx.613: Song, M. 

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.614: Citron, N. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.615: Suzuki, T.D. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T.D."
Processing 00000000.tx.616: Bird, J. 

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "J."
Processing 00000000.tx.617: Hardy, M. 

Phrase: "Hardy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.618: Hutton, W. 

Phrase: "Hutton,"

Phrase: "W."
Processing 00000000.tx.619: Kukull, et al. 

Phrase: "Kukull,"

Phrase: "et al."
Processing 00000000.tx.620: 1996. 

Phrase: "1996."
Processing 00000000.tx.621: Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's Disease. 

Phrase: "Secreted amyloid beta-protein"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0078939:Amyloid beta-Protein [Amino Acid, Peptide, or Protein]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1750295:beta protein [Genetic Function]
   861   C2362547:Beta protein [Amino Acid, Peptide, or Protein]
   861   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0330390:Beta [Plant]
   812   C0439096:Beta [Intellectual Product]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C2004068:Beta [Qualitative Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in the senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "of Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "in vivo by the presenilin 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "APP mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "linked to familial Alzheimer's Disease."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.622: Nat. 

Phrase: "Nat."
Processing 00000000.tx.623: Med. 

Phrase: "Med."
Processing 00000000.tx.624: 2:864870.[Medline] Schubert, D., S. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ":"

Phrase: "864870."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schubert,"

Phrase: "D."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.625: Heinemann, W. 

Phrase: "Heinemann,"

Phrase: "W."
Processing 00000000.tx.626: Carlisle, H. 

Phrase: "Carlisle,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.627: Tarikas, B. 

Phrase: "Tarikas,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.628: Kimes, J. 

Phrase: "Kimes,"

Phrase: "J."
Processing 00000000.tx.629: Patrick, J.H. 

Phrase: "Patrick,"

Phrase: "J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.630: Steinbach, W. 

Phrase: "Steinbach,"

Phrase: "W."
Processing 00000000.tx.631: Culp, and B.L. 

Phrase: "Culp,"

Phrase: "and"

Phrase: "B.L."
Processing 00000000.tx.632: Brandt. 

Phrase: "Brandt."
Processing 00000000.tx.633: 1974. 

Phrase: "1974."
Processing 00000000.tx.634: Clonal cell lines from the rat central nervous system. 

Phrase: "Clonal cell lines from the rat central nervous system."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   784   C0027882:nervous system cell [Cell]
           Nerve cell
   767   C1514733:Rat Cell Line [Cell]
   764   C0007600:Cell lines [Cell]
   745   C1145640:Central line [Medical Device]
   742   C0007634:Cell [Cell]
   742   C0205132:lines [Spatial Concept]
   742   C1269647:Cell [Cell]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   729   C0009013:Clone Cell [Cell]
   708 E C1550648:Line [Substance]
   708 E C1552960:Line [Quantitative Concept]
   706   C0814990:neural cell line [Cell]
Processing 00000000.tx.635: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.636: 249:224227.[Medline] Schubert, U., L.C. 

Phrase: "249"

Phrase: ":"

Phrase: "224227."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schubert,"

Phrase: "U.,"

Phrase: "L.C."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439394:l's [Quantitative Concept]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.637: Anton, J. 

Phrase: "Anton,"

Phrase: "J."
Processing 00000000.tx.638: Gibbs, C.C. 

Phrase: "Gibbs,"

Phrase: "C.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.639: Norbury, J.W. 

Phrase: "Norbury,"

Phrase: "J.W."
Processing 00000000.tx.640: Yewdell, and J.R. 

Phrase: "Yewdell,"

Phrase: "and"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.641: Bennink. 

Phrase: "Bennink."
Processing 00000000.tx.642: 2000. 

Phrase: "2000."
Processing 00000000.tx.643: Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. 

Phrase: "Rapid degradation of a large fraction of newly synthesized proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   741   C0597297:Protein Degradation [Molecular Function]
   741   C0597304:Protein Degradation [Molecular Function]
   741   C1623036:Protein Degradation [Molecular Function]
   739   C0243125:degradation [Functional Concept]
   739   C0699900:Degradation [Organism Function]

Phrase: "by proteasomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   966 E C1325620:proteasome [Cell Component]
   966 E C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.644: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.645: 404:770774.[CrossRef][Medline] Sherrington, R., E.I. 

Phrase: "404"

Phrase: ":"

Phrase: "770774."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "E.I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.646: Rogaev, Y. 

Phrase: "Rogaev,"

Phrase: "Y."
Processing 00000000.tx.647: Liang, E.A. 

Phrase: "Liang,"

Phrase: "E.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0313106:e Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C0947659:E Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.648: Rogaeva, G. 

Phrase: "Rogaeva,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.649: Levesque, M. 

Phrase: "Levesque,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.650: Ikeda, H. 

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.651: Chi, C. 

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.652: Lin, G. 

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.653: Li, and K. 

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.654: Holman. 

Phrase: "Holman."
Processing 00000000.tx.655: 1995. 

Phrase: "1995."
Processing 00000000.tx.656: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. 

Phrase: "Cloning of a gene bearing missense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0009015:Cloning [Research Activity]

Phrase: "in early-onset familial Alzheimer's disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   924   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   897   C0679245:early disease [Temporal Concept]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.657: Nature. 

Phrase: "Nature."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]
Processing 00000000.tx.658: 375:754760.[CrossRef][Medline] Sherwood, S.W., A.L. 

Phrase: "375"

Phrase: ":"

Phrase: "754760."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sherwood,"

Phrase: "S.W.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "A.L."
Processing 00000000.tx.659: Kung, J. 

Phrase: "Kung,"

Phrase: "J."
Processing 00000000.tx.660: Roitelman, R.D. 

Phrase: "Roitelman,"

Phrase: "R.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.661: Simoni, and R.T. 

Phrase: "Simoni,"

Phrase: "and"

Phrase: "R.T."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.662: Schimke. 

Phrase: "Schimke."
Processing 00000000.tx.663: 1993. 

Phrase: "1993."
Processing 00000000.tx.664: In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal. 

Phrase: "In vivo inhibition of cyclin B degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "induction of cell-cycle arrest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "in mammalian cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0081446:acetyl-leucyl-leucyl-norleucinal [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.665: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.666: Natl. 

Phrase: "Natl."
Processing 00000000.tx.667: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.668: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.669: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.670: 90:33533357.[Abstract] Sinha, S., and I. 

Phrase: "90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "33533357."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Sinha,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.671: Lieberburg. 

Phrase: "Lieberburg."
Processing 00000000.tx.672: 1999. 

Phrase: "1999."
Processing 00000000.tx.673: Cellular mechanisms of -amyloid production and secretion. 

Phrase: "Cellular mechanisms of -amyloid production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]
Processing 00000000.tx.674: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.675: Natl. 

Phrase: "Natl."
Processing 00000000.tx.676: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.677: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.678: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.679: 96:1104911053.[Abstract/Free FullText] Sisodia, S.S. 

Phrase: "96"

Phrase: ":"

Phrase: "1104911053."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.680: 2000. 

Phrase: "2000."
Processing 00000000.tx.681: An accomplice for -secretase brought into focus. 

Phrase: "An accomplice for -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0684026:accomplice [Population Group]

Phrase: "brought into focus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205234:Focus [Spatial Concept]
   790   C0332302:brought [Functional Concept]
   790   C1285542:focus [Functional Concept]
Processing 00000000.tx.682: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.683: 289:22962297.[Free FullText] Soriano, S., A.S.C. 

Phrase: "289"

Phrase: ":"

Phrase: "22962297."

Phrase: "[Free FullText"

Phrase: "] Soriano,"

Phrase: "S."

Phrase: ","

Phrase: "A.S.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C0368815:antibodies c [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.684: Chyung, X. 

Phrase: "Chyung,"

Phrase: "X."
Processing 00000000.tx.685: Chen, G.B. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "G.B."
Processing 00000000.tx.686: Stokin, V.M.Y. 

Phrase: "Stokin,"

Phrase: "V.M.Y."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2349138:V/m [Quantitative Concept]
Processing 00000000.tx.687: Lee, and E.H. 

Phrase: "Lee,"

Phrase: "and"

Phrase: "E.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.688: Koo. 

Phrase: "Koo."
Processing 00000000.tx.689: 1999. 

Phrase: "1999."
Processing 00000000.tx.690: Expression of -amyloid precursor protein-CD3g chimeras to demonstrate the selective generation of 1-40 and amyloid 1-42 peptides within secretory and endocytic compartments. 

Phrase: "Expression of -amyloid precursor protein-CD3g chimeras to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0008109:Chimeras [Organism]
   760 E C1318484:Chimera [Disease or Syndrome]

Phrase: "demonstrate"

Phrase: "the selective generation of 1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "amyloid 1-42 peptides within secretory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "endocytic compartments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1185625:Compartments [Body Space or Junction]
   861   C1382196:Compartments [Natural Phenomenon or Process]
   827 E C2986730:Compartment [Spatial Concept]
Processing 00000000.tx.691: J. 

Phrase: "J."
Processing 00000000.tx.692: Biol. 

Phrase: "Biol."
Processing 00000000.tx.693: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.694: 274:3229532300.[Abstract/Free FullText] Suzuki, T., Q. 

Phrase: "274"

Phrase: ":"

Phrase: "3229532300."

Phrase: "[Abstract/Free FullText"

Phrase: "] Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Q."
Processing 00000000.tx.695: Yan, and W.J. 

Phrase: "Yan,"

Phrase: "and"

Phrase: "W.J."
Processing 00000000.tx.696: Lennarz. 

Phrase: "Lennarz."
Processing 00000000.tx.697: 1998. 

Phrase: "1998."
Processing 00000000.tx.698: Complex, two-way traffic of molecules across the membrane of the endoplasmic reticulum. 

Phrase: "Complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "two-way traffic of molecules"

Phrase: "across the membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "of the endoplasmic reticulum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]
Processing 00000000.tx.699: J. 

Phrase: "J."
Processing 00000000.tx.700: Biol. 

Phrase: "Biol."
Processing 00000000.tx.701: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.702: 273:1008310086.[Free FullText] Van Gassen, G., W. 

Phrase: "273"

Phrase: ":"

Phrase: "1008310086."

Phrase: "[Free FullText"

Phrase: "] Van Gassen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "W."
Processing 00000000.tx.703: Annaert, and C. 

Phrase: "Annaert,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.704: Van Broeckhoven. 

Phrase: "Van Broeckhoven."
Processing 00000000.tx.705: 2000. 

Phrase: "2000."
Processing 00000000.tx.706: Binding partners of Alzheimer's disease proteins: are they physiologically relevant? 

Phrase: "Binding partners of Alzheimer's disease proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C0033618:Protein Binding [Molecular Function]
   753   C0243122:binding [Functional Concept]
   753   C0682323:partners [Family Group]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: ":"

Phrase: "are"

Phrase: "they physiologically relevant?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.707: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.708: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.709: 7:135151.[CrossRef][Medline] Wolfe, M.S., and C. 

Phrase: "7"

Phrase: ":"

Phrase: "135151."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wolfe,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.710: Haass. 

Phrase: "Haass."
Processing 00000000.tx.711: 2001. 

Phrase: "2001."
Processing 00000000.tx.712: The role of presenilins in -secretase activity. 

Phrase: "The role of presenilins in -secretase activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.713: J. 

Phrase: "J."
Processing 00000000.tx.714: Biol. 

Phrase: "Biol."
Processing 00000000.tx.715: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.716: 276:54135416.[Free FullText] Wolfe, M.S., W. 

Phrase: "276"

Phrase: ":"

Phrase: "54135416."

Phrase: "[Free FullText"

Phrase: "] Wolfe,"

Phrase: "M.S.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "W."
Processing 00000000.tx.717: Xia, C.L. 

Phrase: "Xia,"

Phrase: "C.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.718: Moore, D.D. 

Phrase: "Moore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443030:moore [Intellectual Product]

Phrase: "D.D."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0112081:D-D [Hazardous or Poisonous Substance,Organic Chemical]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.719: Leatherwood, B.B. 

Phrase: "Leatherwood,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330617:Leatherwood [Plant]

Phrase: "B.B."
Processing 00000000.tx.720: Ostaszewski, T.T. 

Phrase: "Ostaszewski,"

Phrase: "T.T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.721: Rahmati, I.O. 

Phrase: "Rahmati,"

Phrase: "I.O."
Processing 00000000.tx.722: Donkor, and D.J. 

Phrase: "Donkor,"

Phrase: "and"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.723: Selkoe. 

Phrase: "Selkoe."
Processing 00000000.tx.724: 1999. 

Phrase: "1999."
Processing 00000000.tx.725: Peptidomimetic probes and molecular modeling suggest that Alzheimer's -secretase is an intramembrane-cleaving asparty protease. 

Phrase: "Peptidomimetic probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "and"

Phrase: "molecular modeling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600115:Molecular Modeling [Intellectual Product,Research Activity]
   861   C0870071:Modeling [Intellectual Product,Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Alzheimer's -secretase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "an intramembrane-"

Phrase: "cleaving"

Phrase: "asparty protease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]
Processing 00000000.tx.726: Biochemistry. 

Phrase: "Biochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]
Processing 00000000.tx.727: 38:47204727.[CrossRef][Medline] Wu, A., M.N. 

Phrase: "38"

Phrase: ":"

Phrase: "47204727."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A.,"

Phrase: "M."

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.728: Pangalos, S. 

Phrase: "Pangalos,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.729: Efthimiopoulos, J. 

Phrase: "Efthimiopoulos,"

Phrase: "J."
Processing 00000000.tx.730: Shioi, and N.K. 

Phrase: "Shioi,"

Phrase: "and"

Phrase: "N.K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.731: Robakis. 

Phrase: "Robakis."
Processing 00000000.tx.732: 1997. 

Phrase: "1997."
Processing 00000000.tx.733: Appican expression induces morphological changes in C6 glioma cells and promotes adhesion of neural cells to the extracellular matrix. 

Phrase: "Appican expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "morphological changes in C6 glioma cells"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   753   C0543482:morphological [Spatial Concept]
   731   C0243091:cell morphology [Qualitative Concept]
   731   C1521816:Cell morphology [Clinical Attribute]
   731   C2700385:Cell Morphology [Biomedical Occupation or Discipline]
   723   C1260954:Morphologic change [Anatomical Abnormality]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "adhesion of neural cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0007577:Cell Adhesion [Cell Function]
   770   C0001511:Adhesion [Pathologic Function]
   770   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "to the extracellular matrix."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0015350:Extracellular Matrix [Tissue]
   861   C0521119:Extracellular [Cell Component]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]
Processing 00000000.tx.734: J. 

Phrase: "J."
Processing 00000000.tx.735: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.736: 17:49874993.[Abstract/Free FullText] Xia, W., W.J. 

Phrase: "17"

Phrase: ":"

Phrase: "49874993."

Phrase: "[Abstract/Free FullText"

Phrase: "] Xia,"

Phrase: "W.,"

Phrase: "W.J."
Processing 00000000.tx.737: Ray, B.L. 

Phrase: "Ray,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086894:ray [Fish]
  1000   C0851346:ray [Natural Phenomenon or Process]
  1000   C2314876:ray [Fish]

Phrase: "B.L."
Processing 00000000.tx.738: Ostaszewski, T. 

Phrase: "Ostaszewski,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.739: Rahmati, W.T. 

Phrase: "Rahmati,"

Phrase: "W.T."
Processing 00000000.tx.740: Kimberly, M.S. 

Phrase: "Kimberly,"

Phrase: "M.S."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439493:m/s [Quantitative Concept]
  1000   C1513009:M.S. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.741: Wolfe, J. 

Phrase: "Wolfe,"

Phrase: "J."
Processing 00000000.tx.742: Zhang, A.M. 

Phrase: "Zhang,"

Phrase: "A.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0369637:antibodies m [Amino Acid, Peptide, or Protein,Immunologic Factor]
           M NOS
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.743: Goate, and D.J. 

Phrase: "Goate,"

Phrase: "and"

Phrase: "D.J."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.744: Selkoe. 

Phrase: "Selkoe."
Processing 00000000.tx.745: 2000. 

Phrase: "2000."
Processing 00000000.tx.746: Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid -protein generation. 

Phrase: "Presenilin complexes with the C-terminal fragments of amyloid precursor protein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   738   C1704241:Complexes [Chemical Viewed Structurally]
   737   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C1523872:protein complex [Cell Component]
   704 E C0439855:Complex [Qualitative Concept]

Phrase: "at the sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "of amyloid -protein generation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0079411:Generation [Temporal Concept]
   827   C3146294:Generation [Activity]
   734 E C1414672:Genesis [Gene or Genome]
   734   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.747: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.748: Natl. 

Phrase: "Natl."
Processing 00000000.tx.749: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.750: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.751: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.752: 97:92999304.[Abstract/Free FullText] Xu, H., D. 

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "92999304."

Phrase: "[Abstract/Free FullText"

Phrase: "] Xu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.753: Sweeney, R. 

Phrase: "Sweeney,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0270811:Sweeney [Disease or Syndrome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.754: Wang, G. 

Phrase: "Wang,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.755: Thinakaran, A.C. 

Phrase: "Thinakaran,"

Phrase: "A.C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0368815:antibodies c [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.756: Lo, S.S. 

Phrase: "Lo,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.757: Sisodia, P. 

Phrase: "Sisodia,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.758: Greengard, and S. 

Phrase: "Greengard,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.759: Gandy. 

Phrase: "Gandy."
Processing 00000000.tx.760: 1997. 

Phrase: "1997."
Processing 00000000.tx.761: Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. 

Phrase: "Generation of Alzheimer beta-amyloid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079411:Generation [Temporal Concept]
   753   C3146294:Generation [Activity]

Phrase: "in the trans-Golgi network"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0887838:trans-Golgi Network [Cell Component]
   901   C1179875:Golgi network [Cell Component]
   827   C1513822:Network [Professional or Occupational Group]
   827   C1705739:Network [Manufactured Object]
   827   C1882071:Network [Conceptual Entity]

Phrase: "in the apparent absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332197:absence [Quantitative Concept]
   861   C1689985:Absence [Anatomical Abnormality]
   789 E C2699517:ABSENT [Finding]

Phrase: "of vesicle formation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1749557:vesicle formation [Cell Function]
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.762: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.763: Natl. 

Phrase: "Natl."
Processing 00000000.tx.764: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.765: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.766: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.767: 94:37483752.[Abstract/Free FullText] Xu, X., D. 

Phrase: "94"

Phrase: ":"

Phrase: "37483752."

Phrase: "[Abstract/Free FullText"

Phrase: "] Xu,"

Phrase: "X.,"

Phrase: "D."
Processing 00000000.tx.768: Yang, T. 

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.769: Wyss-Coray, J. 

Phrase: "Wyss-Coray,"

Phrase: "J."
Processing 00000000.tx.770: Yan, L. 

Phrase: "Yan,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.771: Gan, Y. 

Phrase: "Gan,"

Phrase: "Y."
Processing 00000000.tx.772: Sun, and L. 

Phrase: "Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.773: Mucke. 

Phrase: "Mucke."
Processing 00000000.tx.774: 1999. 

Phrase: "1999."
Processing 00000000.tx.775: Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis. 

Phrase: "Wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "but"

Phrase: "not Alzheimer-mutant amyloid precursor protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   885   C1955168:Alzheimer precursor protein [Amino Acid, Peptide, or Protein]
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   858   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "confers"

Phrase: "resistance against p53-mediated apoptosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237834:Resistance [Mental Process]
   760   C1514892:Resistance [Physiologic Function]
Processing 00000000.tx.776: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.777: Natl. 

Phrase: "Natl."
Processing 00000000.tx.778: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.779: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.780: USA. 

Phrase: "USA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.781: 96:75477552.[Abstract/Free FullText] Yang, Y., R.S. 

Phrase: "96"

Phrase: ":"

Phrase: "75477552."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Y.,"

Phrase: "R.S."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.782: Turner, and J.R. 

Phrase: "Turner,"

Phrase: "and"

Phrase: "J.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.783: Gaut. 

Phrase: "Gaut."
Processing 00000000.tx.784: 1998. 

Phrase: "1998."
Processing 00000000.tx.785: The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases A40-42 secretion. 

Phrase: "The chaperone BiP/GRP78"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0063423:GRP78 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415761:GRP78 [Gene or Genome]
   827   C1708295:GRP78 [Gene or Genome]

Phrase: "binds to amyloid precursor protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   862   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   862   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   806   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0011560:Amyloid [Pathologic Function]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]
   760   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "A40-42 secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
Processing 00000000.tx.786: J. 

Phrase: "J."
Processing 00000000.tx.787: Biol. 

Phrase: "Biol."
Processing 00000000.tx.788: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.789: 273:2555225555.[Abstract/Free FullText] Yu, C., S.H. 

Phrase: "273"

Phrase: ":"

Phrase: "2555225555."

Phrase: "[Abstract/Free FullText"

Phrase: "] Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "S."

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.790: Kim, T. 

Phrase: "Kim,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.791: Ikeuchi, H. 

Phrase: "Ikeuchi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.792: Xu, L. 

Phrase: "Xu,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.793: Gasparini, R. 

Phrase: "Gasparini,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.794: Wang, and S.S. 

Phrase: "Wang,"

Phrase: "and S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.795: Sisodia. 

Phrase: "Sisodia."
Processing 00000000.tx.796: 2001. 

Phrase: "2001."
Processing 00000000.tx.797: Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. 

Phrase: "Characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterization [Activity]

Phrase: "of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   931   C1099811:amyloid precursor protein carboxyl-terminal fragment gamma [Amino Acid, Peptide, or Protein]
   791   C0017011:Gamma [Natural Phenomenon or Process]
   791   C1552644:Gamma [Intellectual Product]
   791   C2349976:Gamma [Quantitative Concept]
Processing 00000000.tx.798: Evidence for distinct mechanisms involved in gamma-secretase processing of the APP and Notch1 transmembrane domains. 

Phrase: "Evidence for distinct mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "involved in gamma-secretase processing of the APP"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   799   C0171484:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
           secretase
   799   C0699919:Amyloid Precursor Protein Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   782   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   782   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   760   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0379528:gamma-Secretase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0033666:protein processing [Molecular Function]
   757   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   757   C1750297:gamma protein [Genetic Function]
   739   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0011560:Amyloid [Pathologic Function]
   739   C0017011:Gamma [Natural Phenomenon or Process]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1314939:Involved [Functional Concept]
   739   C1552644:Gamma [Intellectual Product]
   739   C1709634:Precursor [Idea or Concept]
   739   C1709694:Processing [Activity]
   739   C2349976:Gamma [Quantitative Concept]

Phrase: "and"

Phrase: "Notch1 transmembrane domains."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C1519623:Transmembrane Domain [Amino Acid Sequence]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.799: J. 

Phrase: "J."
Processing 00000000.tx.800: Biol. 

Phrase: "Biol."
Processing 00000000.tx.801: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.802: 276:4375643760.[Abstract/Free FullText] Zhang, L., L. 

Phrase: "276"

Phrase: ":"

Phrase: "4375643760."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.803: Song, and E.M. 

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "and"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.804: Parker. 

Phrase: "Parker."
Processing 00000000.tx.805: 1999. 

Phrase: "1999."
Processing 00000000.tx.806: Calpain inhibitor I increases -amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase: evidence that substrate availability limits -amyloid peptide production. 

Phrase: "Calpain inhibitor I increases -amyloid peptide production by inhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0033268:production [Occupational Activity]

Phrase: "the degradation of the substrate of gamma-secretase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that substrate availability limits -amyloid peptide production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0033268:production [Occupational Activity]
Processing 00000000.tx.807: J. 

Phrase: "J."
Processing 00000000.tx.808: Biol. 

Phrase: "Biol."
Processing 00000000.tx.809: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.810: 274:89668972.[Abstract/Free FullText]

Phrase: "274"

Phrase: ":"

Phrase: "89668972."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

